id	sid	tid	token	lemma	pos
iajs-3606	1	1	111	111	NUM
iajs-3606	1	2	©	©	PROPN
iajs-3606	1	3	2025	2025	NUM
iajs-3606	1	4	the	the	DET
iajs-3606	1	5	author(s	author(s	NOUN
iajs-3606	1	6	)	)	PUNCT
iajs-3606	1	7	.	.	PUNCT
iajs-3606	2	1	published	publish	VERB
iajs-3606	2	2	by	by	ADP
iajs-3606	2	3	college	college	NOUN
iajs-3606	2	4	of	of	ADP
iajs-3606	2	5	education	education	NOUN
iajs-3606	2	6	for	for	ADP
iajs-3606	2	7	pure	pure	ADJ
iajs-3606	2	8	science	science	NOUN
iajs-3606	2	9	(	(	PUNCT
iajs-3606	2	10	ibn	ibn	PROPN
iajs-3606	2	11	al	al	PROPN
iajs-3606	2	12	-	-	PUNCT
iajs-3606	2	13	haitham	haitham	PROPN
iajs-3606	2	14	)	)	PUNCT
iajs-3606	2	15	,	,	PUNCT
iajs-3606	2	16	university	university	NOUN
iajs-3606	2	17	of	of	ADP
iajs-3606	2	18	baghdad	baghdad	PROPN
iajs-3606	2	19	.	.	PUNCT
iajs-3606	3	1	this	this	PRON
iajs-3606	3	2	is	be	AUX
iajs-3606	3	3	an	an	DET
iajs-3606	3	4	open	open	ADJ
iajs-3606	3	5	-	-	PUNCT
iajs-3606	3	6	access	access	NOUN
iajs-3606	3	7	article	article	NOUN
iajs-3606	3	8	distributed	distribute	VERB
iajs-3606	3	9	under	under	ADP
iajs-3606	3	10	the	the	DET
iajs-3606	3	11	terms	term	NOUN
iajs-3606	3	12	of	of	ADP
iajs-3606	3	13	the	the	DET
iajs-3606	3	14	creative	creative	ADJ
iajs-3606	3	15	commons	common	NOUN
iajs-3606	3	16	attribution	attribution	NOUN
iajs-3606	3	17	4.0	4.0	NUM
iajs-3606	3	18	international	international	ADJ
iajs-3606	3	19	license	license	NOUN
iajs-3606	3	20	estimating	estimate	VERB
iajs-3606	3	21	the	the	DET
iajs-3606	3	22	effectiveness	effectiveness	NOUN
iajs-3606	3	23	of	of	ADP
iajs-3606	3	24	pfizer	pfizer	NOUN
iajs-3606	3	25	and	and	CCONJ
iajs-3606	3	26	sinopharm	sinopharm	NOUN
iajs-3606	3	27	vaccines	vaccine	NOUN
iajs-3606	3	28	and	and	CCONJ
iajs-3606	3	29	their	their	PRON
iajs-3606	3	30	relationship	relationship	NOUN
iajs-3606	3	31	to	to	ADP
iajs-3606	3	32	occupation	occupation	NOUN
iajs-3606	3	33	,	,	PUNCT
iajs-3606	3	34	residence	residence	NOUN
iajs-3606	3	35	,	,	PUNCT
iajs-3606	3	36	smoking	smoking	NOUN
iajs-3606	3	37	,	,	PUNCT
iajs-3606	3	38	and	and	CCONJ
iajs-3606	3	39	body	body	NOUN
iajs-3606	3	40	mass	mass	NOUN
iajs-3606	3	41	index	index	NOUN
iajs-3606	3	42	during	during	ADP
iajs-3606	3	43	pregnancy	pregnancy	NOUN
iajs-3606	3	44	smoking	smoking	NOUN
iajs-3606	3	45	shahad	shahad	VERB
iajs-3606	3	46	th	th	X
iajs-3606	3	47	.	.	PUNCT
iajs-3606	4	1	jameel1	jameel1	PROPN
iajs-3606	4	2	*	*	PUNCT
iajs-3606	4	3	,	,	PUNCT
iajs-3606	4	4	asmaa	asmaa	PROPN
iajs-3606	4	5	haseeb	haseeb	PROPN
iajs-3606	4	6	hwaid2	hwaid2	PROPN
iajs-3606	4	7	,	,	PUNCT
iajs-3606	4	8	and	and	CCONJ
iajs-3606	4	9	abdulrazak	abdulrazak	PROPN
iajs-3606	4	10	sh	sh	PROPN
iajs-3606	4	11	.	.	PUNCT
iajs-3606	4	12	hasan3	hasan3	PROPN
iajs-3606	5	1	1,2department	1,2department	NUM
iajs-3606	5	2	of	of	ADP
iajs-3606	5	3	biology	biology	NOUN
iajs-3606	5	4	,	,	PUNCT
iajs-3606	5	5	college	college	NOUN
iajs-3606	5	6	of	of	ADP
iajs-3606	5	7	education	education	NOUN
iajs-3606	5	8	for	for	ADP
iajs-3606	5	9	pure	pure	ADJ
iajs-3606	5	10	sciences	science	NOUN
iajs-3606	5	11	,	,	PUNCT
iajs-3606	5	12	university	university	NOUN
iajs-3606	5	13	of	of	ADP
iajs-3606	5	14	diyala	diyala	PROPN
iajs-3606	5	15	,	,	PUNCT
iajs-3606	5	16	baquba	baquba	PROPN
iajs-3606	5	17	,	,	PUNCT
iajs-3606	5	18	iraq	iraq	PROPN
iajs-3606	5	19	.	.	PUNCT
iajs-3606	6	1	3department	3department	NUM
iajs-3606	6	2	of	of	ADP
iajs-3606	6	3	biology	biology	NOUN
iajs-3606	6	4	,	,	PUNCT
iajs-3606	6	5	college	college	NOUN
iajs-3606	6	6	of	of	ADP
iajs-3606	6	7	sciences	science	NOUN
iajs-3606	6	8	,	,	PUNCT
iajs-3606	6	9	university	university	NOUN
iajs-3606	6	10	of	of	ADP
iajs-3606	6	11	diyala	diyala	PROPN
iajs-3606	6	12	,	,	PUNCT
iajs-3606	6	13	baquba	baquba	PROPN
iajs-3606	6	14	,	,	PUNCT
iajs-3606	6	15	iraq	iraq	PROPN
iajs-3606	6	16	.	.	PUNCT
iajs-3606	7	1	*	*	PUNCT
iajs-3606	7	2	corresponding	correspond	VERB
iajs-3606	7	3	author	author	NOUN
iajs-3606	7	4	.	.	PUNCT
iajs-3606	8	1	received	receive	VERB
iajs-3606	8	2	:	:	PUNCT
iajs-3606	8	3	21	21	NUM
iajs-3606	8	4	june	june	PROPN
iajs-3606	8	5	2023	2023	NUM
iajs-3606	8	6	accepted	accept	VERB
iajs-3606	8	7	:	:	PUNCT
iajs-3606	8	8	1	1	NUM
iajs-3606	8	9	august	august	PROPN
iajs-3606	8	10	2023	2023	NUM
iajs-3606	8	11	published	publish	VERB
iajs-3606	8	12	:	:	PUNCT
iajs-3606	8	13	20	20	NUM
iajs-3606	8	14	january	january	NOUN
iajs-3606	8	15	2025	2025	NUM
iajs-3606	8	16	doi.org/10.30526/38.1.3606	doi.org/10.30526/38.1.3606	NOUN
iajs-3606	8	17	abstract	abstract	ADJ
iajs-3606	8	18	severe	severe	ADJ
iajs-3606	8	19	acute	acute	ADJ
iajs-3606	8	20	respiratory	respiratory	ADJ
iajs-3606	8	21	syndrome	syndrome	NOUN
iajs-3606	8	22	coronavirus	coronavirus	NOUN
iajs-3606	8	23	2	2	NUM
iajs-3606	8	24	(	(	PUNCT
iajs-3606	8	25	sars	sar	NOUN
iajs-3606	8	26	-	-	PUNCT
iajs-3606	8	27	cov-2	cov-2	NOUN
iajs-3606	8	28	)	)	PUNCT
iajs-3606	8	29	caused	cause	VERB
iajs-3606	8	30	a	a	DET
iajs-3606	8	31	rapid	rapid	ADJ
iajs-3606	8	32	global	global	ADJ
iajs-3606	8	33	demand	demand	NOUN
iajs-3606	8	34	for	for	ADP
iajs-3606	8	35	the	the	DET
iajs-3606	8	36	development	development	NOUN
iajs-3606	8	37	of	of	ADP
iajs-3606	8	38	several	several	ADJ
iajs-3606	8	39	vaccines	vaccine	NOUN
iajs-3606	8	40	by	by	ADP
iajs-3606	8	41	the	the	DET
iajs-3606	8	42	scientific	scientific	ADJ
iajs-3606	8	43	community	community	NOUN
iajs-3606	8	44	.	.	PUNCT
iajs-3606	9	1	vaccination	vaccination	NOUN
iajs-3606	9	2	contributes	contribute	VERB
iajs-3606	9	3	to	to	ADP
iajs-3606	9	4	preventing	prevent	VERB
iajs-3606	9	5	infection	infection	NOUN
iajs-3606	9	6	associated	associate	VERB
iajs-3606	9	7	with	with	ADP
iajs-3606	9	8	symptoms	symptom	NOUN
iajs-3606	9	9	and	and	CCONJ
iajs-3606	9	10	reduces	reduce	VERB
iajs-3606	9	11	the	the	DET
iajs-3606	9	12	risk	risk	NOUN
iajs-3606	9	13	of	of	ADP
iajs-3606	9	14	infection	infection	NOUN
iajs-3606	9	15	by	by	ADP
iajs-3606	9	16	stimulating	stimulate	VERB
iajs-3606	9	17	the	the	DET
iajs-3606	9	18	immune	immune	ADJ
iajs-3606	9	19	system	system	NOUN
iajs-3606	9	20	to	to	PART
iajs-3606	9	21	produce	produce	VERB
iajs-3606	9	22	antibodies	antibody	NOUN
iajs-3606	9	23	.	.	PUNCT
iajs-3606	10	1	this	this	DET
iajs-3606	10	2	study	study	NOUN
iajs-3606	10	3	aimed	aim	VERB
iajs-3606	10	4	to	to	PART
iajs-3606	10	5	determine	determine	VERB
iajs-3606	10	6	the	the	DET
iajs-3606	10	7	effectiveness	effectiveness	NOUN
iajs-3606	10	8	of	of	ADP
iajs-3606	10	9	pfizer	pfizer	NOUN
iajs-3606	10	10	and	and	CCONJ
iajs-3606	10	11	sinopharm	sinopharm	NOUN
iajs-3606	10	12	vaccines	vaccine	NOUN
iajs-3606	10	13	and	and	CCONJ
iajs-3606	10	14	their	their	PRON
iajs-3606	10	15	relationship	relationship	NOUN
iajs-3606	10	16	to	to	ADP
iajs-3606	10	17	occupation	occupation	NOUN
iajs-3606	10	18	,	,	PUNCT
iajs-3606	10	19	residence	residence	NOUN
iajs-3606	10	20	,	,	PUNCT
iajs-3606	10	21	pregnancy	pregnancy	NOUN
iajs-3606	10	22	,	,	PUNCT
iajs-3606	10	23	mass	mass	NOUN
iajs-3606	10	24	index	index	NOUN
iajs-3606	10	25	,	,	PUNCT
iajs-3606	10	26	and	and	CCONJ
iajs-3606	10	27	smoking	smoking	NOUN
iajs-3606	10	28	.	.	PUNCT
iajs-3606	11	1	this	this	DET
iajs-3606	11	2	study	study	NOUN
iajs-3606	11	3	was	be	AUX
iajs-3606	11	4	conducted	conduct	VERB
iajs-3606	11	5	in	in	ADP
iajs-3606	11	6	diyala	diyala	PROPN
iajs-3606	11	7	province	province	PROPN
iajs-3606	11	8	,	,	PUNCT
iajs-3606	11	9	iraq	iraq	PROPN
iajs-3606	11	10	,	,	PUNCT
iajs-3606	11	11	for	for	ADP
iajs-3606	11	12	the	the	DET
iajs-3606	11	13	period	period	NOUN
iajs-3606	11	14	from	from	ADP
iajs-3606	11	15	april	april	PROPN
iajs-3606	11	16	2022	2022	NUM
iajs-3606	11	17	to	to	ADP
iajs-3606	11	18	may	may	PROPN
iajs-3606	11	19	2023	2023	NUM
iajs-3606	11	20	.	.	PUNCT
iajs-3606	12	1	a	a	DET
iajs-3606	12	2	total	total	NOUN
iajs-3606	12	3	of	of	ADP
iajs-3606	12	4	266	266	NUM
iajs-3606	12	5	blood	blood	NOUN
iajs-3606	12	6	samples	sample	NOUN
iajs-3606	12	7	were	be	AUX
iajs-3606	12	8	collected	collect	VERB
iajs-3606	12	9	.	.	PUNCT
iajs-3606	13	1	written	write	VERB
iajs-3606	13	2	consent	consent	NOUN
iajs-3606	13	3	was	be	AUX
iajs-3606	13	4	obtained	obtain	VERB
iajs-3606	13	5	by	by	ADP
iajs-3606	13	6	the	the	DET
iajs-3606	13	7	research	research	NOUN
iajs-3606	13	8	ethics	ethic	NOUN
iajs-3606	13	9	committee	committee	PROPN
iajs-3606	13	10	in	in	ADP
iajs-3606	13	11	the	the	DET
iajs-3606	13	12	diyala	diyala	PROPN
iajs-3606	13	13	health	health	PROPN
iajs-3606	13	14	department	department	PROPN
iajs-3606	13	15	(	(	PUNCT
iajs-3606	13	16	dhd	dhd	NOUN
iajs-3606	13	17	/	/	SYM
iajs-3606	13	18	no-39072	no-39072	NOUN
iajs-3606	13	19	/	/	SYM
iajs-3606	13	20	date-31/8/2022	date-31/8/2022	NOUN
iajs-3606	13	21	)	)	PUNCT
iajs-3606	13	22	.	.	PUNCT
iajs-3606	14	1	the	the	DET
iajs-3606	14	2	researchers	researcher	NOUN
iajs-3606	14	3	collected	collect	VERB
iajs-3606	14	4	the	the	DET
iajs-3606	14	5	data	datum	NOUN
iajs-3606	14	6	using	use	VERB
iajs-3606	14	7	a	a	DET
iajs-3606	14	8	specific	specific	ADJ
iajs-3606	14	9	questionnaire	questionnaire	NOUN
iajs-3606	14	10	they	they	PRON
iajs-3606	14	11	created	create	VERB
iajs-3606	14	12	after	after	ADP
iajs-3606	14	13	conducting	conduct	VERB
iajs-3606	14	14	a	a	DET
iajs-3606	14	15	brief	brief	ADJ
iajs-3606	14	16	interview	interview	NOUN
iajs-3606	14	17	with	with	ADP
iajs-3606	14	18	the	the	DET
iajs-3606	14	19	participants	participant	NOUN
iajs-3606	14	20	.	.	PUNCT
iajs-3606	15	1	the	the	DET
iajs-3606	15	2	elisa	elisa	NOUN
iajs-3606	15	3	technique	technique	NOUN
iajs-3606	15	4	was	be	AUX
iajs-3606	15	5	used	use	VERB
iajs-3606	15	6	to	to	PART
iajs-3606	15	7	detect	detect	VERB
iajs-3606	15	8	igg	igg	NOUN
iajs-3606	15	9	titers	titer	NOUN
iajs-3606	15	10	.	.	PUNCT
iajs-3606	16	1	the	the	DET
iajs-3606	16	2	rate	rate	NOUN
iajs-3606	16	3	of	of	ADP
iajs-3606	16	4	positivity	positivity	NOUN
iajs-3606	16	5	for	for	ADP
iajs-3606	16	6	igg	igg	PROPN
iajs-3606	16	7	antibodies	antibody	NOUN
iajs-3606	16	8	among	among	ADP
iajs-3606	16	9	study	study	NOUN
iajs-3606	16	10	participants	participant	NOUN
iajs-3606	16	11	vaccinated	vaccinate	VERB
iajs-3606	16	12	in	in	ADP
iajs-3606	16	13	diyala	diyala	PROPN
iajs-3606	16	14	province	province	NOUN
iajs-3606	16	15	was	be	AUX
iajs-3606	16	16	53.8	53.8	NUM
iajs-3606	16	17	%	%	NOUN
iajs-3606	16	18	,	,	PUNCT
iajs-3606	16	19	and	and	CCONJ
iajs-3606	16	20	the	the	DET
iajs-3606	16	21	mean±sd	mean±sd	NOUN
iajs-3606	16	22	for	for	ADP
iajs-3606	16	23	those	those	PRON
iajs-3606	16	24	vaccinated	vaccinate	VERB
iajs-3606	16	25	with	with	ADP
iajs-3606	16	26	the	the	DET
iajs-3606	16	27	pfizer	pfizer	NOUN
iajs-3606	16	28	vaccine	vaccine	NOUN
iajs-3606	16	29	was	be	AUX
iajs-3606	16	30	higher	high	ADJ
iajs-3606	16	31	compared	compare	VERB
iajs-3606	16	32	to	to	ADP
iajs-3606	16	33	the	the	DET
iajs-3606	16	34	mean±sd	mean±sd	NOUN
iajs-3606	16	35	for	for	ADP
iajs-3606	16	36	those	those	PRON
iajs-3606	16	37	vaccinated	vaccinate	VERB
iajs-3606	16	38	with	with	ADP
iajs-3606	16	39	the	the	DET
iajs-3606	16	40	sinopharm	sinopharm	NOUN
iajs-3606	16	41	vaccine	vaccine	NOUN
iajs-3606	16	42	,	,	PUNCT
iajs-3606	16	43	and	and	CCONJ
iajs-3606	16	44	the	the	DET
iajs-3606	16	45	statistical	statistical	ADJ
iajs-3606	16	46	difference	difference	NOUN
iajs-3606	16	47	was	be	AUX
iajs-3606	16	48	significant	significant	ADJ
iajs-3606	16	49	.	.	PUNCT
iajs-3606	17	1	despite	despite	SCONJ
iajs-3606	17	2	the	the	DET
iajs-3606	17	3	higher	high	ADJ
iajs-3606	17	4	antibody	antibody	NOUN
iajs-3606	17	5	titer	titer	NOUN
iajs-3606	17	6	among	among	ADP
iajs-3606	17	7	participants	participant	NOUN
iajs-3606	17	8	residing	reside	VERB
iajs-3606	17	9	in	in	ADP
iajs-3606	17	10	khanaqin	khanaqin	NOUN
iajs-3606	17	11	compared	compare	VERB
iajs-3606	17	12	to	to	ADP
iajs-3606	17	13	those	those	PRON
iajs-3606	17	14	from	from	ADP
iajs-3606	17	15	other	other	ADJ
iajs-3606	17	16	locations	location	NOUN
iajs-3606	17	17	,	,	PUNCT
iajs-3606	17	18	the	the	DET
iajs-3606	17	19	current	current	ADJ
iajs-3606	17	20	results	result	NOUN
iajs-3606	17	21	indicate	indicate	VERB
iajs-3606	17	22	no	no	DET
iajs-3606	17	23	significant	significant	ADJ
iajs-3606	17	24	differences	difference	NOUN
iajs-3606	17	25	in	in	ADP
iajs-3606	17	26	antibody	antibody	NOUN
iajs-3606	17	27	titer	titer	NOUN
iajs-3606	17	28	based	base	VERB
iajs-3606	17	29	on	on	ADP
iajs-3606	17	30	the	the	DET
iajs-3606	17	31	participants	participant	NOUN
iajs-3606	17	32	'	'	PART
iajs-3606	17	33	place	place	NOUN
iajs-3606	17	34	of	of	ADP
iajs-3606	17	35	residence	residence	NOUN
iajs-3606	17	36	(	(	PUNCT
iajs-3606	17	37	p	p	X
iajs-3606	17	38	=	=	NOUN
iajs-3606	17	39	0.474	0.474	NUM
iajs-3606	17	40	)	)	PUNCT
iajs-3606	17	41	.	.	PUNCT
iajs-3606	18	1	the	the	DET
iajs-3606	18	2	study	study	NOUN
iajs-3606	18	3	revealed	reveal	VERB
iajs-3606	18	4	no	no	DET
iajs-3606	18	5	statistically	statistically	ADV
iajs-3606	18	6	significant	significant	ADJ
iajs-3606	18	7	influence	influence	NOUN
iajs-3606	18	8	of	of	ADP
iajs-3606	18	9	mass	mass	ADJ
iajs-3606	18	10	weight	weight	NOUN
iajs-3606	18	11	,	,	PUNCT
iajs-3606	18	12	blood	blood	NOUN
iajs-3606	18	13	groups	group	NOUN
iajs-3606	18	14	,	,	PUNCT
iajs-3606	18	15	and	and	CCONJ
iajs-3606	18	16	rhesus	rhesus	NOUN
iajs-3606	18	17	factor	factor	NOUN
iajs-3606	18	18	on	on	ADP
iajs-3606	18	19	antibody	antibody	NOUN
iajs-3606	18	20	titres	titre	NOUN
iajs-3606	18	21	.	.	PUNCT
iajs-3606	19	1	as	as	ADP
iajs-3606	19	2	for	for	ADP
iajs-3606	19	3	smoking	smoking	NOUN
iajs-3606	19	4	,	,	PUNCT
iajs-3606	19	5	the	the	DET
iajs-3606	19	6	study	study	NOUN
iajs-3606	19	7	participants	participant	NOUN
iajs-3606	19	8	who	who	PRON
iajs-3606	19	9	smoked	smoke	VERB
iajs-3606	19	10	had	have	VERB
iajs-3606	19	11	a	a	DET
iajs-3606	19	12	lower	low	ADJ
iajs-3606	19	13	titer	titer	NOUN
iajs-3606	19	14	compared	compare	VERB
iajs-3606	19	15	with	with	ADP
iajs-3606	19	16	non	non	NOUN
iajs-3606	19	17	-	-	NOUN
iajs-3606	19	18	smokers	smoker	NOUN
iajs-3606	19	19	,	,	PUNCT
iajs-3606	19	20	with	with	ADP
iajs-3606	19	21	a	a	DET
iajs-3606	19	22	statistically	statistically	ADV
iajs-3606	19	23	significant	significant	ADJ
iajs-3606	19	24	difference	difference	NOUN
iajs-3606	19	25	(	(	PUNCT
iajs-3606	19	26	p	p	NOUN
iajs-3606	19	27	=	=	NOUN
iajs-3606	19	28	0025	0025	NUM
iajs-3606	19	29	)	)	PUNCT
iajs-3606	19	30	.	.	PUNCT
iajs-3606	20	1	the	the	DET
iajs-3606	20	2	study	study	NOUN
iajs-3606	20	3	concluded	conclude	VERB
iajs-3606	20	4	that	that	SCONJ
iajs-3606	20	5	the	the	DET
iajs-3606	20	6	overall	overall	ADJ
iajs-3606	20	7	protective	protective	ADJ
iajs-3606	20	8	rate	rate	NOUN
iajs-3606	20	9	of	of	ADP
iajs-3606	20	10	sars	sar	NOUN
iajs-3606	20	11	-	-	PUNCT
iajs-3606	20	12	cov-2	cov-2	NOUN
iajs-3606	20	13	vaccines	vaccine	NOUN
iajs-3606	20	14	among	among	ADP
iajs-3606	20	15	participants	participant	NOUN
iajs-3606	20	16	in	in	ADP
iajs-3606	20	17	diyala	diyala	PROPN
iajs-3606	20	18	governorate	governorate	PROPN
iajs-3606	20	19	after	after	ADP
iajs-3606	20	20	twelve	twelve	NUM
iajs-3606	20	21	to	to	PART
iajs-3606	20	22	seventeen	seventeen	NUM
iajs-3606	20	23	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3606	20	24	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3606	20	25	https://orcid.org/0009-0001-4716-7866	https://orcid.org/0009-0001-4716-7866	PROPN
iajs-3606	20	26	mailto:pbiomsc.shehedthemed@uodiyala.edu.iq	mailto:pbiomsc.shehedthemed@uodiyala.edu.iq	PROPN
iajs-3606	20	27	https://orcid.org/0000-0002-3179-6115	https://orcid.org/0000-0002-3179-6115	PROPN
iajs-3606	20	28	mailto:asmaa.haseeb@ymail.com	mailto:asmaa.haseeb@ymail.com	PROPN
iajs-3606	20	29	https://orcid.org/0000-0002-3216-1437	https://orcid.org/0000-0002-3216-1437	PROPN
iajs-3606	20	30	mailto:razak1957@yahoo.com	mailto:razak1957@yahoo.com	PROPN
iajs-3606	20	31	ihjpas	ihjpas	PROPN
iajs-3606	20	32	.	.	PUNCT
iajs-3606	21	1	2025	2025	NUM
iajs-3606	21	2	,	,	PUNCT
iajs-3606	21	3	38	38	NUM
iajs-3606	21	4	(	(	PUNCT
iajs-3606	21	5	1	1	NUM
iajs-3606	21	6	)	)	PUNCT
iajs-3606	21	7	112	112	NUM
iajs-3606	21	8	months	month	NOUN
iajs-3606	21	9	of	of	ADP
iajs-3606	21	10	vaccination	vaccination	NOUN
iajs-3606	21	11	was	be	AUX
iajs-3606	21	12	good	good	ADJ
iajs-3606	21	13	,	,	PUNCT
iajs-3606	21	14	and	and	CCONJ
iajs-3606	21	15	that	that	SCONJ
iajs-3606	21	16	the	the	DET
iajs-3606	21	17	pfizer	pfizer	NOUN
iajs-3606	21	18	mrna	mrna	PROPN
iajs-3606	21	19	vaccine	vaccine	NOUN
iajs-3606	21	20	had	have	VERB
iajs-3606	21	21	a	a	DET
iajs-3606	21	22	better	well	ADJ
iajs-3606	21	23	outcome	outcome	NOUN
iajs-3606	21	24	compared	compare	VERB
iajs-3606	21	25	to	to	ADP
iajs-3606	21	26	the	the	DET
iajs-3606	21	27	inactivated	inactivated	ADJ
iajs-3606	21	28	sinopharm	sinopharm	NOUN
iajs-3606	21	29	vaccine	vaccine	NOUN
iajs-3606	21	30	.	.	PUNCT
iajs-3606	22	1	keywords	keyword	NOUN
iajs-3606	22	2	:	:	PUNCT
iajs-3606	22	3	pfizer	pfizer	NOUN
iajs-3606	22	4	vaccine	vaccine	NOUN
iajs-3606	22	5	,	,	PUNCT
iajs-3606	22	6	sinopharm	sinopharm	NOUN
iajs-3606	22	7	vaccine	vaccine	NOUN
iajs-3606	22	8	,	,	PUNCT
iajs-3606	22	9	sars	sar	NOUN
iajs-3606	22	10	-	-	PUNCT
iajs-3606	22	11	cov-2	cov-2	NOUN
iajs-3606	22	12	,	,	PUNCT
iajs-3606	22	13	covid-19	covid-19	PROPN
iajs-3606	22	14	.	.	PROPN
iajs-3606	22	15	1	1	NUM
iajs-3606	22	16	.	.	X
iajs-3606	23	1	introduction	introduction	NOUN
iajs-3606	23	2	sars	sar	NOUN
iajs-3606	23	3	-	-	PUNCT
iajs-3606	23	4	cov-2	cov-2	NUM
iajs-3606	23	5	is	be	AUX
iajs-3606	23	6	the	the	DET
iajs-3606	23	7	cause	cause	NOUN
iajs-3606	23	8	of	of	ADP
iajs-3606	23	9	covid-19	covid-19	PROPN
iajs-3606	23	10	,	,	PUNCT
iajs-3606	23	11	a	a	DET
iajs-3606	23	12	new	new	ADJ
iajs-3606	23	13	worldwide	worldwide	ADJ
iajs-3606	23	14	infectious	infectious	ADJ
iajs-3606	23	15	disease	disease	NOUN
iajs-3606	23	16	(	(	PUNCT
iajs-3606	23	17	1	1	NUM
iajs-3606	23	18	)	)	PUNCT
iajs-3606	23	19	.	.	PUNCT
iajs-3606	24	1	it	it	PRON
iajs-3606	24	2	is	be	AUX
iajs-3606	24	3	a	a	DET
iajs-3606	24	4	member	member	NOUN
iajs-3606	24	5	of	of	ADP
iajs-3606	24	6	the	the	DET
iajs-3606	24	7	coronaviridae	coronaviridae	NOUN
iajs-3606	24	8	family	family	NOUN
iajs-3606	24	9	within	within	ADP
iajs-3606	24	10	the	the	DET
iajs-3606	24	11	nidovirales	nidovirale	NOUN
iajs-3606	24	12	order	order	NOUN
iajs-3606	24	13	.	.	PUNCT
iajs-3606	25	1	the	the	DET
iajs-3606	25	2	virus	virus	NOUN
iajs-3606	25	3	,	,	PUNCT
iajs-3606	25	4	known	know	VERB
iajs-3606	25	5	as	as	ADP
iajs-3606	25	6	sars	sar	NOUN
iajs-3606	25	7	-	-	PUNCT
iajs-3606	25	8	cov-2	cov-2	NOUN
iajs-3606	25	9	,	,	PUNCT
iajs-3606	25	10	possesses	possess	VERB
iajs-3606	25	11	a	a	DET
iajs-3606	25	12	single	single	ADV
iajs-3606	25	13	-	-	PUNCT
iajs-3606	25	14	stranded	strand	VERB
iajs-3606	25	15	,	,	PUNCT
iajs-3606	25	16	positive	positive	ADJ
iajs-3606	25	17	-	-	PUNCT
iajs-3606	25	18	sense	sense	NOUN
iajs-3606	25	19	rna	rna	NOUN
iajs-3606	25	20	and	and	CCONJ
iajs-3606	25	21	envelopes	envelop	VERB
iajs-3606	25	22	the	the	DET
iajs-3606	25	23	largest	large	ADJ
iajs-3606	25	24	viral	viral	ADJ
iajs-3606	25	25	genome	genome	NOUN
iajs-3606	25	26	,	,	PUNCT
iajs-3606	25	27	measuring	measure	VERB
iajs-3606	25	28	26	26	NUM
iajs-3606	25	29	to	to	PART
iajs-3606	25	30	32	32	NUM
iajs-3606	25	31	kilobases	kilobase	NOUN
iajs-3606	25	32	in	in	ADP
iajs-3606	25	33	length	length	NOUN
iajs-3606	25	34	(	(	PUNCT
iajs-3606	25	35	2	2	NUM
iajs-3606	25	36	,	,	PUNCT
iajs-3606	25	37	3	3	NUM
iajs-3606	25	38	)	)	PUNCT
iajs-3606	25	39	.	.	PUNCT
iajs-3606	26	1	its	its	PRON
iajs-3606	26	2	spherical	spherical	ADJ
iajs-3606	26	3	shape	shape	NOUN
iajs-3606	26	4	and	and	CCONJ
iajs-3606	26	5	corona	corona	NOUN
iajs-3606	26	6	-	-	PUNCT
iajs-3606	26	7	like	like	ADJ
iajs-3606	26	8	crust	crust	NOUN
iajs-3606	26	9	give	give	VERB
iajs-3606	26	10	it	it	PRON
iajs-3606	26	11	its	its	PRON
iajs-3606	26	12	name	name	NOUN
iajs-3606	26	13	(	(	PUNCT
iajs-3606	26	14	4	4	NUM
iajs-3606	26	15	)	)	PUNCT
iajs-3606	26	16	.	.	PUNCT
iajs-3606	27	1	people	people	NOUN
iajs-3606	27	2	exposed	expose	VERB
iajs-3606	27	3	to	to	ADP
iajs-3606	27	4	the	the	DET
iajs-3606	27	5	seafood	seafood	NOUN
iajs-3606	27	6	market	market	NOUN
iajs-3606	27	7	in	in	ADP
iajs-3606	27	8	wuhan	wuhan	PROPN
iajs-3606	27	9	,	,	PUNCT
iajs-3606	27	10	china	china	PROPN
iajs-3606	27	11	,	,	PUNCT
iajs-3606	27	12	first	first	ADV
iajs-3606	27	13	reported	report	VERB
iajs-3606	27	14	the	the	DET
iajs-3606	27	15	origin	origin	NOUN
iajs-3606	27	16	of	of	ADP
iajs-3606	27	17	the	the	DET
iajs-3606	27	18	sars	sar	NOUN
iajs-3606	27	19	-	-	PUNCT
iajs-3606	27	20	cov-2	cov-2	NOUN
iajs-3606	27	21	virus	virus	NOUN
iajs-3606	27	22	in	in	ADP
iajs-3606	27	23	december	december	PROPN
iajs-3606	27	24	2019	2019	NUM
iajs-3606	27	25	,	,	PUNCT
iajs-3606	27	26	after	after	ADP
iajs-3606	27	27	which	which	PRON
iajs-3606	27	28	it	it	PRON
iajs-3606	27	29	spread	spread	VERB
iajs-3606	27	30	to	to	ADP
iajs-3606	27	31	various	various	ADJ
iajs-3606	27	32	parts	part	NOUN
iajs-3606	27	33	of	of	ADP
iajs-3606	27	34	the	the	DET
iajs-3606	27	35	world	world	NOUN
iajs-3606	27	36	and	and	CCONJ
iajs-3606	27	37	caused	cause	VERB
iajs-3606	27	38	severe	severe	ADJ
iajs-3606	27	39	respiratory	respiratory	ADJ
iajs-3606	27	40	disease	disease	NOUN
iajs-3606	27	41	events	event	NOUN
iajs-3606	27	42	.	.	PUNCT
iajs-3606	28	1	the	the	DET
iajs-3606	28	2	first	first	ADJ
iajs-3606	28	3	suggestion	suggestion	NOUN
iajs-3606	28	4	was	be	AUX
iajs-3606	28	5	that	that	SCONJ
iajs-3606	28	6	the	the	DET
iajs-3606	28	7	infection	infection	NOUN
iajs-3606	28	8	originated	originate	VERB
iajs-3606	28	9	from	from	ADP
iajs-3606	28	10	a	a	DET
iajs-3606	28	11	zoonotic	zoonotic	ADJ
iajs-3606	28	12	source	source	NOUN
iajs-3606	28	13	(	(	PUNCT
iajs-3606	28	14	5	5	NUM
iajs-3606	28	15	)	)	PUNCT
iajs-3606	28	16	.	.	PUNCT
iajs-3606	29	1	the	the	DET
iajs-3606	29	2	transmission	transmission	NOUN
iajs-3606	29	3	of	of	ADP
iajs-3606	29	4	sars	sar	NOUN
iajs-3606	29	5	-	-	PUNCT
iajs-3606	29	6	cov-2	cov-2	PART
iajs-3606	29	7	occurs	occur	VERB
iajs-3606	29	8	via	via	ADP
iajs-3606	29	9	respiratory	respiratory	ADJ
iajs-3606	29	10	droplets	droplet	NOUN
iajs-3606	29	11	through	through	ADP
iajs-3606	29	12	direct	direct	ADJ
iajs-3606	29	13	contact	contact	NOUN
iajs-3606	29	14	with	with	ADP
iajs-3606	29	15	an	an	DET
iajs-3606	29	16	infected	infected	ADJ
iajs-3606	29	17	person	person	NOUN
iajs-3606	29	18	(	(	PUNCT
iajs-3606	29	19	6	6	NUM
iajs-3606	29	20	)	)	PUNCT
iajs-3606	29	21	,	,	PUNCT
iajs-3606	29	22	or	or	CCONJ
iajs-3606	29	23	it	it	PRON
iajs-3606	29	24	may	may	AUX
iajs-3606	29	25	occur	occur	VERB
iajs-3606	29	26	through	through	ADP
iajs-3606	29	27	indirect	indirect	ADJ
iajs-3606	29	28	contact	contact	NOUN
iajs-3606	29	29	or	or	CCONJ
iajs-3606	29	30	in	in	ADP
iajs-3606	29	31	the	the	DET
iajs-3606	29	32	pre	pre	ADJ
iajs-3606	29	33	-	-	ADJ
iajs-3606	29	34	symptomatic	symptomatic	ADJ
iajs-3606	29	35	incubation	incubation	NOUN
iajs-3606	29	36	period	period	NOUN
iajs-3606	29	37	(	(	PUNCT
iajs-3606	29	38	7	7	NUM
iajs-3606	29	39	)	)	PUNCT
iajs-3606	29	40	.	.	PUNCT
iajs-3606	30	1	fever	fever	NOUN
iajs-3606	30	2	,	,	PUNCT
iajs-3606	30	3	sore	sore	ADJ
iajs-3606	30	4	throat	throat	NOUN
iajs-3606	30	5	,	,	PUNCT
iajs-3606	30	6	fatigue	fatigue	NOUN
iajs-3606	30	7	,	,	PUNCT
iajs-3606	30	8	headache	headache	NOUN
iajs-3606	30	9	,	,	PUNCT
iajs-3606	30	10	dry	dry	ADJ
iajs-3606	30	11	cough	cough	NOUN
iajs-3606	30	12	,	,	PUNCT
iajs-3606	30	13	and	and	CCONJ
iajs-3606	30	14	loss	loss	NOUN
iajs-3606	30	15	of	of	ADP
iajs-3606	30	16	smell	smell	NOUN
iajs-3606	30	17	are	be	AUX
iajs-3606	30	18	among	among	ADP
iajs-3606	30	19	the	the	DET
iajs-3606	30	20	symptoms	symptom	NOUN
iajs-3606	30	21	of	of	ADP
iajs-3606	30	22	infection	infection	NOUN
iajs-3606	30	23	,	,	PUNCT
iajs-3606	30	24	which	which	PRON
iajs-3606	30	25	can	can	AUX
iajs-3606	30	26	progress	progress	VERB
iajs-3606	30	27	to	to	PART
iajs-3606	30	28	hypoxia	hypoxia	VERB
iajs-3606	30	29	if	if	SCONJ
iajs-3606	30	30	left	leave	VERB
iajs-3606	30	31	untreated	untreated	ADJ
iajs-3606	30	32	(	(	PUNCT
iajs-3606	30	33	8)	8)	NUM
iajs-3606	30	34	.	.	PUNCT
iajs-3606	31	1	the	the	DET
iajs-3606	31	2	lack	lack	NOUN
iajs-3606	31	3	of	of	ADP
iajs-3606	31	4	a	a	DET
iajs-3606	31	5	suitable	suitable	ADJ
iajs-3606	31	6	treatment	treatment	NOUN
iajs-3606	31	7	during	during	ADP
iajs-3606	31	8	the	the	DET
iajs-3606	31	9	virus	virus	NOUN
iajs-3606	31	10	's	's	PART
iajs-3606	31	11	fierce	fierce	ADJ
iajs-3606	31	12	attack	attack	NOUN
iajs-3606	31	13	necessitated	necessitate	VERB
iajs-3606	31	14	the	the	DET
iajs-3606	31	15	urgent	urgent	ADJ
iajs-3606	31	16	and	and	CCONJ
iajs-3606	31	17	necessary	necessary	ADJ
iajs-3606	31	18	development	development	NOUN
iajs-3606	31	19	of	of	ADP
iajs-3606	31	20	various	various	ADJ
iajs-3606	31	21	vaccines	vaccine	NOUN
iajs-3606	31	22	through	through	ADP
iajs-3606	31	23	scientific	scientific	ADJ
iajs-3606	31	24	institutions	institution	NOUN
iajs-3606	31	25	,	,	PUNCT
iajs-3606	31	26	and	and	CCONJ
iajs-3606	31	27	the	the	DET
iajs-3606	31	28	only	only	ADJ
iajs-3606	31	29	way	way	NOUN
iajs-3606	31	30	out	out	ADP
iajs-3606	31	31	of	of	ADP
iajs-3606	31	32	the	the	DET
iajs-3606	31	33	epidemic	epidemic	NOUN
iajs-3606	31	34	crisis	crisis	NOUN
iajs-3606	31	35	was	be	AUX
iajs-3606	31	36	vaccination	vaccination	NOUN
iajs-3606	31	37	with	with	ADP
iajs-3606	31	38	effective	effective	ADJ
iajs-3606	31	39	vaccines	vaccine	NOUN
iajs-3606	31	40	(	(	PUNCT
iajs-3606	31	41	9	9	NUM
iajs-3606	31	42	)	)	PUNCT
iajs-3606	31	43	.	.	PUNCT
iajs-3606	32	1	iraq	iraq	PROPN
iajs-3606	32	2	received	receive	VERB
iajs-3606	32	3	its	its	PRON
iajs-3606	32	4	first	first	ADJ
iajs-3606	32	5	sinopharm	sinopharm	NOUN
iajs-3606	32	6	vaccine	vaccine	NOUN
iajs-3606	32	7	from	from	ADP
iajs-3606	32	8	china	china	PROPN
iajs-3606	32	9	,	,	PUNCT
iajs-3606	32	10	and	and	CCONJ
iajs-3606	32	11	the	the	DET
iajs-3606	32	12	majority	majority	NOUN
iajs-3606	32	13	of	of	ADP
iajs-3606	32	14	its	its	PRON
iajs-3606	32	15	population	population	NOUN
iajs-3606	32	16	received	receive	VERB
iajs-3606	32	17	it	it	PRON
iajs-3606	32	18	(	(	PUNCT
iajs-3606	32	19	6	6	NUM
iajs-3606	32	20	)	)	PUNCT
iajs-3606	32	21	.	.	PUNCT
iajs-3606	33	1	regarding	regard	VERB
iajs-3606	33	2	the	the	DET
iajs-3606	33	3	vaccine	vaccine	NOUN
iajs-3606	33	4	's	's	PART
iajs-3606	33	5	status	status	NOUN
iajs-3606	33	6	in	in	ADP
iajs-3606	33	7	iraq	iraq	PROPN
iajs-3606	33	8	,	,	PUNCT
iajs-3606	33	9	441,121	441,121	NUM
iajs-3606	33	10	people	people	NOUN
iajs-3606	33	11	had	have	AUX
iajs-3606	33	12	received	receive	VERB
iajs-3606	33	13	it	it	PRON
iajs-3606	33	14	by	by	ADP
iajs-3606	33	15	may	may	PROPN
iajs-3606	33	16	10	10	NUM
iajs-3606	33	17	th	th	NOUN
iajs-3606	33	18	,	,	PUNCT
iajs-3606	33	19	with	with	ADP
iajs-3606	33	20	an	an	DET
iajs-3606	33	21	average	average	NOUN
iajs-3606	33	22	of	of	ADP
iajs-3606	33	23	15,000	15,000	NUM
iajs-3606	33	24	doses	dose	NOUN
iajs-3606	33	25	per	per	ADP
iajs-3606	33	26	day	day	NOUN
iajs-3606	33	27	(	(	PUNCT
iajs-3606	33	28	10	10	NUM
iajs-3606	33	29	)	)	PUNCT
iajs-3606	33	30	.	.	PUNCT
iajs-3606	34	1	vaccination	vaccination	NOUN
iajs-3606	34	2	contributes	contribute	VERB
iajs-3606	34	3	to	to	ADP
iajs-3606	34	4	preventing	prevent	VERB
iajs-3606	34	5	asymptomatic	asymptomatic	ADJ
iajs-3606	34	6	infections	infection	NOUN
iajs-3606	34	7	and	and	CCONJ
iajs-3606	34	8	reduces	reduce	VERB
iajs-3606	34	9	the	the	DET
iajs-3606	34	10	risk	risk	NOUN
iajs-3606	34	11	of	of	ADP
iajs-3606	34	12	infection	infection	NOUN
iajs-3606	34	13	by	by	ADP
iajs-3606	34	14	stimulating	stimulate	VERB
iajs-3606	34	15	the	the	DET
iajs-3606	34	16	host	host	NOUN
iajs-3606	34	17	immune	immune	ADJ
iajs-3606	34	18	system	system	NOUN
iajs-3606	34	19	to	to	PART
iajs-3606	34	20	produce	produce	VERB
iajs-3606	34	21	antibodies	antibody	NOUN
iajs-3606	34	22	(	(	PUNCT
iajs-3606	34	23	11	11	NUM
iajs-3606	34	24	,	,	PUNCT
iajs-3606	34	25	12	12	NUM
iajs-3606	34	26	,	,	PUNCT
iajs-3606	34	27	13	13	NUM
iajs-3606	34	28	)	)	PUNCT
iajs-3606	34	29	.	.	PUNCT
iajs-3606	35	1	in	in	ADP
iajs-3606	35	2	general	general	ADJ
iajs-3606	35	3	,	,	PUNCT
iajs-3606	35	4	covid-19	covid-19	PROPN
iajs-3606	35	5	vaccines	vaccine	NOUN
iajs-3606	35	6	stimulate	stimulate	VERB
iajs-3606	35	7	,	,	PUNCT
iajs-3606	35	8	through	through	ADP
iajs-3606	35	9	various	various	ADJ
iajs-3606	35	10	mechanisms	mechanism	NOUN
iajs-3606	35	11	,	,	PUNCT
iajs-3606	35	12	innate	innate	ADJ
iajs-3606	35	13	and	and	CCONJ
iajs-3606	35	14	adaptive	adaptive	ADJ
iajs-3606	35	15	immune	immune	ADJ
iajs-3606	35	16	responses	response	NOUN
iajs-3606	35	17	.	.	PUNCT
iajs-3606	36	1	pfizer	pfizer	NOUN
iajs-3606	36	2	-	-	PUNCT
iajs-3606	36	3	biotech	biotech	ADJ
iajs-3606	36	4	vaccine	vaccine	NOUN
iajs-3606	36	5	developed	develop	VERB
iajs-3606	36	6	by	by	ADP
iajs-3606	36	7	biotech	biotech	NOUN
iajs-3606	36	8	and	and	CCONJ
iajs-3606	36	9	distributed	distribute	VERB
iajs-3606	36	10	by	by	ADP
iajs-3606	36	11	pfizer	pfizer	NOUN
iajs-3606	36	12	and	and	CCONJ
iajs-3606	36	13	fosun	fosun	NOUN
iajs-3606	36	14	pharmaceutical	pharmaceutical	NOUN
iajs-3606	37	1	,	,	PUNCT
iajs-3606	37	2	it	it	PRON
iajs-3606	37	3	is	be	AUX
iajs-3606	37	4	the	the	DET
iajs-3606	37	5	first	first	ADJ
iajs-3606	37	6	eu	eu	PROPN
iajs-3606	37	7	-	-	ADJ
iajs-3606	37	8	approved	approve	VERB
iajs-3606	37	9	vaccine	vaccine	NOUN
iajs-3606	37	10	for	for	ADP
iajs-3606	37	11	emergency	emergency	NOUN
iajs-3606	37	12	use	use	NOUN
iajs-3606	37	13	.	.	PUNCT
iajs-3606	38	1	researchers	researcher	NOUN
iajs-3606	38	2	have	have	AUX
iajs-3606	38	3	conducted	conduct	VERB
iajs-3606	38	4	several	several	ADJ
iajs-3606	38	5	clinical	clinical	ADJ
iajs-3606	38	6	trials	trial	NOUN
iajs-3606	38	7	,	,	PUNCT
iajs-3606	38	8	reporting	report	VERB
iajs-3606	38	9	more	more	ADJ
iajs-3606	38	10	than	than	ADP
iajs-3606	38	11	95	95	NUM
iajs-3606	38	12	%	%	NOUN
iajs-3606	38	13	success	success	NOUN
iajs-3606	38	14	(	(	PUNCT
iajs-3606	38	15	14	14	NUM
iajs-3606	38	16	)	)	PUNCT
iajs-3606	38	17	.	.	PUNCT
iajs-3606	39	1	the	the	PRON
iajs-3606	39	2	who	who	PRON
iajs-3606	39	3	officially	officially	ADV
iajs-3606	39	4	approved	approve	VERB
iajs-3606	39	5	the	the	DET
iajs-3606	39	6	sinopharm	sinopharm	NOUN
iajs-3606	39	7	vaccine	vaccine	NOUN
iajs-3606	39	8	(	(	PUNCT
iajs-3606	39	9	bbibp	bbibp	NOUN
iajs-3606	39	10	-	-	PUNCT
iajs-3606	39	11	corv	corv	NOUN
iajs-3606	39	12	)	)	PUNCT
iajs-3606	39	13	in	in	ADP
iajs-3606	39	14	may	may	PROPN
iajs-3606	39	15	2021	2021	NUM
iajs-3606	39	16	.	.	PUNCT
iajs-3606	40	1	the	the	DET
iajs-3606	40	2	national	national	PROPN
iajs-3606	40	3	medical	medical	PROPN
iajs-3606	40	4	products	product	NOUN
iajs-3606	40	5	administration	administration	PROPN
iajs-3606	40	6	of	of	ADP
iajs-3606	40	7	china	china	PROPN
iajs-3606	40	8	announced	announce	VERB
iajs-3606	40	9	a	a	DET
iajs-3606	40	10	prior	prior	ADJ
iajs-3606	40	11	approval	approval	NOUN
iajs-3606	40	12	of	of	ADP
iajs-3606	40	13	the	the	DET
iajs-3606	40	14	sinopharm	sinopharm	NOUN
iajs-3606	40	15	vaccine	vaccine	NOUN
iajs-3606	40	16	(	(	PUNCT
iajs-3606	40	17	bbibp	bbibp	NOUN
iajs-3606	40	18	-	-	PUNCT
iajs-3606	40	19	corv	corv	NOUN
iajs-3606	40	20	)	)	PUNCT
iajs-3606	40	21	in	in	ADP
iajs-3606	40	22	january	january	PROPN
iajs-3606	40	23	2020	2020	NUM
iajs-3606	40	24	,	,	PUNCT
iajs-3606	40	25	which	which	PRON
iajs-3606	40	26	showed	show	VERB
iajs-3606	40	27	79	79	NUM
iajs-3606	40	28	%	%	NOUN
iajs-3606	40	29	effectiveness	effectiveness	NOUN
iajs-3606	40	30	against	against	ADP
iajs-3606	40	31	symptomatic	symptomatic	ADJ
iajs-3606	40	32	disease	disease	NOUN
iajs-3606	40	33	in	in	ADP
iajs-3606	40	34	the	the	DET
iajs-3606	40	35	phase	phase	NOUN
iajs-3606	40	36	3	3	NUM
iajs-3606	40	37	trial	trial	NOUN
iajs-3606	40	38	(	(	PUNCT
iajs-3606	40	39	15	15	NUM
iajs-3606	40	40	)	)	PUNCT
iajs-3606	40	41	.	.	PUNCT
iajs-3606	41	1	the	the	DET
iajs-3606	41	2	inactivated	inactivated	ADJ
iajs-3606	41	3	virus	virus	NOUN
iajs-3606	41	4	-	-	PUNCT
iajs-3606	41	5	based	base	VERB
iajs-3606	41	6	sinovac	sinovac	NOUN
iajs-3606	41	7	vaccine	vaccine	NOUN
iajs-3606	41	8	worked	work	VERB
iajs-3606	41	9	between	between	ADP
iajs-3606	41	10	59	59	NUM
iajs-3606	41	11	and	and	CCONJ
iajs-3606	41	12	65	65	NUM
iajs-3606	41	13	%	%	NOUN
iajs-3606	41	14	of	of	ADP
iajs-3606	41	15	the	the	DET
iajs-3606	41	16	time	time	NOUN
iajs-3606	41	17	against	against	ADP
iajs-3606	41	18	alpha	alpha	NOUN
iajs-3606	41	19	,	,	PUNCT
iajs-3606	41	20	beta	beta	NOUN
iajs-3606	41	21	,	,	PUNCT
iajs-3606	41	22	and	and	CCONJ
iajs-3606	41	23	kama	kama	PROPN
iajs-3606	41	24	virus	virus	NOUN
iajs-3606	41	25	variants	variant	NOUN
iajs-3606	41	26	(	(	PUNCT
iajs-3606	41	27	16	16	NUM
iajs-3606	41	28	,	,	PUNCT
iajs-3606	41	29	18	18	NUM
iajs-3606	41	30	,	,	PUNCT
iajs-3606	41	31	19	19	NUM
iajs-3606	41	32	)	)	PUNCT
iajs-3606	41	33	,	,	PUNCT
iajs-3606	41	34	as	as	ADV
iajs-3606	41	35	well	well	ADV
iajs-3606	41	36	as	as	ADP
iajs-3606	41	37	against	against	ADP
iajs-3606	41	38	people	people	NOUN
iajs-3606	41	39	who	who	PRON
iajs-3606	41	40	were	be	AUX
iajs-3606	41	41	older	old	ADJ
iajs-3606	41	42	,	,	PUNCT
iajs-3606	41	43	had	have	VERB
iajs-3606	41	44	cancer	cancer	NOUN
iajs-3606	41	45	,	,	PUNCT
iajs-3606	41	46	or	or	CCONJ
iajs-3606	41	47	had	have	VERB
iajs-3606	41	48	a	a	DET
iajs-3606	41	49	transplant	transplant	NOUN
iajs-3606	41	50	,	,	PUNCT
iajs-3606	41	51	were	be	AUX
iajs-3606	41	52	pregnant	pregnant	ADJ
iajs-3606	41	53	,	,	PUNCT
iajs-3606	41	54	or	or	CCONJ
iajs-3606	41	55	had	have	VERB
iajs-3606	41	56	other	other	ADJ
iajs-3606	41	57	health	health	NOUN
iajs-3606	41	58	problems	problem	NOUN
iajs-3606	41	59	,	,	PUNCT
iajs-3606	41	60	compared	compare	VERB
iajs-3606	41	61	to	to	ADP
iajs-3606	41	62	people	people	NOUN
iajs-3606	41	63	who	who	PRON
iajs-3606	41	64	were	be	AUX
iajs-3606	41	65	not	not	PART
iajs-3606	41	66	infected	infect	VERB
iajs-3606	41	67	(	(	PUNCT
iajs-3606	41	68	20	20	NUM
iajs-3606	41	69	)	)	PUNCT
iajs-3606	41	70	.	.	PUNCT
iajs-3606	42	1	2	2	X
iajs-3606	42	2	.	.	X
iajs-3606	42	3	materials	material	NOUN
iajs-3606	42	4	and	and	CCONJ
iajs-3606	42	5	methods	method	NOUN
iajs-3606	42	6	the	the	DET
iajs-3606	42	7	researchers	researcher	NOUN
iajs-3606	42	8	used	use	VERB
iajs-3606	42	9	a	a	DET
iajs-3606	42	10	specific	specific	ADJ
iajs-3606	42	11	questionnaire	questionnaire	NOUN
iajs-3606	42	12	to	to	PART
iajs-3606	42	13	gather	gather	VERB
iajs-3606	42	14	data	datum	NOUN
iajs-3606	42	15	for	for	ADP
iajs-3606	42	16	this	this	DET
iajs-3606	42	17	study	study	NOUN
iajs-3606	42	18	.	.	PUNCT
iajs-3606	43	1	a	a	DET
iajs-3606	43	2	sample	sample	NOUN
iajs-3606	43	3	of	of	ADP
iajs-3606	43	4	266	266	NUM
iajs-3606	43	5	participants	participant	NOUN
iajs-3606	43	6	filled	fill	VERB
iajs-3606	43	7	out	out	ADP
iajs-3606	43	8	the	the	DET
iajs-3606	43	9	questionnaire	questionnaire	NOUN
iajs-3606	43	10	.	.	PUNCT
iajs-3606	44	1	they	they	PRON
iajs-3606	44	2	agreed	agree	VERB
iajs-3606	44	3	to	to	PART
iajs-3606	44	4	participate	participate	VERB
iajs-3606	44	5	in	in	ADP
iajs-3606	44	6	this	this	DET
iajs-3606	44	7	research	research	NOUN
iajs-3606	44	8	project	project	NOUN
iajs-3606	44	9	.	.	PUNCT
iajs-3606	45	1	they	they	PRON
iajs-3606	45	2	represented	represent	VERB
iajs-3606	45	3	both	both	DET
iajs-3606	45	4	sexes	sex	NOUN
iajs-3606	45	5	and	and	CCONJ
iajs-3606	45	6	ranged	range	VERB
iajs-3606	45	7	in	in	ADP
iajs-3606	45	8	age	age	NOUN
iajs-3606	45	9	from	from	ADP
iajs-3606	45	10	18	18	NUM
iajs-3606	45	11	to	to	ADP
iajs-3606	45	12	77	77	NUM
iajs-3606	45	13	.	.	PUNCT
iajs-3606	46	1	the	the	DET
iajs-3606	46	2	obtained	obtain	VERB
iajs-3606	46	3	data	datum	NOUN
iajs-3606	46	4	had	have	VERB
iajs-3606	46	5	variables	variable	NOUN
iajs-3606	46	6	including	include	VERB
iajs-3606	46	7	age	age	NOUN
iajs-3606	46	8	,	,	PUNCT
iajs-3606	46	9	sex	sex	NOUN
iajs-3606	46	10	,	,	PUNCT
iajs-3606	46	11	height	height	NOUN
iajs-3606	46	12	,	,	PUNCT
iajs-3606	46	13	occupation	occupation	NOUN
iajs-3606	46	14	,	,	PUNCT
iajs-3606	46	15	residence	residence	NOUN
iajs-3606	46	16	,	,	PUNCT
iajs-3606	46	17	weight	weight	NOUN
iajs-3606	46	18	,	,	PUNCT
iajs-3606	46	19	number	number	NOUN
iajs-3606	46	20	of	of	ADP
iajs-3606	46	21	doses	dose	NOUN
iajs-3606	46	22	,	,	PUNCT
iajs-3606	46	23	type	type	NOUN
iajs-3606	46	24	of	of	ADP
iajs-3606	46	25	vaccine	vaccine	NOUN
iajs-3606	46	26	,	,	PUNCT
iajs-3606	46	27	date	date	NOUN
iajs-3606	46	28	of	of	ADP
iajs-3606	46	29	last	last	ADJ
iajs-3606	46	30	vaccination	vaccination	NOUN
iajs-3606	46	31	,	,	PUNCT
iajs-3606	46	32	symptoms	symptom	NOUN
iajs-3606	46	33	,	,	PUNCT
iajs-3606	46	34	side	side	ADJ
iajs-3606	46	35	effects	effect	NOUN
iajs-3606	46	36	of	of	ADP
iajs-3606	46	37	the	the	DET
iajs-3606	46	38	vaccine	vaccine	NOUN
iajs-3606	46	39	,	,	PUNCT
iajs-3606	46	40	and	and	CCONJ
iajs-3606	46	41	exposure	exposure	NOUN
iajs-3606	46	42	to	to	ADP
iajs-3606	46	43	sars	sar	NOUN
iajs-3606	46	44	-	-	PUNCT
iajs-3606	46	45	cov-2	cov-2	NOUN
iajs-3606	46	46	.	.	PUNCT
iajs-3606	47	1	we	we	PRON
iajs-3606	47	2	collected	collect	VERB
iajs-3606	47	3	ihjpas	ihjpa	NOUN
iajs-3606	47	4	.	.	PUNCT
iajs-3606	48	1	2025	2025	NUM
iajs-3606	48	2	,	,	PUNCT
iajs-3606	48	3	38	38	NUM
iajs-3606	48	4	(	(	PUNCT
iajs-3606	48	5	1	1	NUM
iajs-3606	48	6	)	)	SYM
iajs-3606	48	7	113	113	NUM
iajs-3606	48	8	samples	sample	NOUN
iajs-3606	48	9	from	from	ADP
iajs-3606	48	10	the	the	DET
iajs-3606	48	11	seemingly	seemingly	ADV
iajs-3606	48	12	healthy	healthy	ADJ
iajs-3606	48	13	volunteers	volunteer	NOUN
iajs-3606	48	14	.	.	PUNCT
iajs-3606	49	1	we	we	PRON
iajs-3606	49	2	conducted	conduct	VERB
iajs-3606	49	3	this	this	DET
iajs-3606	49	4	cross	cross	ADJ
iajs-3606	49	5	-	-	ADJ
iajs-3606	49	6	sectional	sectional	ADJ
iajs-3606	49	7	study	study	NOUN
iajs-3606	49	8	after	after	ADP
iajs-3606	49	9	the	the	DET
iajs-3606	49	10	last	last	ADJ
iajs-3606	49	11	dose	dose	NOUN
iajs-3606	49	12	of	of	ADP
iajs-3606	49	13	the	the	DET
iajs-3606	49	14	vaccine	vaccine	NOUN
iajs-3606	49	15	,	,	PUNCT
iajs-3606	49	16	ensuring	ensure	VERB
iajs-3606	49	17	a	a	DET
iajs-3606	49	18	duration	duration	NOUN
iajs-3606	49	19	of	of	ADP
iajs-3606	49	20	at	at	ADV
iajs-3606	49	21	least	least	ADV
iajs-3606	49	22	3	3	NUM
iajs-3606	49	23	months	month	NOUN
iajs-3606	49	24	.	.	PUNCT
iajs-3606	50	1	the	the	DET
iajs-3606	50	2	number	number	NOUN
iajs-3606	50	3	of	of	ADP
iajs-3606	50	4	doses	dose	NOUN
iajs-3606	50	5	varied	varied	ADJ
iajs-3606	50	6	from	from	ADP
iajs-3606	50	7	one	one	NUM
iajs-3606	50	8	to	to	ADP
iajs-3606	50	9	three	three	NUM
iajs-3606	50	10	.	.	PUNCT
iajs-3606	51	1	diyala	diyala	PROPN
iajs-3606	51	2	province	province	PROPN
iajs-3606	51	3	,	,	PUNCT
iajs-3606	51	4	iraq	iraq	PROPN
iajs-3606	51	5	,	,	PUNCT
iajs-3606	51	6	was	be	AUX
iajs-3606	51	7	the	the	DET
iajs-3606	51	8	investigated	investigated	ADJ
iajs-3606	51	9	area	area	NOUN
iajs-3606	51	10	for	for	ADP
iajs-3606	51	11	the	the	DET
iajs-3606	51	12	period	period	NOUN
iajs-3606	51	13	from	from	ADP
iajs-3606	51	14	april	april	PROPN
iajs-3606	51	15	2022	2022	NUM
iajs-3606	51	16	to	to	ADP
iajs-3606	51	17	may	may	PROPN
iajs-3606	51	18	2023	2023	NUM
iajs-3606	51	19	.	.	PUNCT
iajs-3606	52	1	the	the	DET
iajs-3606	52	2	study	study	NOUN
iajs-3606	52	3	included	include	VERB
iajs-3606	52	4	participants	participant	NOUN
iajs-3606	52	5	from	from	ADP
iajs-3606	52	6	the	the	DET
iajs-3606	52	7	general	general	ADJ
iajs-3606	52	8	community	community	NOUN
iajs-3606	52	9	,	,	PUNCT
iajs-3606	52	10	specifically	specifically	ADV
iajs-3606	52	11	outpatients	outpatient	NOUN
iajs-3606	52	12	from	from	ADP
iajs-3606	52	13	the	the	DET
iajs-3606	52	14	consultation	consultation	NOUN
iajs-3606	52	15	clinic	clinic	NOUN
iajs-3606	52	16	at	at	ADP
iajs-3606	52	17	baquba	baquba	PROPN
iajs-3606	52	18	general	general	ADJ
iajs-3606	52	19	teaching	teaching	NOUN
iajs-3606	52	20	hospital	hospital	NOUN
iajs-3606	52	21	and	and	CCONJ
iajs-3606	52	22	blood	blood	NOUN
iajs-3606	52	23	transfusion	transfusion	NOUN
iajs-3606	52	24	center	center	NOUN
iajs-3606	52	25	,	,	PUNCT
iajs-3606	52	26	and	and	CCONJ
iajs-3606	52	27	received	receive	VERB
iajs-3606	52	28	official	official	ADJ
iajs-3606	52	29	consent	consent	NOUN
iajs-3606	52	30	from	from	ADP
iajs-3606	52	31	the	the	DET
iajs-3606	52	32	research	research	NOUN
iajs-3606	52	33	ethics	ethic	NOUN
iajs-3606	52	34	committee	committee	PROPN
iajs-3606	52	35	of	of	ADP
iajs-3606	52	36	the	the	DET
iajs-3606	52	37	diyala	diyala	PROPN
iajs-3606	52	38	health	health	PROPN
iajs-3606	52	39	department	department	PROPN
iajs-3606	52	40	(	(	PUNCT
iajs-3606	52	41	dhd	dhd	NOUN
iajs-3606	52	42	/	/	SYM
iajs-3606	52	43	no-39072	no-39072	NOUN
iajs-3606	52	44	/	/	SYM
iajs-3606	52	45	date-31/8/2022	date-31/8/2022	NOUN
iajs-3606	52	46	)	)	PUNCT
iajs-3606	52	47	.	.	PUNCT
iajs-3606	53	1	we	we	PRON
iajs-3606	53	2	used	use	VERB
iajs-3606	53	3	the	the	DET
iajs-3606	53	4	elisa	elisa	NOUN
iajs-3606	53	5	technique	technique	NOUN
iajs-3606	53	6	to	to	PART
iajs-3606	53	7	detect	detect	VERB
iajs-3606	53	8	igg	igg	PROPN
iajs-3606	53	9	titers	titer	NOUN
iajs-3606	53	10	,	,	PUNCT
iajs-3606	53	11	and	and	CCONJ
iajs-3606	53	12	used	use	VERB
iajs-3606	53	13	a	a	DET
iajs-3606	53	14	diagnostic	diagnostic	ADJ
iajs-3606	53	15	kit	kit	NOUN
iajs-3606	53	16	(	(	PUNCT
iajs-3606	53	17	dia	dia	PROPN
iajs-3606	53	18	proi	proi	PROPN
iajs-3606	53	19	italy	italy	PROPN
iajs-3606	53	20	)	)	PUNCT
iajs-3606	53	21	to	to	PART
iajs-3606	53	22	coat	coat	VERB
iajs-3606	53	23	the	the	DET
iajs-3606	53	24	wells	well	NOUN
iajs-3606	53	25	of	of	ADP
iajs-3606	53	26	the	the	DET
iajs-3606	53	27	plate	plate	NOUN
iajs-3606	53	28	with	with	ADP
iajs-3606	53	29	spike	spike	ADJ
iajs-3606	53	30	protein	protein	NOUN
iajs-3606	53	31	and	and	CCONJ
iajs-3606	53	32	nucleocapsid	nucleocapsid	NOUN
iajs-3606	53	33	of	of	ADP
iajs-3606	53	34	sars	sar	NOUN
iajs-3606	53	35	-	-	PUNCT
iajs-3606	53	36	cov-2	cov-2	NOUN
iajs-3606	53	37	,	,	PUNCT
iajs-3606	53	38	which	which	PRON
iajs-3606	53	39	target	target	VERB
iajs-3606	53	40	specific	specific	ADJ
iajs-3606	53	41	antibodies	antibody	NOUN
iajs-3606	53	42	for	for	ADP
iajs-3606	53	43	this	this	DET
iajs-3606	53	44	virus	virus	NOUN
iajs-3606	53	45	.	.	PUNCT
iajs-3606	54	1	the	the	DET
iajs-3606	54	2	optical	optical	ADJ
iajs-3606	54	3	signal	signal	NOUN
iajs-3606	54	4	or	or	CCONJ
iajs-3606	54	5	color	color	NOUN
iajs-3606	54	6	change	change	NOUN
iajs-3606	54	7	is	be	AUX
iajs-3606	54	8	proportional	proportional	ADJ
iajs-3606	54	9	to	to	ADP
iajs-3606	54	10	the	the	DET
iajs-3606	54	11	amount	amount	NOUN
iajs-3606	54	12	of	of	ADP
iajs-3606	54	13	anti	anti	ADJ
iajs-3606	54	14	-	-	ADJ
iajs-3606	54	15	sars	sar	NOUN
iajs-3606	54	16	-	-	PUNCT
iajs-3606	54	17	cov-2	cov-2	NOUN
iajs-3606	54	18	igg	igg	PROPN
iajs-3606	54	19	antibodies	antibodie	VERB
iajs-3606	54	20	present	present	ADJ
iajs-3606	54	21	in	in	ADP
iajs-3606	54	22	the	the	DET
iajs-3606	54	23	sample	sample	NOUN
iajs-3606	54	24	.	.	PUNCT
iajs-3606	55	1	through	through	ADP
iajs-3606	55	2	the	the	DET
iajs-3606	55	3	positive	positive	ADJ
iajs-3606	55	4	control	control	NOUN
iajs-3606	55	5	,	,	PUNCT
iajs-3606	55	6	whose	whose	DET
iajs-3606	55	7	igg	igg	NOUN
iajs-3606	55	8	content	content	NOUN
iajs-3606	55	9	is	be	AUX
iajs-3606	55	10	measured	measure	VERB
iajs-3606	55	11	in	in	ADP
iajs-3606	55	12	who	who	PRON
iajs-3606	55	13	iu	iu	ADP
iajs-3606	55	14	/	/	SYM
iajs-3606	55	15	ml	ml	NOUN
iajs-3606	55	16	units	unit	NOUN
iajs-3606	55	17	,	,	PUNCT
iajs-3606	55	18	the	the	DET
iajs-3606	55	19	cut	cut	VERB
iajs-3606	55	20	-	-	PUNCT
iajs-3606	55	21	off	off	ADP
iajs-3606	55	22	value	value	NOUN
iajs-3606	55	23	can	can	AUX
iajs-3606	55	24	be	be	AUX
iajs-3606	55	25	used	use	VERB
iajs-3606	55	26	to	to	PART
iajs-3606	55	27	turn	turn	VERB
iajs-3606	55	28	the	the	DET
iajs-3606	55	29	optical	optical	ADJ
iajs-3606	55	30	density	density	NOUN
iajs-3606	55	31	into	into	ADP
iajs-3606	55	32	negative	negative	ADJ
iajs-3606	55	33	and	and	CCONJ
iajs-3606	55	34	positive	positive	ADJ
iajs-3606	55	35	results	result	NOUN
iajs-3606	55	36	for	for	ADP
iajs-3606	55	37	igg	igg	PROPN
iajs-3606	55	38	antibodies	antibody	NOUN
iajs-3606	55	39	against	against	ADP
iajs-3606	55	40	the	the	DET
iajs-3606	55	41	sars	sar	NOUN
iajs-3606	55	42	-	-	PUNCT
iajs-3606	55	43	cov-2	cov-2	NOUN
iajs-3606	55	44	virus	virus	NOUN
iajs-3606	55	45	.	.	PUNCT
iajs-3606	56	1	spss	spss	PROPN
iajs-3606	56	2	version	version	PROPN
iajs-3606	56	3	28	28	NUM
iajs-3606	56	4	carried	carry	VERB
iajs-3606	56	5	out	out	ADP
iajs-3606	56	6	the	the	DET
iajs-3606	56	7	data	datum	NOUN
iajs-3606	56	8	analysis	analysis	NOUN
iajs-3606	56	9	.	.	PUNCT
iajs-3606	57	1	statistical	statistical	ADJ
iajs-3606	57	2	significance	significance	NOUN
iajs-3606	57	3	was	be	AUX
iajs-3606	57	4	considered	consider	VERB
iajs-3606	57	5	whenever	whenever	SCONJ
iajs-3606	57	6	the	the	DET
iajs-3606	57	7	p	p	NOUN
iajs-3606	57	8	value	value	NOUN
iajs-3606	57	9	was	be	AUX
iajs-3606	57	10	equal	equal	ADJ
iajs-3606	57	11	to	to	ADP
iajs-3606	57	12	or	or	CCONJ
iajs-3606	57	13	less	less	ADJ
iajs-3606	57	14	than	than	ADP
iajs-3606	57	15	0.05	0.05	NUM
iajs-3606	57	16	.	.	PUNCT
iajs-3606	58	1	3	3	NUM
iajs-3606	58	2	.	.	NOUN
iajs-3606	58	3	results	result	VERB
iajs-3606	58	4	the	the	DET
iajs-3606	58	5	results	result	NOUN
iajs-3606	58	6	of	of	ADP
iajs-3606	58	7	table	table	NOUN
iajs-3606	58	8	1	1	NUM
iajs-3606	58	9	showed	show	VERB
iajs-3606	58	10	that	that	SCONJ
iajs-3606	58	11	the	the	DET
iajs-3606	58	12	highest	high	ADJ
iajs-3606	58	13	mean±sd	mean±sd	ADP
iajs-3606	58	14	of	of	ADP
iajs-3606	58	15	pfizer	pfizer	NOUN
iajs-3606	58	16	vaccinators	vaccinator	NOUN
iajs-3606	58	17	were	be	AUX
iajs-3606	58	18	among	among	ADP
iajs-3606	58	19	the	the	DET
iajs-3606	58	20	study	study	NOUN
iajs-3606	58	21	participants	participant	NOUN
iajs-3606	58	22	from	from	ADP
iajs-3606	58	23	(	(	PUNCT
iajs-3606	58	24	baquba	baquba	PROPN
iajs-3606	58	25	,	,	PUNCT
iajs-3606	58	26	al	al	PROPN
iajs-3606	58	27	-	-	PUNCT
iajs-3606	58	28	khalis	khalis	PROPN
iajs-3606	58	29	,	,	PUNCT
iajs-3606	58	30	khanaqin	khanaqin	ADJ
iajs-3606	58	31	,	,	PUNCT
iajs-3606	58	32	and	and	CCONJ
iajs-3606	58	33	muqdadiya	muqdadiya	NOUN
iajs-3606	58	34	)	)	PUNCT
iajs-3606	58	35	with	with	ADP
iajs-3606	58	36	a	a	DET
iajs-3606	58	37	non	non	ADJ
iajs-3606	58	38	-	-	ADJ
iajs-3606	58	39	significant	significant	ADJ
iajs-3606	58	40	statistical	statistical	ADJ
iajs-3606	58	41	difference	difference	NOUN
iajs-3606	58	42	(	(	PUNCT
iajs-3606	58	43	p	p	NOUN
iajs-3606	58	44	=	=	NOUN
iajs-3606	58	45	0.474	0.474	NUM
iajs-3606	58	46	)	)	PUNCT
iajs-3606	58	47	,	,	PUNCT
iajs-3606	58	48	while	while	SCONJ
iajs-3606	58	49	the	the	DET
iajs-3606	58	50	mean±sd	mean±sd	PROPN
iajs-3606	58	51	of	of	ADP
iajs-3606	58	52	the	the	DET
iajs-3606	58	53	sinopharm	sinopharm	NOUN
iajs-3606	58	54	vaccinators	vaccinator	NOUN
iajs-3606	58	55	were	be	AUX
iajs-3606	58	56	higher	high	ADJ
iajs-3606	58	57	among	among	ADP
iajs-3606	58	58	the	the	DET
iajs-3606	58	59	residents	resident	NOUN
iajs-3606	58	60	of	of	ADP
iajs-3606	58	61	the	the	DET
iajs-3606	58	62	city	city	NOUN
iajs-3606	58	63	of	of	ADP
iajs-3606	58	64	khalis	khalis	PROPN
iajs-3606	58	65	and	and	CCONJ
iajs-3606	58	66	baquba	baquba	PROPN
iajs-3606	58	67	,	,	PUNCT
iajs-3606	58	68	with	with	ADP
iajs-3606	58	69	a	a	DET
iajs-3606	58	70	statistically	statistically	ADV
iajs-3606	58	71	significant	significant	ADJ
iajs-3606	58	72	difference	difference	NOUN
iajs-3606	58	73	(	(	PUNCT
iajs-3606	58	74	043.p	043.p	NOUN
iajs-3606	58	75	=	=	NOUN
iajs-3606	58	76	0	0	NUM
iajs-3606	58	77	)	)	PUNCT
iajs-3606	58	78	.	.	PUNCT
iajs-3606	59	1	the	the	DET
iajs-3606	59	2	current	current	ADJ
iajs-3606	59	3	study	study	NOUN
iajs-3606	59	4	also	also	ADV
iajs-3606	59	5	revealed	reveal	VERB
iajs-3606	59	6	that	that	SCONJ
iajs-3606	59	7	the	the	DET
iajs-3606	59	8	antibodies	antibody	NOUN
iajs-3606	59	9	under	under	ADP
iajs-3606	59	10	study	study	NOUN
iajs-3606	59	11	had	have	VERB
iajs-3606	59	12	the	the	DET
iajs-3606	59	13	highest	high	ADJ
iajs-3606	59	14	mean	mean	NOUN
iajs-3606	59	15	sd	sd	ADP
iajs-3606	59	16	concentrations	concentration	NOUN
iajs-3606	59	17	among	among	ADP
iajs-3606	59	18	the	the	DET
iajs-3606	59	19	retired	retire	VERB
iajs-3606	59	20	and	and	CCONJ
iajs-3606	59	21	for	for	ADP
iajs-3606	59	22	both	both	DET
iajs-3606	59	23	vaccines	vaccine	NOUN
iajs-3606	59	24	,	,	PUNCT
iajs-3606	59	25	with	with	ADP
iajs-3606	59	26	a	a	DET
iajs-3606	59	27	statistically	statistically	ADV
iajs-3606	59	28	significant	significant	ADJ
iajs-3606	59	29	difference	difference	NOUN
iajs-3606	59	30	(	(	PUNCT
iajs-3606	59	31	p	p	NOUN
iajs-3606	59	32	=	=	NOUN
iajs-3606	59	33	0.0001	0.0001	NUM
iajs-3606	59	34	)	)	PUNCT
iajs-3606	59	35	for	for	ADP
iajs-3606	59	36	pfizer	pfizer	NOUN
iajs-3606	59	37	and	and	CCONJ
iajs-3606	59	38	a	a	DET
iajs-3606	59	39	non	non	ADJ
iajs-3606	59	40	-	-	ADJ
iajs-3606	59	41	significant	significant	ADJ
iajs-3606	59	42	difference	difference	NOUN
iajs-3606	59	43	(	(	PUNCT
iajs-3606	59	44	p	p	NOUN
iajs-3606	59	45	=	=	NOUN
iajs-3606	59	46	0.234	0.234	NUM
iajs-3606	59	47	)	)	PUNCT
iajs-3606	59	48	for	for	ADP
iajs-3606	59	49	sinopharm	sinopharm	NOUN
iajs-3606	59	50	.	.	PUNCT
iajs-3606	60	1	table	table	NOUN
iajs-3606	60	2	1	1	NUM
iajs-3606	60	3	.	.	PUNCT
iajs-3606	61	1	the	the	DET
iajs-3606	61	2	effect	effect	NOUN
iajs-3606	61	3	of	of	ADP
iajs-3606	61	4	residence	residence	NOUN
iajs-3606	61	5	and	and	CCONJ
iajs-3606	61	6	occupation	occupation	NOUN
iajs-3606	61	7	variables	variable	NOUN
iajs-3606	61	8	on	on	ADP
iajs-3606	61	9	the	the	DET
iajs-3606	61	10	mean±sd	mean±sd	PROPN
iajs-3606	61	11	of	of	ADP
iajs-3606	61	12	antibody	antibody	NOUN
iajs-3606	61	13	concentration	concentration	NOUN
iajs-3606	61	14	.	.	PUNCT
iajs-3606	62	1	variables	variable	NOUN
iajs-3606	62	2	titer	titer	NOUN
iajs-3606	62	3	of	of	ADP
iajs-3606	62	4	ab	ab	PROPN
iajs-3606	62	5	concentration(iu\ml	concentration(iu\ml	PROPN
iajs-3606	62	6	)	)	PUNCT
iajs-3606	62	7	p	p	NOUN
iajs-3606	62	8	value	value	NOUN
iajs-3606	62	9	pfizer	pfizer	NOUN
iajs-3606	62	10	sinopharm	sinopharm	VERB
iajs-3606	62	11	no	no	INTJ
iajs-3606	62	12	mean±sd	mean±sd	ADP
iajs-3606	62	13	no	no	PRON
iajs-3606	62	14	mean±sd	mean±sd	PROPN
iajs-3606	62	15	residence	residence	NOUN
iajs-3606	62	16	baquba	baquba	PROPN
iajs-3606	62	17	172	172	NUM
iajs-3606	62	18	68.21±2641	68.21±2641	NUM
iajs-3606	62	19	.	.	PROPN
iajs-3606	62	20	50	50	NUM
iajs-3606	62	21	58.36±19.44	58.36±19.44	NUM
iajs-3606	62	22	0015	0015	NUM
iajs-3606	62	23	.	.	PUNCT
iajs-3606	63	1	#	#	NOUN
iajs-3606	63	2	khalis	khalis	NOUN
iajs-3606	63	3	20	20	NUM
iajs-3606	63	4	63.97	63.97	NUM
iajs-3606	63	5	±21.86	±21.86	PROPN
iajs-3606	63	6	5	5	NUM
iajs-3606	63	7	33.88±	33.88±	NUM
iajs-3606	63	8	25.65	25.65	NUM
iajs-3606	63	9	0014	0014	NUM
iajs-3606	63	10	.	.	PUNCT
iajs-3606	64	1	#	#	NOUN
iajs-3606	64	2	mukdadia	mukdadia	NOUN
iajs-3606	64	3	11	11	NUM
iajs-3606	64	4	56.24±	56.24±	NUM
iajs-3606	64	5	19.89	19.89	NUM
iajs-3606	64	6	akhanaqin	akhanaqin	ADJ
iajs-3606	64	7	2	2	NUM
iajs-3606	64	8	78.55±28.21	78.55±28.21	NUM
iajs-3606	64	9	3	3	NUM
iajs-3606	64	10	44.83±5.62	44.83±5.62	NUM
iajs-3606	64	11	0.117	0.117	NUM
iajs-3606	64	12	mendyli	mendyli	NOUN
iajs-3606	64	13	2	2	NUM
iajs-3606	64	14	53.60±1.56	53.60±1.56	NUM
iajs-3606	64	15	1	1	NUM
iajs-3606	64	16	39.20±	39.20±	NUM
iajs-3606	64	17	0.084	0.084	NUM
iajs-3606	64	18	p	p	NOUN
iajs-3606	64	19	value	value	NOUN
iajs-3606	64	20	0.474	0.474	NUM
iajs-3606	64	21	0.043^	0.043^	NOUN
iajs-3606	64	22	occupation	occupation	NOUN
iajs-3606	64	23	student	student	NOUN
iajs-3606	64	24	24	24	NUM
iajs-3606	64	25	5378	5378	NUM
iajs-3606	64	26	.	.	PUNCT
iajs-3606	65	1	±969	±969	NOUN
iajs-3606	65	2	.	.	PUNCT
iajs-3606	66	1	9	9	NUM
iajs-3606	66	2	4650	4650	NUM
iajs-3606	66	3	.	.	PUNCT
iajs-3606	67	1	±12.28	±12.28	NOUN
iajs-3606	67	2	0.084	0.084	NUM
iajs-3606	67	3	clerk	clerk	NOUN
iajs-3606	67	4	63	63	NUM
iajs-3606	67	5	61.52±25.06	61.52±25.06	NUM
iajs-3606	67	6	21	21	NUM
iajs-3606	67	7	5462	5462	NUM
iajs-3606	67	8	.	.	PUNCT
iajs-3606	68	1	±	±	NOUN
iajs-3606	68	2	22.73	22.73	NUM
iajs-3606	68	3	0.267	0.267	NUM
iajs-3606	68	4	worker	worker	NOUN
iajs-3606	68	5	22	22	NUM
iajs-3606	68	6	68.74±22.53	68.74±22.53	NOUN
iajs-3606	68	7	11	11	NUM
iajs-3606	68	8	52.31±20.70	52.31±20.70	NUM
iajs-3606	68	9	0.051	0.051	NUM
iajs-3606	68	10	military	military	NOUN
iajs-3606	68	11	23	23	NUM
iajs-3606	68	12	65.66±	65.66±	NUM
iajs-3606	68	13	25.44	25.44	NUM
iajs-3606	68	14	3	3	NUM
iajs-3606	68	15	55.17±0.98	55.17±0.98	NUM
iajs-3606	68	16	0489	0489	NUM
iajs-3606	68	17	.	.	PUNCT
iajs-3606	69	1	housekeeper	housekeeper	NOUN
iajs-3606	69	2	59	59	NUM
iajs-3606	69	3	73.17±	73.17±	NUM
iajs-3606	69	4	26.63	26.63	NUM
iajs-3606	69	5	11	11	NUM
iajs-3606	69	6	58.62±19.45	58.62±19.45	NUM
iajs-3606	69	7	0.089	0.089	NUM
iajs-3606	69	8	retired	retire	VERB
iajs-3606	69	9	16	16	NUM
iajs-3606	69	10	8673	8673	NUM
iajs-3606	69	11	.	.	PUNCT
iajs-3606	70	1	±30.17	±30.17	NOUN
iajs-3606	70	2	4	4	NUM
iajs-3606	70	3	7747.±26.22	7747.±26.22	NUM
iajs-3606	70	4	0.582	0.582	NUM
iajs-3606	70	5	p	p	NOUN
iajs-3606	70	6	value	value	NOUN
iajs-3606	70	7	0.0001^	0.0001^	NOUN
iajs-3606	70	8	0.234	0.234	NUM
iajs-3606	70	9	^significant	^significant	ADJ
iajs-3606	70	10	difference	difference	NOUN
iajs-3606	70	11	among	among	ADP
iajs-3606	70	12	more	more	ADJ
iajs-3606	70	13	than	than	ADP
iajs-3606	70	14	two	two	NUM
iajs-3606	70	15	independent	independent	ADJ
iajs-3606	70	16	means	mean	NOUN
iajs-3606	70	17	using	use	VERB
iajs-3606	70	18	fisher	fisher	PROPN
iajs-3606	70	19	's	's	PART
iajs-3606	70	20	exact	exact	ADJ
iajs-3606	70	21	test	test	NOUN
iajs-3606	70	22	and	and	CCONJ
iajs-3606	70	23	anova	anova	PROPN
iajs-3606	70	24	-	-	NOUN
iajs-3606	70	25	test	test	NOUN
iajs-3606	70	26	and	and	CCONJ
iajs-3606	70	27	at	at	ADP
iajs-3606	70	28	0.05	0.05	NUM
iajs-3606	70	29	ihjpas	ihjpa	NOUN
iajs-3606	70	30	.	.	PUNCT
iajs-3606	71	1	2025	2025	NUM
iajs-3606	71	2	,	,	PUNCT
iajs-3606	71	3	38	38	NUM
iajs-3606	71	4	(	(	PUNCT
iajs-3606	71	5	1	1	NUM
iajs-3606	71	6	)	)	PUNCT
iajs-3606	71	7	114	114	NUM
iajs-3606	71	8	table	table	NOUN
iajs-3606	71	9	2	2	NUM
iajs-3606	71	10	displays	display	VERB
iajs-3606	71	11	the	the	DET
iajs-3606	71	12	mean	mean	ADJ
iajs-3606	71	13	standard	standard	ADJ
iajs-3606	71	14	deviation	deviation	NOUN
iajs-3606	71	15	and	and	CCONJ
iajs-3606	71	16	standard	standard	ADJ
iajs-3606	71	17	deviation	deviation	NOUN
iajs-3606	71	18	of	of	ADP
iajs-3606	71	19	study	study	NOUN
iajs-3606	71	20	participants	participant	NOUN
iajs-3606	71	21	who	who	PRON
iajs-3606	71	22	received	receive	VERB
iajs-3606	71	23	vaccinations	vaccination	NOUN
iajs-3606	71	24	from	from	ADP
iajs-3606	71	25	pfizer	pfizer	NOUN
iajs-3606	71	26	and	and	CCONJ
iajs-3606	71	27	sinopharm	sinopharm	NOUN
iajs-3606	71	28	for	for	ADP
iajs-3606	71	29	pregnancy	pregnancy	NOUN
iajs-3606	71	30	,	,	PUNCT
iajs-3606	71	31	with	with	ADP
iajs-3606	71	32	the	the	DET
iajs-3606	71	33	pfizer	pfizer	NOUN
iajs-3606	71	34	vaccine	vaccine	NOUN
iajs-3606	71	35	showing	show	VERB
iajs-3606	71	36	the	the	DET
iajs-3606	71	37	highest	high	ADJ
iajs-3606	71	38	mean	mean	ADJ
iajs-3606	71	39	standard	standard	ADJ
iajs-3606	71	40	deviation	deviation	NOUN
iajs-3606	71	41	for	for	ADP
iajs-3606	71	42	pregnant	pregnant	ADJ
iajs-3606	71	43	women	woman	NOUN
iajs-3606	71	44	.	.	PUNCT
iajs-3606	72	1	however	however	ADV
iajs-3606	72	2	,	,	PUNCT
iajs-3606	72	3	the	the	DET
iajs-3606	72	4	statistical	statistical	ADJ
iajs-3606	72	5	difference	difference	NOUN
iajs-3606	72	6	was	be	AUX
iajs-3606	72	7	not	not	PART
iajs-3606	72	8	significant	significant	ADJ
iajs-3606	72	9	(	(	PUNCT
iajs-3606	72	10	0.518	0.518	NUM
iajs-3606	72	11	)	)	PUNCT
iajs-3606	72	12	.	.	PUNCT
iajs-3606	73	1	for	for	ADP
iajs-3606	73	2	each	each	DET
iajs-3606	73	3	weight	weight	NOUN
iajs-3606	73	4	group	group	NOUN
iajs-3606	73	5	,	,	PUNCT
iajs-3606	73	6	the	the	DET
iajs-3606	73	7	table	table	NOUN
iajs-3606	73	8	also	also	ADV
iajs-3606	73	9	displayed	display	VERB
iajs-3606	73	10	the	the	DET
iajs-3606	73	11	mean	mean	ADJ
iajs-3606	73	12	,	,	PUNCT
iajs-3606	73	13	standard	standard	ADJ
iajs-3606	73	14	deviation	deviation	NOUN
iajs-3606	73	15	,	,	PUNCT
iajs-3606	73	16	and	and	CCONJ
iajs-3606	73	17	titer	titer	NOUN
iajs-3606	73	18	of	of	ADP
iajs-3606	73	19	ab	ab	PROPN
iajs-3606	73	20	concentration	concentration	NOUN
iajs-3606	73	21	in	in	ADP
iajs-3606	73	22	participants	participant	NOUN
iajs-3606	73	23	vaccinated	vaccinate	VERB
iajs-3606	73	24	with	with	ADP
iajs-3606	73	25	pfizer	pfizer	NOUN
iajs-3606	73	26	and	and	CCONJ
iajs-3606	73	27	sinopharm	sinopharm	NOUN
iajs-3606	73	28	.	.	PUNCT
iajs-3606	74	1	the	the	DET
iajs-3606	74	2	participants	participant	NOUN
iajs-3606	74	3	vaccinated	vaccinate	VERB
iajs-3606	74	4	with	with	ADP
iajs-3606	74	5	the	the	DET
iajs-3606	74	6	pfizer	pfizer	NOUN
iajs-3606	74	7	vaccine	vaccine	NOUN
iajs-3606	74	8	,	,	PUNCT
iajs-3606	74	9	whose	whose	DET
iajs-3606	74	10	weight	weight	NOUN
iajs-3606	74	11	mass	mass	NOUN
iajs-3606	74	12	exceeded	exceed	VERB
iajs-3606	74	13	30	30	NUM
iajs-3606	74	14	,	,	PUNCT
iajs-3606	74	15	had	have	VERB
iajs-3606	74	16	the	the	DET
iajs-3606	74	17	highest	high	ADJ
iajs-3606	74	18	mean	mean	ADJ
iajs-3606	74	19	and	and	CCONJ
iajs-3606	74	20	standard	standard	ADJ
iajs-3606	74	21	deviation	deviation	NOUN
iajs-3606	74	22	,	,	PUNCT
iajs-3606	74	23	indicating	indicate	VERB
iajs-3606	74	24	a	a	DET
iajs-3606	74	25	non	non	ADJ
iajs-3606	74	26	-	-	ADJ
iajs-3606	74	27	significant	significant	ADJ
iajs-3606	74	28	statistical	statistical	ADJ
iajs-3606	74	29	difference	difference	NOUN
iajs-3606	74	30	(	(	PUNCT
iajs-3606	74	31	p	p	NOUN
iajs-3606	74	32	=	=	NOUN
iajs-3606	74	33	0.077	0.077	NUM
iajs-3606	74	34	)	)	PUNCT
iajs-3606	74	35	.	.	PUNCT
iajs-3606	75	1	table	table	NOUN
iajs-3606	75	2	2	2	NUM
iajs-3606	75	3	.	.	PUNCT
iajs-3606	76	1	the	the	DET
iajs-3606	76	2	effect	effect	NOUN
iajs-3606	76	3	of	of	ADP
iajs-3606	76	4	pregnancy	pregnancy	NOUN
iajs-3606	76	5	and	and	CCONJ
iajs-3606	76	6	weight	weight	NOUN
iajs-3606	76	7	-	-	PUNCT
iajs-3606	76	8	mass	mass	NOUN
iajs-3606	76	9	index	index	NOUN
iajs-3606	76	10	with	with	ADP
iajs-3606	76	11	the	the	DET
iajs-3606	76	12	mean±sd	mean±sd	PROPN
iajs-3606	76	13	antibody	antibody	NOUN
iajs-3606	76	14	concentration	concentration	NOUN
iajs-3606	76	15	after	after	ADP
iajs-3606	76	16	vaccination	vaccination	NOUN
iajs-3606	76	17	.	.	PUNCT
iajs-3606	77	1	variables	variable	NOUN
iajs-3606	77	2	titer	titer	NOUN
iajs-3606	77	3	of	of	ADP
iajs-3606	77	4	ab	ab	PROPN
iajs-3606	77	5	concentration(iu\ml	concentration(iu\ml	PROPN
iajs-3606	77	6	)	)	PUNCT
iajs-3606	77	7	p	p	NOUN
iajs-3606	77	8	value	value	NOUN
iajs-3606	77	9	pfizer	pfizer	NOUN
iajs-3606	77	10	sinopharm	sinopharm	VERB
iajs-3606	77	11	no	no	INTJ
iajs-3606	77	12	mean±sd	mean±sd	ADP
iajs-3606	77	13	no	no	PRON
iajs-3606	77	14	mean±sd	mean±sd	ADP
iajs-3606	77	15	pregnant	pregnant	ADJ
iajs-3606	77	16	pregnant	pregnant	ADJ
iajs-3606	77	17	12	12	NUM
iajs-3606	77	18	7750	7750	NUM
iajs-3606	77	19	.	.	PUNCT
iajs-3606	78	1	±26.79	±26.79	DET
iajs-3606	78	2	3	3	NUM
iajs-3606	78	3	6117	6117	NUM
iajs-3606	78	4	.	.	PUNCT
iajs-3606	79	1	±12.11	±12.11	VERB
iajs-3606	79	2	0.332	0.332	NUM
iajs-3606	79	3	not	not	PART
iajs-3606	79	4	pregnant	pregnant	ADJ
iajs-3606	79	5	93	93	NUM
iajs-3606	79	6	6633	6633	NUM
iajs-3606	79	7	.	.	PUNCT
iajs-3606	80	1	±25.83	±25.83	ADV
iajs-3606	80	2	23	23	NUM
iajs-3606	80	3	5327	5327	NUM
iajs-3606	80	4	.	.	PUNCT
iajs-3606	81	1	±2014	±2014	PROPN
iajs-3606	81	2	.	.	PUNCT
iajs-3606	82	1	0.026	0.026	NUM
iajs-3606	82	2	p	p	NOUN
iajs-3606	82	3	value	value	NOUN
iajs-3606	82	4	0.163	0.163	NUM
iajs-3606	82	5	0.518	0.518	NUM
iajs-3606	82	6	bmi	bmi	NOUN
iajs-3606	82	7	(	(	PUNCT
iajs-3606	82	8	18.5	18.5	NUM
iajs-3606	82	9	-	-	SYM
iajs-3606	82	10	249	249	NUM
iajs-3606	82	11	.	.	PUNCT
iajs-3606	82	12	)	)	PUNCT
iajs-3606	83	1	62	62	NUM
iajs-3606	83	2	6123	6123	NUM
iajs-3606	83	3	.	.	PUNCT
iajs-3606	84	1	±23.30	±23.30	VERB
iajs-3606	84	2	15	15	NUM
iajs-3606	84	3	50.97±9.31	50.97±9.31	NUM
iajs-3606	84	4	0.100	0.100	NUM
iajs-3606	84	5	(	(	PUNCT
iajs-3606	84	6	25	25	NUM
iajs-3606	84	7	-	-	SYM
iajs-3606	84	8	29.9	29.9	NUM
iajs-3606	84	9	)	)	PUNCT
iajs-3606	84	10	78	78	NUM
iajs-3606	85	1	68.32±	68.32±	NUM
iajs-3606	85	2	26.22	26.22	NUM
iajs-3606	85	3	24	24	NUM
iajs-3606	85	4	60.71±21	60.71±21	NUM
iajs-3606	85	5	.	.	PUNCT
iajs-3606	86	1	73	73	NUM
iajs-3606	86	2	0.200	0.200	NUM
iajs-3606	86	3	>	>	SYM
iajs-3606	86	4	30	30	NUM
iajs-3606	86	5	67	67	NUM
iajs-3606	86	6	71.17±	71.17±	NUM
iajs-3606	86	7	26.40	26.40	NUM
iajs-3606	86	8	20	20	NUM
iajs-3606	86	9	51.97±	51.97±	NUM
iajs-3606	86	10	24.37	24.37	NUM
iajs-3606	86	11	0.005	0.005	NUM
iajs-3606	86	12	#	#	NOUN
iajs-3606	86	13	p	p	NOUN
iajs-3606	86	14	value	value	NOUN
iajs-3606	86	15	0.077	0.077	NUM
iajs-3606	86	16	0.245	0.245	NUM
iajs-3606	86	17	#	#	NOUN
iajs-3606	86	18	significant	significant	ADJ
iajs-3606	86	19	difference	difference	NOUN
iajs-3606	86	20	between	between	ADP
iajs-3606	86	21	two	two	NUM
iajs-3606	86	22	independent	independent	ADJ
iajs-3606	86	23	means	mean	NOUN
iajs-3606	86	24	using	use	VERB
iajs-3606	86	25	students	student	NOUN
iajs-3606	86	26	-	-	PUNCT
iajs-3606	86	27	t	t	NOUN
iajs-3606	86	28	-	-	PUNCT
iajs-3606	86	29	test	test	NOUN
iajs-3606	86	30	at	at	ADP
iajs-3606	86	31	0.05	0.05	NUM
iajs-3606	86	32	level	level	NOUN
iajs-3606	86	33	.	.	PUNCT
iajs-3606	87	1	table	table	NOUN
iajs-3606	87	2	3	3	NUM
iajs-3606	87	3	showed	show	VERB
iajs-3606	87	4	the	the	DET
iajs-3606	87	5	differences	difference	NOUN
iajs-3606	87	6	in	in	ADP
iajs-3606	87	7	mean±sd	mean±sd	ADP
iajs-3606	87	8	of	of	ADP
iajs-3606	87	9	the	the	DET
iajs-3606	87	10	antibody	antibody	NOUN
iajs-3606	87	11	titer	titer	NOUN
iajs-3606	87	12	of	of	ADP
iajs-3606	87	13	the	the	DET
iajs-3606	87	14	participants	participant	NOUN
iajs-3606	87	15	and	and	CCONJ
iajs-3606	87	16	blood	blood	NOUN
iajs-3606	87	17	groups	group	NOUN
iajs-3606	87	18	,	,	PUNCT
iajs-3606	87	19	where	where	SCONJ
iajs-3606	87	20	the	the	DET
iajs-3606	87	21	highest	high	ADJ
iajs-3606	87	22	mean	mean	ADJ
iajs-3606	87	23	and	and	CCONJ
iajs-3606	87	24	standard	standard	ADJ
iajs-3606	87	25	deviation	deviation	NOUN
iajs-3606	87	26	of	of	ADP
iajs-3606	87	27	titer	titer	NOUN
iajs-3606	87	28	of	of	ADP
iajs-3606	87	29	ab	ab	PROPN
iajs-3606	87	30	concentration	concentration	NOUN
iajs-3606	87	31	were	be	AUX
iajs-3606	87	32	among	among	ADP
iajs-3606	87	33	pfizer	pfizer	NOUN
iajs-3606	87	34	vaccinators	vaccinator	NOUN
iajs-3606	87	35	with	with	ADP
iajs-3606	87	36	blood	blood	NOUN
iajs-3606	87	37	type	type	NOUN
iajs-3606	87	38	ab	ab	PROPN
iajs-3606	87	39	.	.	PUNCT
iajs-3606	88	1	however	however	ADV
iajs-3606	88	2	,	,	PUNCT
iajs-3606	88	3	the	the	DET
iajs-3606	88	4	statistical	statistical	ADJ
iajs-3606	88	5	difference	difference	NOUN
iajs-3606	88	6	was	be	AUX
iajs-3606	88	7	not	not	PART
iajs-3606	88	8	significant	significant	ADJ
iajs-3606	88	9	(	(	PUNCT
iajs-3606	88	10	p	p	X
iajs-3606	88	11	=	=	NOUN
iajs-3606	88	12	0.474	0.474	NUM
iajs-3606	88	13	)	)	PUNCT
iajs-3606	88	14	.	.	PUNCT
iajs-3606	89	1	the	the	DET
iajs-3606	89	2	table	table	NOUN
iajs-3606	89	3	's	's	PART
iajs-3606	89	4	results	result	NOUN
iajs-3606	89	5	also	also	ADV
iajs-3606	89	6	revealed	reveal	VERB
iajs-3606	89	7	the	the	DET
iajs-3606	89	8	average	average	ADJ
iajs-3606	89	9	and	and	CCONJ
iajs-3606	89	10	standard	standard	ADJ
iajs-3606	89	11	deviation	deviation	NOUN
iajs-3606	89	12	of	of	ADP
iajs-3606	89	13	the	the	DET
iajs-3606	89	14	rhesus	rhesus	NOUN
iajs-3606	89	15	factorvaccinated	factorvaccinate	VERB
iajs-3606	89	16	participants	participant	NOUN
iajs-3606	89	17	,	,	PUNCT
iajs-3606	89	18	indicating	indicate	VERB
iajs-3606	89	19	that	that	SCONJ
iajs-3606	89	20	those	those	PRON
iajs-3606	89	21	who	who	PRON
iajs-3606	89	22	received	receive	VERB
iajs-3606	89	23	pfizer	pfizer	NOUN
iajs-3606	89	24	's	's	PART
iajs-3606	89	25	vaccine	vaccine	NOUN
iajs-3606	89	26	with	with	ADP
iajs-3606	89	27	a	a	DET
iajs-3606	89	28	positive	positive	ADJ
iajs-3606	89	29	rhesus	rhesus	NOUN
iajs-3606	89	30	factor	factor	NOUN
iajs-3606	89	31	had	have	VERB
iajs-3606	89	32	the	the	DET
iajs-3606	89	33	highest	high	ADJ
iajs-3606	89	34	titer	titer	NOUN
iajs-3606	89	35	of	of	ADP
iajs-3606	89	36	ab	ab	PROPN
iajs-3606	89	37	concentration	concentration	NOUN
iajs-3606	89	38	.	.	PUNCT
iajs-3606	90	1	consequently	consequently	ADV
iajs-3606	90	2	,	,	PUNCT
iajs-3606	90	3	the	the	DET
iajs-3606	90	4	statistical	statistical	ADJ
iajs-3606	90	5	difference	difference	NOUN
iajs-3606	90	6	for	for	ADP
iajs-3606	90	7	the	the	DET
iajs-3606	90	8	same	same	ADJ
iajs-3606	90	9	vaccine	vaccine	NOUN
iajs-3606	90	10	was	be	AUX
iajs-3606	90	11	not	not	PART
iajs-3606	90	12	significant	significant	ADJ
iajs-3606	90	13	(	(	PUNCT
iajs-3606	90	14	p	p	X
iajs-3606	90	15	=	=	NOUN
iajs-3606	90	16	0.867	0.867	NUM
iajs-3606	90	17	)	)	PUNCT
iajs-3606	90	18	.	.	PUNCT
iajs-3606	91	1	table	table	NOUN
iajs-3606	91	2	3	3	NUM
iajs-3606	91	3	.	.	PUNCT
iajs-3606	92	1	the	the	DET
iajs-3606	92	2	effect	effect	NOUN
iajs-3606	92	3	of	of	ADP
iajs-3606	92	4	blood	blood	NOUN
iajs-3606	92	5	group	group	NOUN
iajs-3606	92	6	variables	variable	NOUN
iajs-3606	92	7	and	and	CCONJ
iajs-3606	92	8	the	the	DET
iajs-3606	92	9	rhesus	rhesus	NOUN
iajs-3606	92	10	factor	factor	NOUN
iajs-3606	92	11	mean±sd	mean±sd	ADP
iajs-3606	92	12	on	on	ADP
iajs-3606	92	13	antibody	antibody	NOUN
iajs-3606	92	14	concentration	concentration	NOUN
iajs-3606	92	15	.	.	PUNCT
iajs-3606	93	1	variables	variable	NOUN
iajs-3606	93	2	titer	titer	NOUN
iajs-3606	93	3	of	of	ADP
iajs-3606	93	4	ab	ab	PROPN
iajs-3606	93	5	concentration	concentration	NOUN
iajs-3606	93	6	p	p	PROPN
iajs-3606	93	7	value	value	NOUN
iajs-3606	93	8	pfizer	pfizer	NOUN
iajs-3606	93	9	sinopharm	sinopharm	VERB
iajs-3606	93	10	no	no	INTJ
iajs-3606	93	11	mean±sd	mean±sd	ADP
iajs-3606	93	12	no	no	PRON
iajs-3606	93	13	mean±sd	mean±sd	ADP
iajs-3606	93	14	a	a	DET
iajs-3606	93	15	40	40	NUM
iajs-3606	93	16	61.66±22.33	61.66±22.33	NUM
iajs-3606	93	17	16	16	NUM
iajs-3606	93	18	54.08±16.66	54.08±16.66	NUM
iajs-3606	93	19	0.225	0.225	NUM
iajs-3606	93	20	b	b	SYM
iajs-3606	93	21	41	41	NUM
iajs-3606	93	22	65.85±	65.85±	NUM
iajs-3606	93	23	24.28	24.28	NUM
iajs-3606	93	24	11	11	NUM
iajs-3606	93	25	51.05±624	51.05±624	NUM
iajs-3606	93	26	.	.	PUNCT
iajs-3606	94	1	0.052	0.052	NUM
iajs-3606	94	2	ab	ab	PROPN
iajs-3606	94	3	10	10	NUM
iajs-3606	94	4	69.55±21.73	69.55±21.73	NOUN
iajs-3606	94	5	3	3	NUM
iajs-3606	94	6	76.20±26.70	76.20±26.70	NUM
iajs-3606	94	7	0.662	0.662	NUM
iajs-3606	94	8	o	o	NOUN
iajs-3606	94	9	116	116	NUM
iajs-3606	94	10	69.24±27.40	69.24±27.40	NUM
iajs-3606	94	11	29	29	NUM
iajs-3606	94	12	55.37±2470	55.37±2470	NUM
iajs-3606	94	13	.	.	PUNCT
iajs-3606	94	14	0014	0014	NUM
iajs-3606	94	15	.	.	PUNCT
iajs-3606	95	1	#	#	NOUN
iajs-3606	95	2	p	p	NOUN
iajs-3606	95	3	value	value	NOUN
iajs-3606	95	4	0.427	0.427	NUM
iajs-3606	95	5	0.311	0.311	NUM
iajs-3606	95	6	rh+	rh+	NOUN
iajs-3606	95	7	184	184	NUM
iajs-3606	95	8	67.23±25.92	67.23±25.92	NOUN
iajs-3606	95	9	52	52	NUM
iajs-3606	95	10	54.75±21.43	54.75±21.43	NUM
iajs-3606	95	11	0002	0002	NUM
iajs-3606	95	12	.	.	PUNCT
iajs-3606	96	1	#	#	NOUN
iajs-3606	96	2	rh23	rh23	PROPN
iajs-3606	96	3	6627	6627	NUM
iajs-3606	96	4	.	.	PUNCT
iajs-3606	97	1	±23.77	±23.77	ADV
iajs-3606	97	2	7	7	NUM
iajs-3606	97	3	59.12±1312	59.12±1312	NUM
iajs-3606	97	4	.	.	PUNCT
iajs-3606	97	5	0.456	0.456	NUM
iajs-3606	97	6	p	p	NOUN
iajs-3606	97	7	value	value	NOUN
iajs-3606	97	8	0.867	0.867	NUM
iajs-3606	97	9	0.603	0.603	NUM
iajs-3606	97	10	#	#	NOUN
iajs-3606	97	11	significant	significant	ADJ
iajs-3606	97	12	difference	difference	NOUN
iajs-3606	97	13	between	between	ADP
iajs-3606	97	14	two	two	NUM
iajs-3606	97	15	independent	independent	ADJ
iajs-3606	97	16	means	mean	NOUN
iajs-3606	97	17	using	use	VERB
iajs-3606	97	18	students	student	NOUN
iajs-3606	97	19	-	-	PUNCT
iajs-3606	97	20	t	t	NOUN
iajs-3606	97	21	-	-	PUNCT
iajs-3606	97	22	test	test	NOUN
iajs-3606	97	23	at	at	ADP
iajs-3606	97	24	0.05	0.05	NUM
iajs-3606	97	25	level	level	NOUN
iajs-3606	97	26	.	.	PUNCT
iajs-3606	98	1	ihjpas	ihjpas	PROPN
iajs-3606	98	2	.	.	PUNCT
iajs-3606	99	1	2025	2025	NUM
iajs-3606	99	2	,	,	PUNCT
iajs-3606	99	3	38	38	NUM
iajs-3606	99	4	(	(	PUNCT
iajs-3606	99	5	1	1	NUM
iajs-3606	99	6	)	)	SYM
iajs-3606	99	7	115	115	NUM
iajs-3606	99	8	table	table	NOUN
iajs-3606	99	9	4	4	NUM
iajs-3606	99	10	displays	display	VERB
iajs-3606	99	11	the	the	DET
iajs-3606	99	12	mean±sd	mean±sd	PROPN
iajs-3606	99	13	titer	titer	NOUN
iajs-3606	99	14	of	of	ADP
iajs-3606	99	15	ab	ab	PROPN
iajs-3606	99	16	concentration	concentration	NOUN
iajs-3606	99	17	of	of	ADP
iajs-3606	99	18	people	people	NOUN
iajs-3606	99	19	who	who	PRON
iajs-3606	99	20	were	be	AUX
iajs-3606	99	21	vaccinated	vaccinate	VERB
iajs-3606	99	22	with	with	ADP
iajs-3606	99	23	the	the	DET
iajs-3606	99	24	pfizer	pfizer	NOUN
iajs-3606	99	25	and	and	CCONJ
iajs-3606	99	26	sinopharm	sinopharm	NOUN
iajs-3606	99	27	vaccines	vaccine	NOUN
iajs-3606	99	28	based	base	VERB
iajs-3606	99	29	on	on	ADP
iajs-3606	99	30	their	their	PRON
iajs-3606	99	31	smoking	smoking	NOUN
iajs-3606	99	32	status	status	NOUN
iajs-3606	99	33	.	.	PUNCT
iajs-3606	100	1	the	the	DET
iajs-3606	100	2	nonsmokers	nonsmoker	NOUN
iajs-3606	100	3	who	who	PRON
iajs-3606	100	4	got	get	VERB
iajs-3606	100	5	the	the	DET
iajs-3606	100	6	pfizer	pfizer	NOUN
iajs-3606	100	7	vaccine	vaccine	NOUN
iajs-3606	100	8	had	have	VERB
iajs-3606	100	9	the	the	DET
iajs-3606	100	10	highest	high	ADJ
iajs-3606	100	11	mean±sd	mean±sd	NOUN
iajs-3606	100	12	,	,	PUNCT
iajs-3606	100	13	so	so	ADV
iajs-3606	100	14	the	the	DET
iajs-3606	100	15	statistical	statistical	ADJ
iajs-3606	100	16	difference	difference	NOUN
iajs-3606	100	17	was	be	AUX
iajs-3606	100	18	not	not	PART
iajs-3606	100	19	significant	significant	ADJ
iajs-3606	100	20	(	(	PUNCT
iajs-3606	100	21	p	p	X
iajs-3606	100	22	=	=	NOUN
iajs-3606	100	23	0.944	0.944	NUM
iajs-3606	100	24	)	)	PUNCT
iajs-3606	100	25	.	.	PUNCT
iajs-3606	101	1	table	table	NOUN
iajs-3606	101	2	4	4	NUM
iajs-3606	101	3	.	.	PUNCT
iajs-3606	102	1	the	the	DET
iajs-3606	102	2	effect	effect	NOUN
iajs-3606	102	3	of	of	ADP
iajs-3606	102	4	the	the	DET
iajs-3606	102	5	smoking	smoking	NOUN
iajs-3606	102	6	mean±sd	mean±sd	ADP
iajs-3606	102	7	on	on	ADP
iajs-3606	102	8	antibody	antibody	NOUN
iajs-3606	102	9	concentration	concentration	NOUN
iajs-3606	102	10	.	.	PUNCT
iajs-3606	103	1	variables	variable	NOUN
iajs-3606	103	2	titer	titer	NOUN
iajs-3606	103	3	of	of	ADP
iajs-3606	103	4	ab	ab	PROPN
iajs-3606	103	5	concentration(iu\ml	concentration(iu\ml	PROPN
iajs-3606	103	6	)	)	PUNCT
iajs-3606	103	7	p	p	NOUN
iajs-3606	103	8	value	value	NOUN
iajs-3606	103	9	pfizer	pfizer	NOUN
iajs-3606	103	10	sinopharm	sinopharm	VERB
iajs-3606	103	11	no	no	INTJ
iajs-3606	103	12	mean±sd	mean±sd	ADP
iajs-3606	103	13	no	no	PRON
iajs-3606	103	14	mean±sd	mean±sd	NOUN
iajs-3606	103	15	smoking	smoking	NOUN
iajs-3606	103	16	yes	yes	INTJ
iajs-3606	103	17	48	48	NUM
iajs-3606	103	18	5988	5988	NUM
iajs-3606	103	19	.	.	PUNCT
iajs-3606	104	1	±18.74	±18.74	VERB
iajs-3606	104	2	15	15	NUM
iajs-3606	104	3	59.51±15.78	59.51±15.78	NUM
iajs-3606	104	4	0944	0944	NUM
iajs-3606	104	5	.	.	PUNCT
iajs-3606	105	1	no	no	DET
iajs-3606	105	2	146	146	NUM
iajs-3606	105	3	69.30±27.05	69.30±27.05	NUM
iajs-3606	105	4	44	44	NUM
iajs-3606	105	5	5383	5383	NUM
iajs-3606	105	6	.	.	PUNCT
iajs-3606	106	1	±21.95	±21.95	NOUN
iajs-3606	106	2	0.001	0.001	NUM
iajs-3606	106	3	p	p	NOUN
iajs-3606	106	4	value	value	NOUN
iajs-3606	106	5	0.025	0.025	NUM
iajs-3606	106	6	#	#	NOUN
iajs-3606	106	7	0.361	0.361	NUM
iajs-3606	106	8	#	#	NOUN
iajs-3606	106	9	significant	significant	ADJ
iajs-3606	106	10	difference	difference	NOUN
iajs-3606	106	11	between	between	ADP
iajs-3606	106	12	two	two	NUM
iajs-3606	106	13	independent	independent	ADJ
iajs-3606	106	14	means	mean	NOUN
iajs-3606	106	15	using	use	VERB
iajs-3606	106	16	students	student	NOUN
iajs-3606	106	17	-	-	PUNCT
iajs-3606	106	18	t	t	NOUN
iajs-3606	106	19	-	-	PUNCT
iajs-3606	106	20	test	test	NOUN
iajs-3606	106	21	at	at	ADP
iajs-3606	106	22	0.05	0.05	NUM
iajs-3606	106	23	level	level	NOUN
iajs-3606	106	24	.	.	PUNCT
iajs-3606	107	1	4	4	X
iajs-3606	107	2	.	.	X
iajs-3606	107	3	discussion	discussion	NOUN
iajs-3606	107	4	the	the	DET
iajs-3606	107	5	results	result	NOUN
iajs-3606	107	6	of	of	ADP
iajs-3606	107	7	the	the	DET
iajs-3606	107	8	current	current	ADJ
iajs-3606	107	9	study	study	NOUN
iajs-3606	107	10	revealed	reveal	VERB
iajs-3606	107	11	that	that	SCONJ
iajs-3606	107	12	the	the	DET
iajs-3606	107	13	study	study	NOUN
iajs-3606	107	14	participants	participant	NOUN
iajs-3606	107	15	from	from	ADP
iajs-3606	107	16	baquba	baquba	ADJ
iajs-3606	107	17	,	,	PUNCT
iajs-3606	107	18	khalis	khalis	PROPN
iajs-3606	107	19	,	,	PUNCT
iajs-3606	107	20	khanaqin	khanaqin	NOUN
iajs-3606	107	21	,	,	PUNCT
iajs-3606	107	22	and	and	CCONJ
iajs-3606	107	23	al	al	PROPN
iajs-3606	107	24	-	-	PUNCT
iajs-3606	107	25	maqdiya	maqdiya	PROPN
iajs-3606	107	26	who	who	PRON
iajs-3606	107	27	received	receive	VERB
iajs-3606	107	28	the	the	DET
iajs-3606	107	29	pfizer	pfizer	NOUN
iajs-3606	107	30	vaccine	vaccine	NOUN
iajs-3606	107	31	had	have	VERB
iajs-3606	107	32	the	the	DET
iajs-3606	107	33	highest	high	ADJ
iajs-3606	107	34	titers	titer	NOUN
iajs-3606	107	35	of	of	ADP
iajs-3606	107	36	antibody	antibody	NOUN
iajs-3606	107	37	concentrations	concentration	NOUN
iajs-3606	107	38	,	,	PUNCT
iajs-3606	107	39	and	and	CCONJ
iajs-3606	107	40	the	the	DET
iajs-3606	107	41	statistical	statistical	ADJ
iajs-3606	107	42	difference	difference	NOUN
iajs-3606	107	43	was	be	AUX
iajs-3606	107	44	non	non	ADJ
iajs-3606	107	45	-	-	ADJ
iajs-3606	107	46	significant	significant	ADJ
iajs-3606	107	47	.	.	PUNCT
iajs-3606	108	1	as	as	ADP
iajs-3606	108	2	for	for	ADP
iajs-3606	108	3	the	the	DET
iajs-3606	108	4	sinopharm	sinopharm	NOUN
iajs-3606	108	5	vacciners	vacciner	NOUN
iajs-3606	108	6	,	,	PUNCT
iajs-3606	108	7	the	the	DET
iajs-3606	108	8	difference	difference	NOUN
iajs-3606	108	9	was	be	AUX
iajs-3606	108	10	significant	significant	ADJ
iajs-3606	108	11	for	for	ADP
iajs-3606	108	12	khalis	khalis	PROPN
iajs-3606	108	13	and	and	CCONJ
iajs-3606	108	14	baquba	baquba	PROPN
iajs-3606	108	15	.	.	PUNCT
iajs-3606	109	1	there	there	PRON
iajs-3606	109	2	are	be	VERB
iajs-3606	109	3	no	no	DET
iajs-3606	109	4	studies	study	NOUN
iajs-3606	109	5	evaluating	evaluate	VERB
iajs-3606	109	6	the	the	DET
iajs-3606	109	7	relationship	relationship	NOUN
iajs-3606	109	8	between	between	ADP
iajs-3606	109	9	residence	residence	NOUN
iajs-3606	109	10	and	and	CCONJ
iajs-3606	109	11	igg	igg	PROPN
iajs-3606	109	12	antibody	antibody	NOUN
iajs-3606	109	13	levels	level	NOUN
iajs-3606	109	14	,	,	PUNCT
iajs-3606	109	15	but	but	CCONJ
iajs-3606	109	16	it	it	PRON
iajs-3606	109	17	's	be	AUX
iajs-3606	109	18	possible	possible	ADJ
iajs-3606	109	19	that	that	SCONJ
iajs-3606	109	20	people	people	NOUN
iajs-3606	109	21	who	who	PRON
iajs-3606	109	22	live	live	VERB
iajs-3606	109	23	in	in	ADP
iajs-3606	109	24	densely	densely	ADV
iajs-3606	109	25	populated	populate	VERB
iajs-3606	109	26	areas	area	NOUN
iajs-3606	109	27	are	be	AUX
iajs-3606	109	28	susceptible	susceptible	ADJ
iajs-3606	109	29	to	to	ADP
iajs-3606	109	30	the	the	DET
iajs-3606	109	31	virus	virus	NOUN
iajs-3606	109	32	due	due	ADP
iajs-3606	109	33	to	to	ADP
iajs-3606	109	34	population	population	NOUN
iajs-3606	109	35	density	density	NOUN
iajs-3606	109	36	.	.	PUNCT
iajs-3606	110	1	furthermore	furthermore	ADV
iajs-3606	110	2	,	,	PUNCT
iajs-3606	110	3	process	process	NOUN
iajs-3606	110	4	exposure	exposure	NOUN
iajs-3606	110	5	and	and	CCONJ
iajs-3606	110	6	natural	natural	ADJ
iajs-3606	110	7	infection	infection	NOUN
iajs-3606	110	8	may	may	AUX
iajs-3606	110	9	increase	increase	VERB
iajs-3606	110	10	the	the	DET
iajs-3606	110	11	vaccine	vaccine	NOUN
iajs-3606	110	12	's	's	PART
iajs-3606	110	13	protection	protection	NOUN
iajs-3606	110	14	and	and	CCONJ
iajs-3606	110	15	efficiency	efficiency	NOUN
iajs-3606	110	16	in	in	ADP
iajs-3606	110	17	terms	term	NOUN
iajs-3606	110	18	of	of	ADP
iajs-3606	110	19	igg	igg	NOUN
iajs-3606	110	20	antibody	antibody	NOUN
iajs-3606	110	21	levels	level	NOUN
iajs-3606	110	22	.	.	PUNCT
iajs-3606	111	1	the	the	DET
iajs-3606	111	2	current	current	ADJ
iajs-3606	111	3	study	study	NOUN
iajs-3606	111	4	's	's	PART
iajs-3606	111	5	results	result	NOUN
iajs-3606	111	6	revealed	reveal	VERB
iajs-3606	111	7	a	a	DET
iajs-3606	111	8	statistically	statistically	ADV
iajs-3606	111	9	significant	significant	ADJ
iajs-3606	111	10	difference	difference	NOUN
iajs-3606	111	11	in	in	ADP
iajs-3606	111	12	antibody	antibody	NOUN
iajs-3606	111	13	titers	titer	NOUN
iajs-3606	111	14	between	between	ADP
iajs-3606	111	15	retired	retire	VERB
iajs-3606	111	16	individuals	individual	NOUN
iajs-3606	111	17	and	and	CCONJ
iajs-3606	111	18	those	those	PRON
iajs-3606	111	19	in	in	ADP
iajs-3606	111	20	other	other	ADJ
iajs-3606	111	21	studies	study	NOUN
iajs-3606	111	22	.	.	PUNCT
iajs-3606	112	1	previous	previous	ADJ
iajs-3606	112	2	research	research	NOUN
iajs-3606	112	3	on	on	ADP
iajs-3606	112	4	italian	italian	ADJ
iajs-3606	112	5	healthcare	healthcare	NOUN
iajs-3606	112	6	workers	worker	NOUN
iajs-3606	112	7	confirmed	confirm	VERB
iajs-3606	112	8	that	that	SCONJ
iajs-3606	112	9	there	there	PRON
iajs-3606	112	10	were	be	VERB
iajs-3606	112	11	no	no	DET
iajs-3606	112	12	statistically	statistically	ADV
iajs-3606	112	13	significant	significant	ADJ
iajs-3606	112	14	differences	difference	NOUN
iajs-3606	112	15	between	between	ADP
iajs-3606	112	16	health	health	NOUN
iajs-3606	112	17	workers	worker	NOUN
iajs-3606	112	18	and	and	CCONJ
iajs-3606	112	19	non	non	NOUN
iajs-3606	112	20	-	-	NOUN
iajs-3606	112	21	workers	worker	NOUN
iajs-3606	112	22	.	.	PUNCT
iajs-3606	113	1	however	however	ADV
iajs-3606	113	2	,	,	PUNCT
iajs-3606	113	3	when	when	SCONJ
iajs-3606	113	4	comparing	compare	VERB
iajs-3606	113	5	occupation	occupation	NOUN
iajs-3606	113	6	categories	category	NOUN
iajs-3606	113	7	based	base	VERB
iajs-3606	113	8	on	on	ADP
iajs-3606	113	9	risk	risk	NOUN
iajs-3606	113	10	,	,	PUNCT
iajs-3606	113	11	it	it	PRON
iajs-3606	113	12	was	be	AUX
iajs-3606	113	13	found	find	VERB
iajs-3606	113	14	that	that	SCONJ
iajs-3606	113	15	workers	worker	NOUN
iajs-3606	113	16	in	in	ADP
iajs-3606	113	17	dangerous	dangerous	ADJ
iajs-3606	113	18	jobs	job	NOUN
iajs-3606	113	19	had	have	VERB
iajs-3606	113	20	much	much	ADV
iajs-3606	113	21	higher	high	ADJ
iajs-3606	113	22	concentrations	concentration	NOUN
iajs-3606	113	23	of	of	ADP
iajs-3606	113	24	antibodies	antibody	NOUN
iajs-3606	113	25	than	than	ADP
iajs-3606	113	26	workers	worker	NOUN
iajs-3606	113	27	in	in	ADP
iajs-3606	113	28	medium	medium	ADJ
iajs-3606	113	29	or	or	CCONJ
iajs-3606	113	30	low	low	ADJ
iajs-3606	113	31	risk	risk	NOUN
iajs-3606	113	32	jobs	job	NOUN
iajs-3606	113	33	.	.	PUNCT
iajs-3606	114	1	this	this	PRON
iajs-3606	114	2	is	be	AUX
iajs-3606	114	3	not	not	PART
iajs-3606	114	4	consistent	consistent	ADJ
iajs-3606	114	5	with	with	ADP
iajs-3606	114	6	the	the	DET
iajs-3606	114	7	results	result	NOUN
iajs-3606	114	8	of	of	ADP
iajs-3606	114	9	this	this	DET
iajs-3606	114	10	study	study	NOUN
iajs-3606	114	11	(	(	PUNCT
iajs-3606	114	12	21	21	NUM
iajs-3606	114	13	)	)	PUNCT
iajs-3606	114	14	.	.	PUNCT
iajs-3606	115	1	the	the	DET
iajs-3606	115	2	protective	protective	ADJ
iajs-3606	115	3	efficacy	efficacy	NOUN
iajs-3606	115	4	of	of	ADP
iajs-3606	115	5	study	study	NOUN
iajs-3606	115	6	participants	participant	NOUN
iajs-3606	115	7	with	with	ADP
iajs-3606	115	8	sars	sar	NOUN
iajs-3606	115	9	-	-	PUNCT
iajs-3606	115	10	cov-2	cov-2	PART
iajs-3606	115	11	vaccines	vaccine	NOUN
iajs-3606	115	12	was	be	AUX
iajs-3606	115	13	moderate	moderate	ADJ
iajs-3606	115	14	compared	compare	VERB
iajs-3606	115	15	to	to	ADP
iajs-3606	115	16	other	other	ADJ
iajs-3606	115	17	studies	study	NOUN
iajs-3606	115	18	.	.	PUNCT
iajs-3606	116	1	this	this	DET
iajs-3606	116	2	study	study	NOUN
iajs-3606	116	3	reported	report	VERB
iajs-3606	116	4	a	a	DET
iajs-3606	116	5	persistent	persistent	ADJ
iajs-3606	116	6	decrease	decrease	NOUN
iajs-3606	116	7	in	in	ADP
iajs-3606	116	8	antibody	antibody	NOUN
iajs-3606	116	9	levels	level	NOUN
iajs-3606	116	10	to	to	ADP
iajs-3606	116	11	approximately	approximately	ADV
iajs-3606	116	12	40	40	NUM
iajs-3606	116	13	%	%	NOUN
iajs-3606	116	14	by	by	ADP
iajs-3606	116	15	20	20	NUM
iajs-3606	116	16	-	-	SYM
iajs-3606	116	17	34	34	NUM
iajs-3606	116	18	weeks	week	NOUN
iajs-3606	116	19	after	after	ADP
iajs-3606	116	20	the	the	DET
iajs-3606	116	21	initial	initial	ADJ
iajs-3606	116	22	vaccination	vaccination	NOUN
iajs-3606	116	23	series	series	NOUN
iajs-3606	116	24	for	for	ADP
iajs-3606	116	25	individuals	individual	NOUN
iajs-3606	116	26	who	who	PRON
iajs-3606	116	27	received	receive	VERB
iajs-3606	116	28	the	the	DET
iajs-3606	116	29	pfizer	pfizer	NOUN
iajs-3606	116	30	vaccine	vaccine	NOUN
iajs-3606	116	31	,	,	PUNCT
iajs-3606	116	32	with	with	ADP
iajs-3606	116	33	high	high	ADJ
iajs-3606	116	34	concentrations	concentration	NOUN
iajs-3606	116	35	of	of	ADP
iajs-3606	116	36	igg	igg	PROPN
iajs-3606	116	37	antibodies	antibodie	VERB
iajs-3606	116	38	ranging	range	VERB
iajs-3606	116	39	from	from	ADP
iajs-3606	116	40	81%-90	81%-90	NUM
iajs-3606	116	41	%	%	NOUN
iajs-3606	116	42	.	.	PUNCT
iajs-3606	117	1	the	the	DET
iajs-3606	117	2	second	second	ADJ
iajs-3606	117	3	dose	dose	NOUN
iajs-3606	117	4	was	be	AUX
iajs-3606	117	5	administered	administer	VERB
iajs-3606	117	6	1	1	NUM
iajs-3606	117	7	-	-	SYM
iajs-3606	117	8	5	5	NUM
iajs-3606	117	9	weeks	week	NOUN
iajs-3606	117	10	after	after	ADP
iajs-3606	117	11	the	the	DET
iajs-3606	117	12	first	first	ADJ
iajs-3606	117	13	one	one	NUM
iajs-3606	117	14	(	(	PUNCT
iajs-3606	117	15	22	22	NUM
iajs-3606	117	16	)	)	PUNCT
iajs-3606	117	17	.	.	PUNCT
iajs-3606	118	1	and	and	CCONJ
iajs-3606	118	2	this	this	PRON
iajs-3606	118	3	may	may	AUX
iajs-3606	118	4	be	be	AUX
iajs-3606	118	5	due	due	ADJ
iajs-3606	118	6	to	to	ADP
iajs-3606	118	7	the	the	DET
iajs-3606	118	8	long	long	ADJ
iajs-3606	118	9	period	period	NOUN
iajs-3606	118	10	,	,	PUNCT
iajs-3606	118	11	which	which	PRON
iajs-3606	118	12	is	be	AUX
iajs-3606	118	13	12–17	12–17	NUM
iajs-3606	118	14	months	month	NOUN
iajs-3606	118	15	after	after	ADP
iajs-3606	118	16	the	the	DET
iajs-3606	118	17	last	last	ADJ
iajs-3606	118	18	dose	dose	NOUN
iajs-3606	118	19	between	between	ADP
iajs-3606	118	20	the	the	DET
iajs-3606	118	21	time	time	NOUN
iajs-3606	118	22	of	of	ADP
iajs-3606	118	23	drawing	draw	VERB
iajs-3606	118	24	the	the	DET
iajs-3606	118	25	sample	sample	NOUN
iajs-3606	118	26	and	and	CCONJ
iajs-3606	118	27	the	the	DET
iajs-3606	118	28	date	date	NOUN
iajs-3606	118	29	of	of	ADP
iajs-3606	118	30	the	the	DET
iajs-3606	118	31	dose	dose	NOUN
iajs-3606	118	32	,	,	PUNCT
iajs-3606	118	33	or	or	CCONJ
iajs-3606	118	34	that	that	SCONJ
iajs-3606	118	35	the	the	DET
iajs-3606	118	36	iraqi	iraqi	ADJ
iajs-3606	118	37	citizens	citizen	NOUN
iajs-3606	118	38	in	in	ADP
iajs-3606	118	39	general	general	ADJ
iajs-3606	118	40	of	of	ADP
iajs-3606	118	41	diyala	diyala	PROPN
iajs-3606	118	42	province	province	NOUN
iajs-3606	118	43	in	in	ADP
iajs-3606	118	44	particular	particular	ADJ
iajs-3606	118	45	preferred	prefer	VERB
iajs-3606	118	46	to	to	PART
iajs-3606	118	47	be	be	AUX
iajs-3606	118	48	vaccinated	vaccinate	VERB
iajs-3606	118	49	with	with	ADP
iajs-3606	118	50	the	the	DET
iajs-3606	118	51	sinopharm	sinopharm	NOUN
iajs-3606	118	52	vaccine	vaccine	NOUN
iajs-3606	118	53	due	due	ADP
iajs-3606	118	54	to	to	ADP
iajs-3606	118	55	fewer	few	ADJ
iajs-3606	118	56	side	side	ADJ
iajs-3606	118	57	effects	effect	NOUN
iajs-3606	118	58	compared	compare	VERB
iajs-3606	118	59	with	with	ADP
iajs-3606	118	60	the	the	DET
iajs-3606	118	61	pfizer	pfizer	NOUN
iajs-3606	118	62	vaccine	vaccine	NOUN
iajs-3606	118	63	.	.	PUNCT
iajs-3606	119	1	table	table	NOUN
iajs-3606	119	2	2	2	NUM
iajs-3606	119	3	of	of	ADP
iajs-3606	119	4	the	the	DET
iajs-3606	119	5	current	current	ADJ
iajs-3606	119	6	study	study	NOUN
iajs-3606	119	7	revealed	reveal	VERB
iajs-3606	119	8	that	that	SCONJ
iajs-3606	119	9	pregnant	pregnant	ADJ
iajs-3606	119	10	women	woman	NOUN
iajs-3606	119	11	had	have	VERB
iajs-3606	119	12	a	a	DET
iajs-3606	119	13	higher	high	ADJ
iajs-3606	119	14	igg	igg	NOUN
iajs-3606	119	15	antibody	antibody	NOUN
iajs-3606	119	16	titer	titer	NOUN
iajs-3606	119	17	than	than	ADP
iajs-3606	119	18	non	non	ADJ
iajs-3606	119	19	-	-	ADJ
iajs-3606	119	20	pregnant	pregnant	ADJ
iajs-3606	119	21	women	woman	NOUN
iajs-3606	119	22	,	,	PUNCT
iajs-3606	119	23	although	although	SCONJ
iajs-3606	119	24	the	the	DET
iajs-3606	119	25	statistical	statistical	ADJ
iajs-3606	119	26	difference	difference	NOUN
iajs-3606	119	27	was	be	AUX
iajs-3606	119	28	not	not	PART
iajs-3606	119	29	significant	significant	ADJ
iajs-3606	119	30	.	.	PUNCT
iajs-3606	120	1	in	in	ADP
iajs-3606	120	2	a	a	DET
iajs-3606	120	3	previous	previous	ADJ
iajs-3606	120	4	study	study	NOUN
iajs-3606	120	5	evaluating	evaluate	VERB
iajs-3606	120	6	the	the	DET
iajs-3606	120	7	effectiveness	effectiveness	NOUN
iajs-3606	120	8	of	of	ADP
iajs-3606	120	9	vaccination	vaccination	NOUN
iajs-3606	120	10	in	in	ADP
iajs-3606	120	11	pregnant	pregnant	ADJ
iajs-3606	120	12	women	woman	NOUN
iajs-3606	120	13	in	in	ADP
iajs-3606	120	14	england	england	PROPN
iajs-3606	120	15	,	,	PUNCT
iajs-3606	120	16	the	the	DET
iajs-3606	120	17	pfizer	pfizer	NOUN
iajs-3606	120	18	vaccine	vaccine	NOUN
iajs-3606	120	19	administered	administer	VERB
iajs-3606	120	20	during	during	ADP
iajs-3606	120	21	pregnancy	pregnancy	NOUN
iajs-3606	120	22	elicited	elicit	VERB
iajs-3606	120	23	a	a	DET
iajs-3606	120	24	good	good	ADJ
iajs-3606	120	25	immune	immune	ADJ
iajs-3606	120	26	response	response	NOUN
iajs-3606	120	27	.	.	PUNCT
iajs-3606	121	1	high	high	ADJ
iajs-3606	121	2	levels	level	NOUN
iajs-3606	121	3	of	of	ADP
iajs-3606	121	4	igg	igg	PROPN
iajs-3606	121	5	antibodies	antibodies	PROPN
iajs-3606	121	6	ihjpas	ihjpas	PROPN
iajs-3606	121	7	.	.	PUNCT
iajs-3606	122	1	2025	2025	NUM
iajs-3606	122	2	,	,	PUNCT
iajs-3606	122	3	38	38	NUM
iajs-3606	122	4	(	(	PUNCT
iajs-3606	122	5	1	1	NUM
iajs-3606	122	6	)	)	PUNCT
iajs-3606	122	7	116	116	NUM
iajs-3606	122	8	are	be	AUX
iajs-3606	122	9	similar	similar	ADJ
iajs-3606	122	10	to	to	ADP
iajs-3606	122	11	those	those	PRON
iajs-3606	122	12	found	find	VERB
iajs-3606	122	13	in	in	ADP
iajs-3606	122	14	non	non	ADJ
iajs-3606	122	15	-	-	ADJ
iajs-3606	122	16	pregnant	pregnant	ADJ
iajs-3606	122	17	women	woman	NOUN
iajs-3606	122	18	(	(	PUNCT
iajs-3606	122	19	23	23	NUM
iajs-3606	122	20	,	,	PUNCT
iajs-3606	122	21	24	24	NUM
iajs-3606	122	22	)	)	PUNCT
iajs-3606	122	23	.	.	PUNCT
iajs-3606	123	1	in	in	ADP
iajs-3606	123	2	contrast	contrast	NOUN
iajs-3606	123	3	,	,	PUNCT
iajs-3606	123	4	it	it	PRON
iajs-3606	123	5	is	be	AUX
iajs-3606	123	6	consistent	consistent	ADJ
iajs-3606	123	7	with	with	ADP
iajs-3606	123	8	your	your	PRON
iajs-3606	123	9	study	study	NOUN
iajs-3606	123	10	since	since	SCONJ
iajs-3606	123	11	this	this	DET
iajs-3606	123	12	study	study	NOUN
iajs-3606	123	13	also	also	ADV
iajs-3606	123	14	found	find	VERB
iajs-3606	123	15	that	that	SCONJ
iajs-3606	123	16	there	there	PRON
iajs-3606	123	17	were	be	VERB
iajs-3606	123	18	no	no	DET
iajs-3606	123	19	significant	significant	ADJ
iajs-3606	123	20	differences	difference	NOUN
iajs-3606	123	21	between	between	ADP
iajs-3606	123	22	pregnant	pregnant	ADJ
iajs-3606	123	23	and	and	CCONJ
iajs-3606	123	24	non	non	ADJ
iajs-3606	123	25	-	-	ADJ
iajs-3606	123	26	pregnant	pregnant	ADJ
iajs-3606	123	27	women	woman	NOUN
iajs-3606	123	28	regarding	regard	VERB
iajs-3606	123	29	ab	ab	PROPN
iajs-3606	123	30	titers	titer	NOUN
iajs-3606	123	31	after	after	ADP
iajs-3606	123	32	vaccination	vaccination	NOUN
iajs-3606	123	33	.	.	PUNCT
iajs-3606	124	1	pregnancy	pregnancy	NOUN
iajs-3606	124	2	is	be	AUX
iajs-3606	124	3	also	also	ADV
iajs-3606	124	4	a	a	DET
iajs-3606	124	5	state	state	NOUN
iajs-3606	124	6	of	of	ADP
iajs-3606	124	7	immune	immune	ADJ
iajs-3606	124	8	tolerance	tolerance	NOUN
iajs-3606	124	9	to	to	PART
iajs-3606	124	10	prevent	prevent	VERB
iajs-3606	124	11	the	the	DET
iajs-3606	124	12	body	body	NOUN
iajs-3606	124	13	from	from	ADP
iajs-3606	124	14	rejecting	reject	VERB
iajs-3606	124	15	the	the	DET
iajs-3606	124	16	foreign	foreign	ADJ
iajs-3606	124	17	body	body	NOUN
iajs-3606	124	18	,	,	PUNCT
iajs-3606	124	19	which	which	PRON
iajs-3606	124	20	is	be	AUX
iajs-3606	124	21	the	the	DET
iajs-3606	124	22	fetus	fetus	NOUN
iajs-3606	124	23	.	.	PUNCT
iajs-3606	125	1	thus	thus	ADV
iajs-3606	125	2	,	,	PUNCT
iajs-3606	125	3	their	their	PRON
iajs-3606	125	4	immune	immune	ADJ
iajs-3606	125	5	response	response	NOUN
iajs-3606	125	6	is	be	AUX
iajs-3606	125	7	less	less	ADV
iajs-3606	125	8	active	active	ADJ
iajs-3606	125	9	compared	compare	VERB
iajs-3606	125	10	to	to	ADP
iajs-3606	125	11	non	non	ADJ
iajs-3606	125	12	-	-	ADJ
iajs-3606	125	13	pregnant	pregnant	ADJ
iajs-3606	125	14	women	woman	NOUN
iajs-3606	125	15	,	,	PUNCT
iajs-3606	125	16	pregnant	pregnant	ADJ
iajs-3606	125	17	women	woman	NOUN
iajs-3606	125	18	are	be	AUX
iajs-3606	125	19	more	more	ADV
iajs-3606	125	20	likely	likely	ADJ
iajs-3606	125	21	to	to	PART
iajs-3606	125	22	contract	contract	VERB
iajs-3606	125	23	many	many	ADJ
iajs-3606	125	24	diseases	disease	NOUN
iajs-3606	125	25	,	,	PUNCT
iajs-3606	125	26	including	include	VERB
iajs-3606	125	27	covid-19	covid-19	PROPN
iajs-3606	125	28	.	.	PUNCT
iajs-3606	126	1	regarding	regard	VERB
iajs-3606	126	2	the	the	DET
iajs-3606	126	3	weight	weight	NOUN
iajs-3606	126	4	-	-	PUNCT
iajs-3606	126	5	mass	mass	NOUN
iajs-3606	126	6	index	index	NOUN
iajs-3606	126	7	,	,	PUNCT
iajs-3606	126	8	a	a	DET
iajs-3606	126	9	previous	previous	ADJ
iajs-3606	126	10	study	study	NOUN
iajs-3606	126	11	conducted	conduct	VERB
iajs-3606	126	12	on	on	ADP
iajs-3606	126	13	residents	resident	NOUN
iajs-3606	126	14	in	in	ADP
iajs-3606	126	15	a	a	DET
iajs-3606	126	16	city	city	NOUN
iajs-3606	126	17	in	in	ADP
iajs-3606	126	18	england	england	PROPN
iajs-3606	126	19	examined	examine	VERB
iajs-3606	126	20	the	the	DET
iajs-3606	126	21	relationship	relationship	NOUN
iajs-3606	126	22	between	between	ADP
iajs-3606	126	23	body	body	NOUN
iajs-3606	126	24	mass	mass	NOUN
iajs-3606	126	25	index	index	NOUN
iajs-3606	126	26	(	(	PUNCT
iajs-3606	126	27	bmi	bmi	PROPN
iajs-3606	126	28	)	)	PUNCT
iajs-3606	126	29	and	and	CCONJ
iajs-3606	126	30	the	the	DET
iajs-3606	126	31	effectiveness	effectiveness	NOUN
iajs-3606	126	32	of	of	ADP
iajs-3606	126	33	sars	sar	NOUN
iajs-3606	126	34	-	-	PUNCT
iajs-3606	126	35	cov-2	cov-2	NOUN
iajs-3606	126	36	vaccines	vaccine	NOUN
iajs-3606	126	37	.	.	PUNCT
iajs-3606	127	1	the	the	DET
iajs-3606	127	2	results	result	NOUN
iajs-3606	127	3	showed	show	VERB
iajs-3606	127	4	that	that	SCONJ
iajs-3606	127	5	the	the	DET
iajs-3606	127	6	vaccine	vaccine	NOUN
iajs-3606	127	7	was	be	AUX
iajs-3606	127	8	more	more	ADV
iajs-3606	127	9	effective	effective	ADJ
iajs-3606	127	10	for	for	ADP
iajs-3606	127	11	individuals	individual	NOUN
iajs-3606	127	12	who	who	PRON
iajs-3606	127	13	were	be	AUX
iajs-3606	127	14	overweight	overweight	ADJ
iajs-3606	127	15	or	or	CCONJ
iajs-3606	127	16	of	of	ADP
iajs-3606	127	17	a	a	DET
iajs-3606	127	18	healthy	healthy	ADJ
iajs-3606	127	19	weight	weight	NOUN
iajs-3606	127	20	,	,	PUNCT
iajs-3606	127	21	compared	compare	VERB
iajs-3606	127	22	to	to	ADP
iajs-3606	127	23	those	those	PRON
iajs-3606	127	24	who	who	PRON
iajs-3606	127	25	experienced	experience	VERB
iajs-3606	127	26	a	a	DET
iajs-3606	127	27	decrease	decrease	NOUN
iajs-3606	127	28	in	in	ADP
iajs-3606	127	29	their	their	PRON
iajs-3606	127	30	weight	weight	NOUN
iajs-3606	127	31	-	-	PUNCT
iajs-3606	127	32	mass	mass	NOUN
iajs-3606	127	33	index	index	NOUN
iajs-3606	127	34	(	(	PUNCT
iajs-3606	127	35	25	25	NUM
iajs-3606	127	36	)	)	PUNCT
iajs-3606	127	37	.	.	PUNCT
iajs-3606	128	1	this	this	DET
iajs-3606	128	2	study	study	NOUN
iajs-3606	128	3	roughly	roughly	ADV
iajs-3606	128	4	aligns	align	VERB
iajs-3606	128	5	with	with	ADP
iajs-3606	128	6	the	the	DET
iajs-3606	128	7	results	result	NOUN
iajs-3606	128	8	of	of	ADP
iajs-3606	128	9	the	the	DET
iajs-3606	128	10	current	current	ADJ
iajs-3606	128	11	study	study	NOUN
iajs-3606	128	12	for	for	ADP
iajs-3606	128	13	participants	participant	NOUN
iajs-3606	128	14	who	who	PRON
iajs-3606	128	15	received	receive	VERB
iajs-3606	128	16	the	the	DET
iajs-3606	128	17	pfizer	pfizer	NOUN
iajs-3606	128	18	vaccine	vaccine	NOUN
iajs-3606	128	19	,	,	PUNCT
iajs-3606	128	20	but	but	CCONJ
iajs-3606	128	21	it	it	PRON
iajs-3606	128	22	differs	differ	VERB
iajs-3606	128	23	slightly	slightly	ADV
iajs-3606	128	24	for	for	ADP
iajs-3606	128	25	those	those	PRON
iajs-3606	128	26	who	who	PRON
iajs-3606	128	27	received	receive	VERB
iajs-3606	128	28	the	the	DET
iajs-3606	128	29	sinopharm	sinopharm	NOUN
iajs-3606	128	30	vaccine	vaccine	NOUN
iajs-3606	128	31	.	.	PUNCT
iajs-3606	129	1	the	the	DET
iajs-3606	129	2	difference	difference	NOUN
iajs-3606	129	3	in	in	ADP
iajs-3606	129	4	results	result	NOUN
iajs-3606	129	5	with	with	ADP
iajs-3606	129	6	different	different	ADJ
iajs-3606	129	7	outcomes	outcome	NOUN
iajs-3606	129	8	with	with	ADP
iajs-3606	129	9	this	this	DET
iajs-3606	129	10	vaccine	vaccine	NOUN
iajs-3606	129	11	might	might	AUX
iajs-3606	129	12	be	be	AUX
iajs-3606	129	13	because	because	SCONJ
iajs-3606	129	14	european	european	ADJ
iajs-3606	129	15	countries	country	NOUN
iajs-3606	129	16	mostly	mostly	ADV
iajs-3606	129	17	used	use	VERB
iajs-3606	129	18	the	the	DET
iajs-3606	129	19	pfizer	pfizer	NOUN
iajs-3606	129	20	vaccine	vaccine	NOUN
iajs-3606	129	21	and	and	CCONJ
iajs-3606	129	22	not	not	PART
iajs-3606	129	23	the	the	DET
iajs-3606	129	24	sinopharm	sinopharm	NOUN
iajs-3606	129	25	vaccine	vaccine	NOUN
iajs-3606	129	26	.	.	PUNCT
iajs-3606	130	1	alternatively	alternatively	ADV
iajs-3606	130	2	,	,	PUNCT
iajs-3606	130	3	the	the	DET
iajs-3606	130	4	people	people	NOUN
iajs-3606	130	5	in	in	ADP
iajs-3606	130	6	this	this	DET
iajs-3606	130	7	study	study	NOUN
iajs-3606	130	8	may	may	AUX
iajs-3606	130	9	have	have	VERB
iajs-3606	130	10	weak	weak	ADJ
iajs-3606	130	11	immune	immune	ADJ
iajs-3606	130	12	systems	system	NOUN
iajs-3606	130	13	or	or	CCONJ
iajs-3606	130	14	have	have	VERB
iajs-3606	130	15	chronic	chronic	ADJ
iajs-3606	130	16	diseases	disease	NOUN
iajs-3606	130	17	that	that	PRON
iajs-3606	130	18	make	make	VERB
iajs-3606	130	19	it	it	PRON
iajs-3606	130	20	harder	hard	ADJ
iajs-3606	130	21	for	for	SCONJ
iajs-3606	130	22	their	their	PRON
iajs-3606	130	23	bodies	body	NOUN
iajs-3606	130	24	to	to	PART
iajs-3606	130	25	respond	respond	VERB
iajs-3606	130	26	to	to	ADP
iajs-3606	130	27	this	this	DET
iajs-3606	130	28	vaccine	vaccine	NOUN
iajs-3606	130	29	,	,	PUNCT
iajs-3606	130	30	which	which	PRON
iajs-3606	130	31	lowers	lower	VERB
iajs-3606	130	32	their	their	PRON
iajs-3606	130	33	levels	level	NOUN
iajs-3606	130	34	of	of	ADP
iajs-3606	130	35	antibodies	antibody	NOUN
iajs-3606	130	36	compared	compare	VERB
iajs-3606	130	37	to	to	ADP
iajs-3606	130	38	people	people	NOUN
iajs-3606	130	39	of	of	ADP
iajs-3606	130	40	other	other	ADJ
iajs-3606	130	41	weights	weight	NOUN
iajs-3606	130	42	.	.	PUNCT
iajs-3606	131	1	fictiveness	fictiveness	NOUN
iajs-3606	131	2	of	of	ADP
iajs-3606	131	3	sarscov	sarscov	PROPN
iajs-3606	131	4	vaccines	vaccine	NOUN
iajs-3606	131	5	with	with	ADP
iajs-3606	131	6	weight	weight	NOUN
iajs-3606	131	7	-	-	PUNCT
iajs-3606	131	8	mass	mass	NOUN
iajs-3606	131	9	index	index	NOUN
iajs-3606	131	10	found	find	VERB
iajs-3606	131	11	that	that	SCONJ
iajs-3606	131	12	obese	obese	ADJ
iajs-3606	131	13	people	people	NOUN
iajs-3606	131	14	were	be	AUX
iajs-3606	131	15	significantly	significantly	ADV
iajs-3606	131	16	associated	associate	VERB
iajs-3606	131	17	with	with	ADP
iajs-3606	131	18	low	low	ADJ
iajs-3606	131	19	antibody	antibody	NOUN
iajs-3606	131	20	titers	titer	NOUN
iajs-3606	131	21	(	(	PUNCT
iajs-3606	131	22	26	26	NUM
iajs-3606	131	23	)	)	PUNCT
iajs-3606	131	24	.	.	PUNCT
iajs-3606	132	1	this	this	DET
iajs-3606	132	2	study	study	NOUN
iajs-3606	132	3	is	be	AUX
iajs-3606	132	4	not	not	PART
iajs-3606	132	5	consistent	consistent	ADJ
iajs-3606	132	6	with	with	ADP
iajs-3606	132	7	the	the	DET
iajs-3606	132	8	current	current	ADJ
iajs-3606	132	9	study	study	NOUN
iajs-3606	132	10	's	's	PART
iajs-3606	132	11	results	result	NOUN
iajs-3606	132	12	.	.	PUNCT
iajs-3606	133	1	the	the	DET
iajs-3606	133	2	reason	reason	NOUN
iajs-3606	133	3	could	could	AUX
iajs-3606	133	4	be	be	AUX
iajs-3606	133	5	that	that	SCONJ
iajs-3606	133	6	the	the	DET
iajs-3606	133	7	age	age	NOUN
iajs-3606	133	8	groups	group	NOUN
iajs-3606	133	9	of	of	ADP
iajs-3606	133	10	vaccinated	vaccinated	ADJ
iajs-3606	133	11	individuals	individual	NOUN
iajs-3606	133	12	suffering	suffer	VERB
iajs-3606	133	13	from	from	ADP
iajs-3606	133	14	obesity	obesity	NOUN
iajs-3606	133	15	differ	differ	VERB
iajs-3606	133	16	between	between	ADP
iajs-3606	133	17	this	this	DET
iajs-3606	133	18	study	study	NOUN
iajs-3606	133	19	and	and	CCONJ
iajs-3606	133	20	the	the	DET
iajs-3606	133	21	current	current	ADJ
iajs-3606	133	22	study	study	NOUN
iajs-3606	133	23	.	.	PUNCT
iajs-3606	134	1	adipose	adipose	ADP
iajs-3606	134	2	tissue	tissue	NOUN
iajs-3606	134	3	plays	play	VERB
iajs-3606	134	4	a	a	DET
iajs-3606	134	5	role	role	NOUN
iajs-3606	134	6	in	in	ADP
iajs-3606	134	7	the	the	DET
iajs-3606	134	8	ability	ability	NOUN
iajs-3606	134	9	to	to	PART
iajs-3606	134	10	absorb	absorb	VERB
iajs-3606	134	11	the	the	DET
iajs-3606	134	12	titer	titer	NOUN
iajs-3606	134	13	of	of	ADP
iajs-3606	134	14	antibodies	antibody	NOUN
iajs-3606	134	15	based	base	VERB
iajs-3606	134	16	on	on	ADP
iajs-3606	134	17	the	the	DET
iajs-3606	134	18	date	date	NOUN
iajs-3606	134	19	of	of	ADP
iajs-3606	134	20	the	the	DET
iajs-3606	134	21	last	last	ADJ
iajs-3606	134	22	vaccination	vaccination	NOUN
iajs-3606	134	23	and	and	CCONJ
iajs-3606	134	24	the	the	DET
iajs-3606	134	25	previous	previous	ADJ
iajs-3606	134	26	infection	infection	NOUN
iajs-3606	134	27	with	with	ADP
iajs-3606	134	28	sars	sar	NOUN
iajs-3606	134	29	-	-	PUNCT
iajs-3606	134	30	cov-2	cov-2	NOUN
iajs-3606	134	31	.	.	PUNCT
iajs-3606	135	1	in	in	ADP
iajs-3606	135	2	an	an	DET
iajs-3606	135	3	iranian	iranian	ADJ
iajs-3606	135	4	study	study	NOUN
iajs-3606	135	5	evaluating	evaluate	VERB
iajs-3606	135	6	antibodies	antibody	NOUN
iajs-3606	135	7	to	to	ADP
iajs-3606	135	8	sinopharm	sinopharm	NOUN
iajs-3606	135	9	vaccine	vaccine	NOUN
iajs-3606	135	10	with	with	ADP
iajs-3606	135	11	weight	weight	NOUN
iajs-3606	135	12	-	-	PUNCT
iajs-3606	135	13	mass	mass	NOUN
iajs-3606	135	14	index	index	NOUN
iajs-3606	135	15	,	,	PUNCT
iajs-3606	135	16	igg	igg	PROPN
iajs-3606	135	17	antibody	antibody	NOUN
iajs-3606	135	18	levels	level	NOUN
iajs-3606	135	19	were	be	AUX
iajs-3606	135	20	significantly	significantly	ADV
iajs-3606	135	21	lower	low	ADJ
iajs-3606	135	22	in	in	ADP
iajs-3606	135	23	obese	obese	ADJ
iajs-3606	135	24	subjects	subject	NOUN
iajs-3606	135	25	compared	compare	VERB
iajs-3606	135	26	to	to	ADP
iajs-3606	135	27	other	other	ADJ
iajs-3606	135	28	groups	group	NOUN
iajs-3606	135	29	(	(	PUNCT
iajs-3606	135	30	27	27	NUM
iajs-3606	135	31	)	)	PUNCT
iajs-3606	135	32	,	,	PUNCT
iajs-3606	135	33	and	and	CCONJ
iajs-3606	135	34	this	this	PRON
iajs-3606	135	35	is	be	AUX
iajs-3606	135	36	almost	almost	ADV
iajs-3606	135	37	in	in	ADP
iajs-3606	135	38	agreement	agreement	NOUN
iajs-3606	135	39	with	with	ADP
iajs-3606	135	40	the	the	DET
iajs-3606	135	41	current	current	ADJ
iajs-3606	135	42	study	study	NOUN
iajs-3606	135	43	's	's	PART
iajs-3606	135	44	results	result	NOUN
iajs-3606	135	45	.	.	PUNCT
iajs-3606	136	1	the	the	DET
iajs-3606	136	2	results	result	NOUN
iajs-3606	136	3	presented	present	VERB
iajs-3606	136	4	in	in	ADP
iajs-3606	136	5	table	table	NOUN
iajs-3606	136	6	3	3	NUM
iajs-3606	136	7	of	of	ADP
iajs-3606	136	8	the	the	DET
iajs-3606	136	9	current	current	ADJ
iajs-3606	136	10	study	study	NOUN
iajs-3606	136	11	show	show	VERB
iajs-3606	136	12	that	that	SCONJ
iajs-3606	136	13	study	study	NOUN
iajs-3606	136	14	participants	participant	NOUN
iajs-3606	136	15	with	with	ADP
iajs-3606	136	16	type	type	NOUN
iajs-3606	136	17	ab	ab	PROPN
iajs-3606	136	18	had	have	VERB
iajs-3606	136	19	a	a	DET
iajs-3606	136	20	higher	high	ADJ
iajs-3606	136	21	titer	titer	NOUN
iajs-3606	136	22	of	of	ADP
iajs-3606	136	23	igg	igg	PROPN
iajs-3606	136	24	antibodies	antibody	NOUN
iajs-3606	136	25	compared	compare	VERB
iajs-3606	136	26	to	to	ADP
iajs-3606	136	27	those	those	PRON
iajs-3606	136	28	who	who	PRON
iajs-3606	136	29	received	receive	VERB
iajs-3606	136	30	the	the	DET
iajs-3606	136	31	pfizer	pfizer	NOUN
iajs-3606	136	32	vaccine	vaccine	NOUN
iajs-3606	136	33	.	.	PUNCT
iajs-3606	137	1	however	however	ADV
iajs-3606	137	2	,	,	PUNCT
iajs-3606	137	3	this	this	DET
iajs-3606	137	4	statistical	statistical	ADJ
iajs-3606	137	5	difference	difference	NOUN
iajs-3606	137	6	was	be	AUX
iajs-3606	137	7	not	not	PART
iajs-3606	137	8	significant	significant	ADJ
iajs-3606	137	9	.	.	PUNCT
iajs-3606	138	1	in	in	ADP
iajs-3606	138	2	comparison	comparison	NOUN
iajs-3606	138	3	to	to	ADP
iajs-3606	138	4	other	other	ADJ
iajs-3606	138	5	studies	study	NOUN
iajs-3606	138	6	,	,	PUNCT
iajs-3606	138	7	previous	previous	ADJ
iajs-3606	138	8	studies	study	NOUN
iajs-3606	138	9	have	have	AUX
iajs-3606	138	10	reported	report	VERB
iajs-3606	138	11	no	no	DET
iajs-3606	138	12	significant	significant	ADJ
iajs-3606	138	13	effect	effect	NOUN
iajs-3606	138	14	of	of	ADP
iajs-3606	138	15	blood	blood	NOUN
iajs-3606	138	16	types	type	NOUN
iajs-3606	138	17	on	on	ADP
iajs-3606	138	18	the	the	DET
iajs-3606	138	19	concentration	concentration	NOUN
iajs-3606	138	20	of	of	ADP
iajs-3606	138	21	immunoglobulin	immunoglobulin	NOUN
iajs-3606	138	22	igg	igg	PROPN
iajs-3606	138	23	(	(	PUNCT
iajs-3606	138	24	28	28	NUM
iajs-3606	138	25	,	,	PUNCT
iajs-3606	138	26	29	29	NUM
iajs-3606	138	27	)	)	PUNCT
iajs-3606	138	28	.	.	PUNCT
iajs-3606	139	1	the	the	DET
iajs-3606	139	2	main	main	ADJ
iajs-3606	139	3	factor	factor	NOUN
iajs-3606	139	4	affecting	affect	VERB
iajs-3606	139	5	igg	igg	NOUN
iajs-3606	139	6	antibody	antibody	NOUN
iajs-3606	139	7	level	level	NOUN
iajs-3606	139	8	was	be	AUX
iajs-3606	139	9	prior	prior	ADJ
iajs-3606	139	10	natural	natural	ADJ
iajs-3606	139	11	immunization	immunization	NOUN
iajs-3606	139	12	as	as	ADP
iajs-3606	139	13	a	a	DET
iajs-3606	139	14	result	result	NOUN
iajs-3606	139	15	of	of	ADP
iajs-3606	139	16	sars	sar	NOUN
iajs-3606	139	17	-	-	PUNCT
iajs-3606	139	18	cov-2	cov-2	PART
iajs-3606	139	19	infection	infection	NOUN
iajs-3606	139	20	.	.	PUNCT
iajs-3606	140	1	the	the	DET
iajs-3606	140	2	results	result	NOUN
iajs-3606	140	3	of	of	ADP
iajs-3606	140	4	some	some	DET
iajs-3606	140	5	studies	study	NOUN
iajs-3606	140	6	also	also	ADV
iajs-3606	140	7	showed	show	VERB
iajs-3606	140	8	significant	significant	ADJ
iajs-3606	140	9	differences	difference	NOUN
iajs-3606	140	10	in	in	ADP
iajs-3606	140	11	the	the	DET
iajs-3606	140	12	type	type	NOUN
iajs-3606	140	13	of	of	ADP
iajs-3606	140	14	vaccine	vaccine	NOUN
iajs-3606	140	15	and	and	CCONJ
iajs-3606	140	16	the	the	DET
iajs-3606	140	17	previous	previous	ADJ
iajs-3606	140	18	infection	infection	NOUN
iajs-3606	140	19	.	.	PUNCT
iajs-3606	141	1	specifically	specifically	ADV
iajs-3606	141	2	,	,	PUNCT
iajs-3606	141	3	the	the	DET
iajs-3606	141	4	antibody	antibody	NOUN
iajs-3606	141	5	levels	level	NOUN
iajs-3606	141	6	for	for	ADP
iajs-3606	141	7	sars	sar	NOUN
iajs-3606	141	8	-	-	PUNCT
iajs-3606	141	9	cov-2	cov-2	PART
iajs-3606	141	10	were	be	AUX
iajs-3606	141	11	significantly	significantly	ADV
iajs-3606	141	12	lower	low	ADJ
iajs-3606	141	13	in	in	ADP
iajs-3606	141	14	individuals	individual	NOUN
iajs-3606	141	15	without	without	ADP
iajs-3606	141	16	a	a	DET
iajs-3606	141	17	natural	natural	ADJ
iajs-3606	141	18	infection	infection	NOUN
iajs-3606	141	19	to	to	ADP
iajs-3606	141	20	the	the	DET
iajs-3606	141	21	virus	virus	NOUN
iajs-3606	141	22	compared	compare	VERB
iajs-3606	141	23	to	to	ADP
iajs-3606	141	24	those	those	PRON
iajs-3606	141	25	suffering	suffer	VERB
iajs-3606	141	26	from	from	ADP
iajs-3606	141	27	an	an	DET
iajs-3606	141	28	infection	infection	NOUN
iajs-3606	141	29	,	,	PUNCT
iajs-3606	141	30	with	with	ADP
iajs-3606	141	31	a	a	DET
iajs-3606	141	32	statistically	statistically	ADV
iajs-3606	141	33	significant	significant	ADJ
iajs-3606	141	34	difference	difference	NOUN
iajs-3606	141	35	(	(	PUNCT
iajs-3606	141	36	greater	great	ADJ
iajs-3606	141	37	than	than	ADP
iajs-3606	141	38	001	001	NUM
iajs-3606	141	39	)	)	PUNCT
iajs-3606	141	40	.	.	PUNCT
iajs-3606	142	1	however	however	ADV
iajs-3606	142	2	,	,	PUNCT
iajs-3606	142	3	the	the	DET
iajs-3606	142	4	type	type	NOUN
iajs-3606	142	5	of	of	ADP
iajs-3606	142	6	vaccine	vaccine	NOUN
iajs-3606	142	7	was	be	AUX
iajs-3606	142	8	found	find	VERB
iajs-3606	142	9	to	to	PART
iajs-3606	142	10	have	have	VERB
iajs-3606	142	11	the	the	DET
iajs-3606	142	12	highest	high	ADJ
iajs-3606	142	13	concentration	concentration	NOUN
iajs-3606	142	14	of	of	ADP
iajs-3606	142	15	igg	igg	PROPN
iajs-3606	142	16	antibodies	antibodies	PROPN
iajs-3606	142	17	(	(	PUNCT
iajs-3606	142	18	30	30	NUM
iajs-3606	142	19	)	)	PUNCT
iajs-3606	142	20	.	.	PUNCT
iajs-3606	143	1	the	the	DET
iajs-3606	143	2	pfizer	pfizer	NOUN
iajs-3606	143	3	vaccine	vaccine	NOUN
iajs-3606	143	4	was	be	AUX
iajs-3606	143	5	administered	administer	VERB
iajs-3606	143	6	to	to	ADP
iajs-3606	143	7	those	those	DET
iajs-3606	143	8	individuals	individual	NOUN
iajs-3606	143	9	(	(	PUNCT
iajs-3606	143	10	30	30	NUM
iajs-3606	143	11	)	)	PUNCT
iajs-3606	143	12	.	.	PUNCT
iajs-3606	144	1	studies	study	NOUN
iajs-3606	144	2	have	have	AUX
iajs-3606	144	3	not	not	PART
iajs-3606	144	4	directly	directly	ADV
iajs-3606	144	5	linked	link	VERB
iajs-3606	144	6	the	the	DET
iajs-3606	144	7	effectiveness	effectiveness	NOUN
iajs-3606	144	8	of	of	ADP
iajs-3606	144	9	vaccination	vaccination	NOUN
iajs-3606	144	10	with	with	ADP
iajs-3606	144	11	different	different	ADJ
iajs-3606	144	12	blood	blood	NOUN
iajs-3606	144	13	groups	group	NOUN
iajs-3606	144	14	abo	abo	VERB
iajs-3606	144	15	,	,	PUNCT
iajs-3606	144	16	but	but	CCONJ
iajs-3606	144	17	a	a	DET
iajs-3606	144	18	december	december	PROPN
iajs-3606	144	19	study	study	NOUN
iajs-3606	144	20	found	find	VERB
iajs-3606	144	21	that	that	SCONJ
iajs-3606	144	22	individuals	individual	NOUN
iajs-3606	144	23	with	with	ADP
iajs-3606	144	24	blood	blood	NOUN
iajs-3606	144	25	type	type	NOUN
iajs-3606	144	26	a	a	DET
iajs-3606	144	27	experienced	experienced	ADJ
iajs-3606	144	28	more	more	ADV
iajs-3606	144	29	severe	severe	ADJ
iajs-3606	144	30	side	side	NOUN
iajs-3606	144	31	effects	effect	NOUN
iajs-3606	144	32	than	than	ADP
iajs-3606	144	33	those	those	PRON
iajs-3606	144	34	with	with	ADP
iajs-3606	144	35	type	type	NOUN
iajs-3606	144	36	o	o	NOUN
iajs-3606	144	37	blood	blood	NOUN
iajs-3606	144	38	,	,	PUNCT
iajs-3606	144	39	suggesting	suggest	VERB
iajs-3606	144	40	a	a	DET
iajs-3606	144	41	stronger	strong	ADJ
iajs-3606	144	42	immune	immune	ADJ
iajs-3606	144	43	response	response	NOUN
iajs-3606	144	44	.	.	PUNCT
iajs-3606	145	1	particularly	particularly	ADV
iajs-3606	145	2	,	,	PUNCT
iajs-3606	145	3	individuals	individual	NOUN
iajs-3606	145	4	under	under	ADP
iajs-3606	145	5	the	the	DET
iajs-3606	145	6	age	age	NOUN
iajs-3606	145	7	of	of	ADP
iajs-3606	145	8	55	55	NUM
iajs-3606	145	9	,	,	PUNCT
iajs-3606	145	10	females	female	NOUN
iajs-3606	145	11	,	,	PUNCT
iajs-3606	145	12	and	and	CCONJ
iajs-3606	145	13	those	those	PRON
iajs-3606	145	14	with	with	ADP
iajs-3606	145	15	a	a	DET
iajs-3606	145	16	history	history	NOUN
iajs-3606	145	17	of	of	ADP
iajs-3606	145	18	covid-19	covid-19	PROPN
iajs-3606	145	19	infection	infection	NOUN
iajs-3606	145	20	are	be	AUX
iajs-3606	145	21	more	more	ADV
iajs-3606	145	22	likely	likely	ADJ
iajs-3606	145	23	to	to	PART
iajs-3606	145	24	experience	experience	VERB
iajs-3606	145	25	negative	negative	ADJ
iajs-3606	145	26	side	side	NOUN
iajs-3606	145	27	effects	effect	NOUN
iajs-3606	145	28	after	after	ADP
iajs-3606	145	29	vaccination	vaccination	NOUN
iajs-3606	145	30	compared	compare	VERB
iajs-3606	145	31	to	to	ADP
iajs-3606	145	32	other	other	ADJ
iajs-3606	145	33	groups	group	NOUN
iajs-3606	145	34	(	(	PUNCT
iajs-3606	145	35	31	31	NUM
iajs-3606	145	36	)	)	PUNCT
iajs-3606	145	37	.	.	PUNCT
iajs-3606	146	1	it	it	PRON
iajs-3606	146	2	may	may	AUX
iajs-3606	146	3	be	be	AUX
iajs-3606	146	4	the	the	DET
iajs-3606	146	5	reason	reason	NOUN
iajs-3606	146	6	for	for	ADP
iajs-3606	146	7	the	the	DET
iajs-3606	146	8	insufficiency	insufficiency	NOUN
iajs-3606	146	9	of	of	ADP
iajs-3606	146	10	studies	study	NOUN
iajs-3606	146	11	related	relate	VERB
iajs-3606	146	12	to	to	ADP
iajs-3606	146	13	this	this	DET
iajs-3606	146	14	regard	regard	NOUN
iajs-3606	146	15	and	and	CCONJ
iajs-3606	146	16	that	that	SCONJ
iajs-3606	146	17	this	this	DET
iajs-3606	146	18	study	study	NOUN
iajs-3606	146	19	did	do	AUX
iajs-3606	146	20	not	not	PART
iajs-3606	146	21	confirm	confirm	VERB
iajs-3606	146	22	the	the	DET
iajs-3606	146	23	actual	actual	ADJ
iajs-3606	146	24	association	association	NOUN
iajs-3606	146	25	between	between	ADP
iajs-3606	146	26	vaccine	vaccine	NOUN
iajs-3606	146	27	efficacy	efficacy	NOUN
iajs-3606	146	28	and	and	CCONJ
iajs-3606	146	29	abo	abo	VERB
iajs-3606	146	30	blood	blood	NOUN
iajs-3606	146	31	groups	group	NOUN
iajs-3606	146	32	.	.	PUNCT
iajs-3606	147	1	since	since	SCONJ
iajs-3606	147	2	vaccination	vaccination	NOUN
iajs-3606	147	3	ihjpas	ihjpa	NOUN
iajs-3606	147	4	.	.	PUNCT
iajs-3606	148	1	2025	2025	NUM
iajs-3606	148	2	,	,	PUNCT
iajs-3606	148	3	38	38	NUM
iajs-3606	148	4	(	(	PUNCT
iajs-3606	148	5	1	1	NUM
iajs-3606	148	6	)	)	PUNCT
iajs-3606	148	7	117	117	NUM
iajs-3606	148	8	is	be	AUX
iajs-3606	148	9	a	a	DET
iajs-3606	148	10	process	process	NOUN
iajs-3606	148	11	that	that	PRON
iajs-3606	148	12	mimics	mimic	VERB
iajs-3606	148	13	infection	infection	NOUN
iajs-3606	148	14	naturally	naturally	ADV
iajs-3606	148	15	,	,	PUNCT
iajs-3606	148	16	it	it	PRON
iajs-3606	148	17	may	may	AUX
iajs-3606	148	18	be	be	AUX
iajs-3606	148	19	possible	possible	ADJ
iajs-3606	148	20	to	to	PART
iajs-3606	148	21	rely	rely	VERB
iajs-3606	148	22	on	on	ADP
iajs-3606	148	23	the	the	DET
iajs-3606	148	24	relationship	relationship	NOUN
iajs-3606	148	25	between	between	ADP
iajs-3606	148	26	abo	abo	NOUN
iajs-3606	148	27	blood	blood	NOUN
iajs-3606	148	28	groups	group	NOUN
iajs-3606	148	29	and	and	CCONJ
iajs-3606	148	30	infection	infection	NOUN
iajs-3606	148	31	with	with	ADP
iajs-3606	148	32	covid-19	covid-19	PROPN
iajs-3606	148	33	.	.	PUNCT
iajs-3606	149	1	a	a	DET
iajs-3606	149	2	study	study	NOUN
iajs-3606	149	3	was	be	AUX
iajs-3606	149	4	conducted	conduct	VERB
iajs-3606	149	5	in	in	ADP
iajs-3606	149	6	china	china	PROPN
iajs-3606	149	7	at	at	ADP
iajs-3606	149	8	wuhan	wuhan	PROPN
iajs-3606	149	9	central	central	PROPN
iajs-3606	149	10	hospital	hospital	NOUN
iajs-3606	149	11	to	to	PART
iajs-3606	149	12	evaluate	evaluate	VERB
iajs-3606	149	13	the	the	DET
iajs-3606	149	14	relationship	relationship	NOUN
iajs-3606	149	15	between	between	ADP
iajs-3606	149	16	abo	abo	NOUN
iajs-3606	149	17	blood	blood	NOUN
iajs-3606	149	18	groups	group	NOUN
iajs-3606	149	19	and	and	CCONJ
iajs-3606	149	20	susceptibility	susceptibility	NOUN
iajs-3606	149	21	to	to	ADP
iajs-3606	149	22	infection	infection	NOUN
iajs-3606	149	23	with	with	ADP
iajs-3606	149	24	covid-19	covid-19	PROPN
iajs-3606	149	25	,	,	PUNCT
iajs-3606	149	26	where	where	SCONJ
iajs-3606	149	27	the	the	DET
iajs-3606	149	28	incidence	incidence	NOUN
iajs-3606	149	29	of	of	ADP
iajs-3606	149	30	covid-19	covid-19	PROPN
iajs-3606	149	31	for	for	ADP
iajs-3606	149	32	people	people	NOUN
iajs-3606	149	33	with	with	ADP
iajs-3606	149	34	blood	blood	NOUN
iajs-3606	149	35	group	group	NOUN
iajs-3606	149	36	a	a	PROPN
iajs-3606	149	37	was	be	AUX
iajs-3606	149	38	higher	high	ADJ
iajs-3606	149	39	compared	compare	VERB
iajs-3606	149	40	to	to	ADP
iajs-3606	149	41	those	those	PRON
iajs-3606	149	42	with	with	ADP
iajs-3606	149	43	blood	blood	NOUN
iajs-3606	149	44	group	group	NOUN
iajs-3606	149	45	o	o	X
iajs-3606	149	46	(	(	PUNCT
iajs-3606	149	47	32	32	NUM
iajs-3606	149	48	)	)	PUNCT
iajs-3606	149	49	.	.	PUNCT
iajs-3606	150	1	there	there	PRON
iajs-3606	150	2	are	be	VERB
iajs-3606	150	3	no	no	DET
iajs-3606	150	4	previous	previous	ADJ
iajs-3606	150	5	studies	study	NOUN
iajs-3606	150	6	in	in	ADP
iajs-3606	150	7	the	the	DET
iajs-3606	150	8	international	international	ADJ
iajs-3606	150	9	literature	literature	NOUN
iajs-3606	150	10	that	that	PRON
iajs-3606	150	11	demonstrate	demonstrate	VERB
iajs-3606	150	12	the	the	DET
iajs-3606	150	13	actual	actual	ADJ
iajs-3606	150	14	association	association	NOUN
iajs-3606	150	15	between	between	ADP
iajs-3606	150	16	abo	abo	NOUN
iajs-3606	150	17	blood	blood	NOUN
iajs-3606	150	18	groups	group	NOUN
iajs-3606	150	19	and	and	CCONJ
iajs-3606	150	20	the	the	DET
iajs-3606	150	21	rh	rh	NOUN
iajs-3606	150	22	factor	factor	NOUN
iajs-3606	150	23	with	with	ADP
iajs-3606	150	24	the	the	DET
iajs-3606	150	25	titer	titer	NOUN
iajs-3606	150	26	of	of	ADP
iajs-3606	150	27	igg	igg	PROPN
iajs-3606	150	28	antibodies	antibodie	VERB
iajs-3606	150	29	.	.	PUNCT
iajs-3606	151	1	the	the	DET
iajs-3606	151	2	current	current	ADJ
iajs-3606	151	3	study	study	NOUN
iajs-3606	151	4	found	find	VERB
iajs-3606	151	5	no	no	DET
iajs-3606	151	6	significant	significant	ADJ
iajs-3606	151	7	differences	difference	NOUN
iajs-3606	151	8	in	in	ADP
iajs-3606	151	9	the	the	DET
iajs-3606	151	10	mean	mean	NOUN
iajs-3606	151	11	of	of	ADP
iajs-3606	151	12	the	the	DET
iajs-3606	151	13	ab	ab	NOUN
iajs-3606	151	14	titer	titer	NOUN
iajs-3606	151	15	between	between	ADP
iajs-3606	151	16	the	the	DET
iajs-3606	151	17	different	different	ADJ
iajs-3606	151	18	abo	abo	NOUN
iajs-3606	151	19	groups	group	NOUN
iajs-3606	151	20	or	or	CCONJ
iajs-3606	151	21	between	between	ADP
iajs-3606	151	22	the	the	DET
iajs-3606	151	23	different	different	ADJ
iajs-3606	151	24	rh	rh	NOUN
iajs-3606	151	25	factors	factor	NOUN
iajs-3606	151	26	in	in	ADP
iajs-3606	151	27	both	both	DET
iajs-3606	151	28	vaccinated	vaccinated	ADJ
iajs-3606	151	29	patients	patient	NOUN
iajs-3606	151	30	from	from	ADP
iajs-3606	151	31	pfizer	pfizer	NOUN
iajs-3606	151	32	and	and	CCONJ
iajs-3606	151	33	sinopharm	sinopharm	NOUN
iajs-3606	151	34	.	.	PUNCT
iajs-3606	152	1	table	table	NOUN
iajs-3606	152	2	4	4	NUM
iajs-3606	152	3	shows	show	VERB
iajs-3606	152	4	that	that	SCONJ
iajs-3606	152	5	the	the	DET
iajs-3606	152	6	level	level	NOUN
iajs-3606	152	7	of	of	ADP
iajs-3606	152	8	igg	igg	NOUN
iajs-3606	152	9	antibody	antibody	NOUN
iajs-3606	152	10	was	be	AUX
iajs-3606	152	11	higher	high	ADJ
iajs-3606	152	12	in	in	ADP
iajs-3606	152	13	people	people	NOUN
iajs-3606	152	14	who	who	PRON
iajs-3606	152	15	did	do	AUX
iajs-3606	152	16	not	not	PART
iajs-3606	152	17	smoke	smoke	VERB
iajs-3606	152	18	.	.	PUNCT
iajs-3606	153	1	this	this	DET
iajs-3606	153	2	difference	difference	NOUN
iajs-3606	153	3	was	be	AUX
iajs-3606	153	4	significant	significant	ADJ
iajs-3606	153	5	in	in	ADP
iajs-3606	153	6	a	a	DET
iajs-3606	153	7	previous	previous	ADJ
iajs-3606	153	8	study	study	NOUN
iajs-3606	153	9	that	that	PRON
iajs-3606	153	10	looked	look	VERB
iajs-3606	153	11	at	at	ADP
iajs-3606	153	12	how	how	SCONJ
iajs-3606	153	13	smoking	smoking	NOUN
iajs-3606	153	14	affected	affect	VERB
iajs-3606	153	15	people	people	NOUN
iajs-3606	153	16	who	who	PRON
iajs-3606	153	17	got	get	VERB
iajs-3606	153	18	the	the	DET
iajs-3606	153	19	sars	sar	NOUN
iajs-3606	153	20	-	-	PUNCT
iajs-3606	153	21	cov-2	cov-2	PART
iajs-3606	153	22	vaccine	vaccine	NOUN
iajs-3606	153	23	.	.	PUNCT
iajs-3606	154	1	that	that	DET
iajs-3606	154	2	study	study	NOUN
iajs-3606	154	3	found	find	VERB
iajs-3606	154	4	that	that	SCONJ
iajs-3606	154	5	the	the	DET
iajs-3606	154	6	level	level	NOUN
iajs-3606	154	7	of	of	ADP
iajs-3606	154	8	igg	igg	NOUN
iajs-3606	154	9	antibody	antibody	NOUN
iajs-3606	154	10	dropped	drop	VERB
iajs-3606	154	11	faster	fast	ADV
iajs-3606	154	12	in	in	ADP
iajs-3606	154	13	vaccinated	vaccinated	ADJ
iajs-3606	154	14	smokers	smoker	NOUN
iajs-3606	154	15	than	than	ADP
iajs-3606	154	16	in	in	ADP
iajs-3606	154	17	vaccinated	vaccinated	ADJ
iajs-3606	154	18	non	non	NOUN
iajs-3606	154	19	-	-	NOUN
iajs-3606	154	20	smokers	smoker	NOUN
iajs-3606	154	21	(	(	PUNCT
iajs-3606	154	22	33	33	NUM
iajs-3606	154	23	,	,	PUNCT
iajs-3606	154	24	34	34	NUM
iajs-3606	154	25	)	)	PUNCT
iajs-3606	154	26	.	.	PUNCT
iajs-3606	155	1	this	this	PRON
iajs-3606	155	2	is	be	AUX
iajs-3606	155	3	consistent	consistent	ADJ
iajs-3606	155	4	with	with	ADP
iajs-3606	155	5	the	the	DET
iajs-3606	155	6	results	result	NOUN
iajs-3606	155	7	of	of	ADP
iajs-3606	155	8	the	the	DET
iajs-3606	155	9	current	current	ADJ
iajs-3606	155	10	study	study	NOUN
iajs-3606	155	11	.	.	PUNCT
iajs-3606	156	1	in	in	ADP
iajs-3606	156	2	a	a	DET
iajs-3606	156	3	previous	previous	ADJ
iajs-3606	156	4	study	study	NOUN
iajs-3606	156	5	of	of	ADP
iajs-3606	156	6	healthcare	healthcare	NOUN
iajs-3606	156	7	workers	worker	NOUN
iajs-3606	156	8	at	at	ADP
iajs-3606	156	9	the	the	DET
iajs-3606	156	10	national	national	ADJ
iajs-3606	156	11	hospital	hospital	NOUN
iajs-3606	156	12	in	in	ADP
iajs-3606	156	13	japan	japan	PROPN
iajs-3606	156	14	to	to	PART
iajs-3606	156	15	assess	assess	VERB
iajs-3606	156	16	igg	igg	NOUN
iajs-3606	156	17	antibody	antibody	NOUN
iajs-3606	156	18	titers	titer	NOUN
iajs-3606	156	19	,	,	PUNCT
iajs-3606	156	20	smokers	smoker	NOUN
iajs-3606	156	21	had	have	VERB
iajs-3606	156	22	lower	low	ADJ
iajs-3606	156	23	antibody	antibody	NOUN
iajs-3606	156	24	levels	level	NOUN
iajs-3606	156	25	compared	compare	VERB
iajs-3606	156	26	to	to	ADP
iajs-3606	156	27	non	non	ADJ
iajs-3606	156	28	-	-	ADJ
iajs-3606	156	29	smoker	smoker	ADJ
iajs-3606	156	30	participants	participant	NOUN
iajs-3606	156	31	,	,	PUNCT
iajs-3606	156	32	indicating	indicate	VERB
iajs-3606	156	33	that	that	SCONJ
iajs-3606	156	34	smoking	smoking	NOUN
iajs-3606	156	35	cessation	cessation	NOUN
iajs-3606	156	36	will	will	AUX
iajs-3606	156	37	reduce	reduce	VERB
iajs-3606	156	38	the	the	DET
iajs-3606	156	39	risk	risk	NOUN
iajs-3606	156	40	of	of	ADP
iajs-3606	156	41	antibody	antibody	NOUN
iajs-3606	156	42	loss	loss	NOUN
iajs-3606	156	43	(	(	PUNCT
iajs-3606	156	44	35	35	NUM
iajs-3606	156	45	)	)	PUNCT
iajs-3606	156	46	.	.	PUNCT
iajs-3606	157	1	this	this	DET
iajs-3606	157	2	study	study	NOUN
iajs-3606	157	3	is	be	AUX
iajs-3606	157	4	consistent	consistent	ADJ
iajs-3606	157	5	with	with	ADP
iajs-3606	157	6	the	the	DET
iajs-3606	157	7	current	current	ADJ
iajs-3606	157	8	study	study	NOUN
iajs-3606	157	9	's	's	PART
iajs-3606	157	10	findings	finding	NOUN
iajs-3606	157	11	.	.	PUNCT
iajs-3606	158	1	5	5	X
iajs-3606	158	2	.	.	X
iajs-3606	158	3	conclusion	conclusion	NOUN
iajs-3606	158	4	the	the	DET
iajs-3606	158	5	study	study	NOUN
iajs-3606	158	6	concluded	conclude	VERB
iajs-3606	158	7	that	that	SCONJ
iajs-3606	158	8	the	the	DET
iajs-3606	158	9	effect	effect	NOUN
iajs-3606	158	10	of	of	ADP
iajs-3606	158	11	the	the	DET
iajs-3606	158	12	housing	housing	NOUN
iajs-3606	158	13	factor	factor	NOUN
iajs-3606	158	14	was	be	AUX
iajs-3606	158	15	significant	significant	ADJ
iajs-3606	158	16	for	for	ADP
iajs-3606	158	17	study	study	NOUN
iajs-3606	158	18	participants	participant	NOUN
iajs-3606	158	19	who	who	PRON
iajs-3606	158	20	received	receive	VERB
iajs-3606	158	21	sinopharm	sinopharm	NOUN
iajs-3606	158	22	vaccine	vaccine	NOUN
iajs-3606	158	23	and	and	CCONJ
iajs-3606	158	24	insignificant	insignificant	ADJ
iajs-3606	158	25	for	for	ADP
iajs-3606	158	26	pfizer	pfizer	NOUN
iajs-3606	158	27	vaccinators	vaccinator	NOUN
iajs-3606	158	28	,	,	PUNCT
iajs-3606	158	29	while	while	SCONJ
iajs-3606	158	30	the	the	DET
iajs-3606	158	31	effect	effect	NOUN
iajs-3606	158	32	of	of	ADP
iajs-3606	158	33	occupation	occupation	NOUN
iajs-3606	158	34	and	and	CCONJ
iajs-3606	158	35	smoking	smoking	NOUN
iajs-3606	158	36	was	be	AUX
iajs-3606	158	37	significant	significant	ADJ
iajs-3606	158	38	for	for	ADP
iajs-3606	158	39	pfizer	pfizer	NOUN
iajs-3606	158	40	vaccinators	vaccinator	NOUN
iajs-3606	158	41	and	and	CCONJ
iajs-3606	158	42	insignificant	insignificant	ADJ
iajs-3606	158	43	for	for	ADP
iajs-3606	158	44	sinopharm	sinopharm	NOUN
iajs-3606	158	45	vaccinators	vaccinator	NOUN
iajs-3606	158	46	.	.	PUNCT
iajs-3606	159	1	the	the	DET
iajs-3606	159	2	study	study	NOUN
iajs-3606	159	3	also	also	ADV
iajs-3606	159	4	found	find	VERB
iajs-3606	159	5	significant	significant	ADJ
iajs-3606	159	6	effects	effect	NOUN
iajs-3606	159	7	on	on	ADP
iajs-3606	159	8	antibody	antibody	NOUN
iajs-3606	159	9	titer	titer	NOUN
iajs-3606	159	10	levels	level	NOUN
iajs-3606	159	11	among	among	ADP
iajs-3606	159	12	study	study	NOUN
iajs-3606	159	13	participants	participant	NOUN
iajs-3606	159	14	in	in	ADP
iajs-3606	159	15	diyala	diyala	PROPN
iajs-3606	159	16	province	province	NOUN
iajs-3606	159	17	.	.	PUNCT
iajs-3606	160	1	therefore	therefore	ADV
iajs-3606	160	2	,	,	PUNCT
iajs-3606	160	3	the	the	DET
iajs-3606	160	4	study	study	NOUN
iajs-3606	160	5	recommends	recommend	VERB
iajs-3606	160	6	the	the	DET
iajs-3606	160	7	necessity	necessity	NOUN
iajs-3606	160	8	of	of	ADP
iajs-3606	160	9	vaccination	vaccination	NOUN
iajs-3606	160	10	with	with	ADP
iajs-3606	160	11	a	a	DET
iajs-3606	160	12	preventive	preventive	ADJ
iajs-3606	160	13	dose	dose	NOUN
iajs-3606	160	14	,	,	PUNCT
iajs-3606	160	15	not	not	PART
iajs-3606	160	16	neglecting	neglect	VERB
iajs-3606	160	17	vaccination	vaccination	NOUN
iajs-3606	160	18	schedules	schedule	NOUN
iajs-3606	160	19	,	,	PUNCT
iajs-3606	160	20	and	and	CCONJ
iajs-3606	160	21	periodic	periodic	ADJ
iajs-3606	160	22	examinations	examination	NOUN
iajs-3606	160	23	to	to	PART
iajs-3606	160	24	ensure	ensure	VERB
iajs-3606	160	25	safety	safety	NOUN
iajs-3606	160	26	from	from	ADP
iajs-3606	160	27	covid-19	covid-19	PROPN
iajs-3606	160	28	.	.	PUNCT
iajs-3606	161	1	acknowledgment	acknowledgment	NOUN
iajs-3606	161	2	we	we	PRON
iajs-3606	161	3	express	express	VERB
iajs-3606	161	4	our	our	PRON
iajs-3606	161	5	gratitude	gratitude	NOUN
iajs-3606	161	6	to	to	ADP
iajs-3606	161	7	professor	professor	PROPN
iajs-3606	161	8	dr	dr	PROPN
iajs-3606	161	9	.	.	PROPN
iajs-3606	161	10	abdulrazak	abdulrazak	PROPN
iajs-3606	161	11	sh	sh	PROPN
iajs-3606	161	12	.	.	PROPN
iajs-3606	161	13	hasan	hasan	PROPN
iajs-3606	161	14	,	,	PUNCT
iajs-3606	162	1	for	for	ADP
iajs-3606	162	2	the	the	DET
iajs-3606	162	3	scientific	scientific	ADJ
iajs-3606	162	4	advice	advice	NOUN
iajs-3606	162	5	he	he	PRON
iajs-3606	162	6	provided	provide	VERB
iajs-3606	162	7	support	support	NOUN
iajs-3606	162	8	and	and	CCONJ
iajs-3606	162	9	assistant	assistant	NOUN
iajs-3606	162	10	professor	professor	NOUN
iajs-3606	162	11	asmaa	asmaa	PROPN
iajs-3606	162	12	haseeb	haseeb	PROPN
iajs-3606	162	13	hwaid	hwaid	PROPN
iajs-3606	162	14	,	,	PUNCT
iajs-3606	162	15	for	for	ADP
iajs-3606	162	16	scientific	scientific	ADJ
iajs-3606	162	17	support	support	NOUN
iajs-3606	162	18	and	and	CCONJ
iajs-3606	162	19	guidance	guidance	NOUN
iajs-3606	162	20	payment	payment	NOUN
iajs-3606	162	21	during	during	ADP
iajs-3606	162	22	the	the	DET
iajs-3606	162	23	study	study	NOUN
iajs-3606	162	24	period	period	NOUN
iajs-3606	162	25	.	.	PUNCT
iajs-3606	163	1	conflict	conflict	NOUN
iajs-3606	163	2	of	of	ADP
iajs-3606	163	3	interest	interest	NOUN
iajs-3606	163	4	the	the	DET
iajs-3606	163	5	authors	author	NOUN
iajs-3606	163	6	declare	declare	VERB
iajs-3606	163	7	no	no	DET
iajs-3606	163	8	conflicts	conflict	NOUN
iajs-3606	163	9	of	of	ADP
iajs-3606	163	10	interest	interest	NOUN
iajs-3606	163	11	.	.	PUNCT
iajs-3606	164	1	funding	funding	NOUN
iajs-3606	164	2	funding	funding	NOUN
iajs-3606	164	3	for	for	ADP
iajs-3606	164	4	the	the	DET
iajs-3606	164	5	research	research	NOUN
iajs-3606	164	6	was	be	AUX
iajs-3606	164	7	self	self	NOUN
iajs-3606	164	8	-	-	PUNCT
iajs-3606	164	9	funded	fund	VERB
iajs-3606	164	10	.	.	PUNCT
iajs-3606	165	1	ethical	ethical	ADJ
iajs-3606	165	2	clearance	clearance	NOUN
iajs-3606	165	3	approval	approval	NOUN
iajs-3606	165	4	scientific	scientific	ADJ
iajs-3606	165	5	approval	approval	NOUN
iajs-3606	165	6	has	have	AUX
iajs-3606	165	7	been	be	AUX
iajs-3606	165	8	obtained	obtain	VERB
iajs-3606	165	9	from	from	ADP
iajs-3606	165	10	diyala	diyala	PROPN
iajs-3606	165	11	health	health	PROPN
iajs-3606	165	12	department	department	PROPN
iajs-3606	165	13	,	,	PUNCT
iajs-3606	165	14	in	in	ADP
iajs-3606	165	15	letter	letter	NOUN
iajs-3606	165	16	no	no	INTJ
iajs-3606	165	17	.	.	PROPN
iajs-3606	165	18	2790	2790	NUM
iajs-3606	165	19	dated	date	VERB
iajs-3606	165	20	8/2/2022	8/2/2022	NOUN
iajs-3606	165	21	,	,	PUNCT
iajs-3606	165	22	and	and	CCONJ
iajs-3606	165	23	the	the	DET
iajs-3606	165	24	procedures	procedure	NOUN
iajs-3606	165	25	were	be	AUX
iajs-3606	165	26	complies	complie	NOUN
iajs-3606	165	27	with	with	ADP
iajs-3606	165	28	ethical	ethical	ADJ
iajs-3606	165	29	standards	standard	NOUN
iajs-3606	165	30	and	and	CCONJ
iajs-3606	165	31	follows	follow	VERB
iajs-3606	165	32	the	the	DET
iajs-3606	165	33	institution	institution	NOUN
iajs-3606	165	34	's	's	PART
iajs-3606	165	35	health	health	NOUN
iajs-3606	165	36	guidelines	guideline	NOUN
iajs-3606	165	37	.	.	PUNCT
iajs-3606	166	1	ihjpas	ihjpas	PROPN
iajs-3606	166	2	.	.	PUNCT
iajs-3606	167	1	2025	2025	NUM
iajs-3606	167	2	,	,	PUNCT
iajs-3606	167	3	38	38	NUM
iajs-3606	167	4	(	(	PUNCT
iajs-3606	167	5	1	1	NUM
iajs-3606	167	6	)	)	PUNCT
iajs-3606	167	7	118	118	NUM
iajs-3606	167	8	references	reference	NOUN
iajs-3606	167	9	1	1	NUM
iajs-3606	167	10	.	.	PUNCT
iajs-3606	168	1	sohrabi	sohrabi	NOUN
iajs-3606	168	2	c	c	X
iajs-3606	168	3	,	,	PUNCT
iajs-3606	168	4	alsafi	alsafi	PROPN
iajs-3606	168	5	z	z	PROPN
iajs-3606	168	6	,	,	PUNCT
iajs-3606	168	7	o'neill	o'neill	PROPN
iajs-3606	168	8	n	n	SYM
iajs-3606	168	9	,	,	PUNCT
iajs-3606	168	10	khan	khan	PROPN
iajs-3606	168	11	m	m	PROPN
iajs-3606	168	12	,	,	PUNCT
iajs-3606	168	13	kerwan	kerwan	PROPN
iajs-3606	168	14	a	a	PROPN
iajs-3606	168	15	,	,	PUNCT
iajs-3606	168	16	al	al	PROPN
iajs-3606	168	17	-	-	PUNCT
iajs-3606	168	18	jabir	jabir	PROPN
iajs-3606	168	19	a	a	PROPN
iajs-3606	168	20	,	,	PUNCT
iajs-3606	168	21	iosifidis	iosifidis	PROPN
iajs-3606	168	22	c	c	PROPN
iajs-3606	168	23	,	,	PUNCT
iajs-3606	168	24	agha	agha	PROPN
iajs-3606	168	25	r.	r.	PROPN
iajs-3606	168	26	world	world	PROPN
iajs-3606	168	27	health	health	PROPN
iajs-3606	168	28	organization	organization	PROPN
iajs-3606	168	29	declares	declare	VERB
iajs-3606	168	30	global	global	ADJ
iajs-3606	168	31	emergency	emergency	NOUN
iajs-3606	168	32	:	:	PUNCT
iajs-3606	168	33	a	a	DET
iajs-3606	168	34	review	review	NOUN
iajs-3606	168	35	of	of	ADP
iajs-3606	168	36	the	the	DET
iajs-3606	168	37	2019	2019	NUM
iajs-3606	168	38	novel	novel	ADJ
iajs-3606	168	39	coronavirus	coronavirus	NOUN
iajs-3606	168	40	(	(	PUNCT
iajs-3606	168	41	covid-19	covid-19	PROPN
iajs-3606	168	42	)	)	PUNCT
iajs-3606	168	43	.	.	PUNCT
iajs-3606	169	1	international	international	ADJ
iajs-3606	169	2	journal	journal	NOUN
iajs-3606	169	3	of	of	ADP
iajs-3606	169	4	surgery	surgery	NOUN
iajs-3606	169	5	.	.	PUNCT
iajs-3606	170	1	2020	2020	NUM
iajs-3606	170	2	apr	apr	NOUN
iajs-3606	170	3	1	1	NUM
iajs-3606	170	4	;	;	PUNCT
iajs-3606	170	5	76:71	76:71	NUM
iajs-3606	170	6	-	-	SYM
iajs-3606	170	7	6	6	NUM
iajs-3606	170	8	.	.	PUNCT
iajs-3606	171	1	https://doi.org/10.1016/j.ijsu.2020.02.034	https://doi.org/10.1016/j.ijsu.2020.02.034	NOUN
iajs-3606	171	2	2	2	NUM
iajs-3606	171	3	.	.	X
iajs-3606	171	4	velavan	velavan	NOUN
iajs-3606	171	5	,	,	PUNCT
iajs-3606	171	6	t.	t.	PROPN
iajs-3606	171	7	p.	p.	PROPN
iajs-3606	171	8	;	;	PUNCT
iajs-3606	171	9	&	&	CCONJ
iajs-3606	171	10	meyer	meyer	PROPN
iajs-3606	171	11	,	,	PUNCT
iajs-3606	171	12	c.	c.	PROPN
iajs-3606	171	13	g.	g.	PROPN
iajs-3606	171	14	la	la	PROPN
iajs-3606	171	15	epidemia	epidemia	PROPN
iajs-3606	171	16	de	de	PROPN
iajs-3606	171	17	covid-19	covid-19	PROPN
iajs-3606	171	18	.	.	PUNCT
iajs-3606	172	1	trop	trop	PROPN
iajs-3606	172	2	med	med	PROPN
iajs-3606	172	3	int	int	PROPN
iajs-3606	172	4	health.2020	health.2020	PROPN
iajs-3606	172	5	;	;	PUNCT
iajs-3606	172	6	25(3	25(3	NUM
iajs-3606	172	7	):	):	PUNCT
iajs-3606	172	8	278	278	NUM
iajs-3606	172	9	-	-	SYM
iajs-3606	172	10	280	280	NUM
iajs-3606	172	11	.	.	PUNCT
iajs-3606	173	1	https://doi.org/10.1016/j.ijid.2020.11.189	https://doi.org/10.1016/j.ijid.2020.11.189	NUM
iajs-3606	173	2	3	3	NUM
iajs-3606	173	3	.	.	X
iajs-3606	173	4	weiss	weiss	PROPN
iajs-3606	173	5	,	,	PUNCT
iajs-3606	173	6	s.	s.	PROPN
iajs-3606	173	7	r	r	PROPN
iajs-3606	173	8	;	;	PUNCT
iajs-3606	173	9	,	,	PUNCT
iajs-3606	173	10	&	&	CCONJ
iajs-3606	173	11	leibowitz	leibowitz	PROPN
iajs-3606	173	12	,	,	PUNCT
iajs-3606	173	13	j.	j.	PROPN
iajs-3606	173	14	l.	l.	PROPN
iajs-3606	173	15	advances	advance	VERB
iajs-3606	173	16	in	in	ADP
iajs-3606	173	17	virus	virus	NOUN
iajs-3606	173	18	research	research	NOUN
iajs-3606	173	19	.	.	PUNCT
iajs-3606	174	1	adv	adv	PROPN
iajs-3606	174	2	virus	virus	PROPN
iajs-3606	174	3	res,2021	res,2021	PROPN
iajs-3606	174	4	;	;	PUNCT
iajs-3606	174	5	81	81	NUM
iajs-3606	174	6	:	:	SYM
iajs-3606	174	7	85	85	NUM
iajs-3606	174	8	-	-	SYM
iajs-3606	174	9	164	164	NUM
iajs-3606	174	10	.	.	PUNCT
iajs-3606	175	1	4	4	NUM
iajs-3606	175	2	.	.	X
iajs-3606	176	1	zhai	zhai	PROPN
iajs-3606	176	2	,	,	PUNCT
iajs-3606	176	3	p.	p.	NOUN
iajs-3606	176	4	;	;	PUNCT
iajs-3606	176	5	ding	ding	NOUN
iajs-3606	176	6	,	,	PUNCT
iajs-3606	176	7	y.	y.	PROPN
iajs-3606	176	8	;	;	PUNCT
iajs-3606	176	9	wu	wu	PROPN
iajs-3606	176	10	,	,	PUNCT
iajs-3606	176	11	x.	x.	PROPN
iajs-3606	176	12	;	;	PUNCT
iajs-3606	176	13	long	long	ADV
iajs-3606	176	14	,	,	PUNCT
iajs-3606	176	15	j.	j.	PROPN
iajs-3606	176	16	;	;	PUNCT
iajs-3606	176	17	zhong	zhong	PROPN
iajs-3606	176	18	,	,	PUNCT
iajs-3606	176	19	y.	y.	PROPN
iajs-3606	176	20	;	;	PUNCT
iajs-3606	176	21	and	and	CCONJ
iajs-3606	176	22	li	li	PROPN
iajs-3606	176	23	,	,	PUNCT
iajs-3606	176	24	y.	y.	PROPN
iajs-3606	176	25	(	(	PUNCT
iajs-3606	176	26	2020	2020	NUM
iajs-3606	176	27	)	)	PUNCT
iajs-3606	176	28	.	.	PUNCT
iajs-3606	177	1	the	the	DET
iajs-3606	177	2	epidemiology	epidemiology	NOUN
iajs-3606	177	3	,	,	PUNCT
iajs-3606	177	4	diagnosis	diagnosis	NOUN
iajs-3606	177	5	and	and	CCONJ
iajs-3606	177	6	treatment	treatment	NOUN
iajs-3606	177	7	of	of	ADP
iajs-3606	177	8	covid-19	covid-19	PROPN
iajs-3606	177	9	.	.	PUNCT
iajs-3606	178	1	international	international	PROPN
iajs-3606	178	2	journal	journal	PROPN
iajs-3606	178	3	of	of	ADP
iajs-3606	178	4	antimicrobial	antimicrobial	ADJ
iajs-3606	178	5	agents	agent	NOUN
iajs-3606	178	6	,	,	PUNCT
iajs-3606	178	7	2020;55(5	2020;55(5	NUM
iajs-3606	178	8	):	):	PUNCT
iajs-3606	178	9	105955	105955	NUM
iajs-3606	178	10	.	.	PUNCT
iajs-3606	179	1	https://doi.org/10.1016/j.ijantimicag.2020.105955	https://doi.org/10.1016/j.ijantimicag.2020.105955	ADJ
iajs-3606	179	2	5	5	NUM
iajs-3606	179	3	.	.	X
iajs-3606	179	4	zhou	zhou	PROPN
iajs-3606	179	5	,	,	PUNCT
iajs-3606	179	6	p.	p.	PROPN
iajs-3606	179	7	;	;	PUNCT
iajs-3606	179	8	yang	yang	PROPN
iajs-3606	179	9	,	,	PUNCT
iajs-3606	179	10	x.	x.	PROPN
iajs-3606	179	11	l.	l.	PROPN
iajs-3606	179	12	;	;	PUNCT
iajs-3606	179	13	wang	wang	PROPN
iajs-3606	179	14	,	,	PUNCT
iajs-3606	179	15	x.	x.	PROPN
iajs-3606	179	16	g.	g.	PROPN
iajs-3606	179	17	;	;	PUNCT
iajs-3606	179	18	hu	hu	PROPN
iajs-3606	179	19	,	,	PUNCT
iajs-3606	179	20	b.	b.	PROPN
iajs-3606	179	21	;	;	PUNCT
iajs-3606	179	22	zhang	zhang	PROPN
iajs-3606	179	23	,	,	PUNCT
iajs-3606	179	24	l.	l.	PROPN
iajs-3606	179	25	;	;	PUNCT
iajs-3606	179	26	zhang	zhang	PROPN
iajs-3606	179	27	,	,	PUNCT
iajs-3606	179	28	w.	w.	PROPN
iajs-3606	179	29	;	;	PUNCT
iajs-3606	179	30	and	and	CCONJ
iajs-3606	179	31	shi	shi	PROPN
iajs-3606	179	32	,	,	PUNCT
iajs-3606	179	33	z.	z.	PROPN
iajs-3606	179	34	l.	l.	PROPN
iajs-3606	179	35	(	(	PUNCT
iajs-3606	179	36	2020	2020	NUM
iajs-3606	179	37	)	)	PUNCT
iajs-3606	179	38	.	.	PUNCT
iajs-3606	180	1	a	a	DET
iajs-3606	180	2	pneumonia	pneumonia	NOUN
iajs-3606	180	3	outbreak	outbreak	NOUN
iajs-3606	180	4	associated	associate	VERB
iajs-3606	180	5	with	with	ADP
iajs-3606	180	6	a	a	DET
iajs-3606	180	7	new	new	ADJ
iajs-3606	180	8	coronavirus	coronavirus	NOUN
iajs-3606	180	9	of	of	ADP
iajs-3606	180	10	probable	probable	ADJ
iajs-3606	180	11	bat	bat	NOUN
iajs-3606	180	12	origin	origin	NOUN
iajs-3606	180	13	.	.	PUNCT
iajs-3606	181	1	nature,2020	nature,2020	ADV
iajs-3606	181	2	;	;	PUNCT
iajs-3606	181	3	579(7798	579(7798	NUM
iajs-3606	181	4	):	):	PUNCT
iajs-3606	181	5	270	270	NUM
iajs-3606	181	6	-	-	SYM
iajs-3606	181	7	273	273	NUM
iajs-3606	181	8	.	.	NOUN
iajs-3606	182	1	6	6	NUM
iajs-3606	182	2	.	.	X
iajs-3606	182	3	world	world	PROPN
iajs-3606	182	4	health	health	PROPN
iajs-3606	182	5	organization	organization	PROPN
iajs-3606	182	6	.	.	PUNCT
iajs-3606	183	1	modes	mode	NOUN
iajs-3606	183	2	of	of	ADP
iajs-3606	183	3	transmission	transmission	NOUN
iajs-3606	183	4	of	of	ADP
iajs-3606	183	5	virus	virus	NOUN
iajs-3606	183	6	causing	cause	VERB
iajs-3606	183	7	covid-19	covid-19	PROPN
iajs-3606	183	8	:	:	PUNCT
iajs-3606	183	9	implications	implication	NOUN
iajs-3606	183	10	for	for	ADP
iajs-3606	183	11	ipc	ipc	PROPN
iajs-3606	183	12	precaution	precaution	NOUN
iajs-3606	183	13	recommendations	recommendation	NOUN
iajs-3606	183	14	.	.	PUNCT
iajs-3606	184	1	(	(	PUNCT
iajs-3606	184	2	2020	2020	NUM
iajs-3606	184	3	)	)	PUNCT
iajs-3606	184	4	.	.	PUNCT
iajs-3606	185	1	available	available	ADJ
iajs-3606	185	2	online	online	ADV
iajs-3606	185	3	at	at	ADP
iajs-3606	185	4	:	:	PUNCT
iajs-3606	185	5	https://www.who.int/newsroom/commentaries/detail/.modes-of-transmission-of-virus-causing-covid-19-implications-foripcprecaution-recommendations	https://www.who.int/newsroom/commentaries/detail/.modes-of-transmission-of-virus-causing-covid-19-implications-foripcprecaution-recommendation	NOUN
iajs-3606	185	6	(	(	PUNCT
iajs-3606	185	7	accessed	access	VERB
iajs-3606	185	8	june	june	PROPN
iajs-3606	185	9	11	11	NUM
iajs-3606	185	10	,	,	PUNCT
iajs-3606	185	11	2020	2020	NUM
iajs-3606	185	12	)	)	PUNCT
iajs-3606	185	13	.	.	PUNCT
iajs-3606	186	1	7	7	X
iajs-3606	186	2	.	.	X
iajs-3606	186	3	arons	aron	NOUN
iajs-3606	186	4	,	,	PUNCT
iajs-3606	186	5	m.	m.	NOUN
iajs-3606	186	6	m.	m.	NOUN
iajs-3606	186	7	;	;	PUNCT
iajs-3606	186	8	hatfield	hatfield	PROPN
iajs-3606	186	9	,	,	PUNCT
iajs-3606	186	10	k.	k.	PROPN
iajs-3606	186	11	m.	m.	PROPN
iajs-3606	186	12	;	;	PUNCT
iajs-3606	186	13	reddy	reddy	PROPN
iajs-3606	186	14	,	,	PUNCT
iajs-3606	186	15	s.	s.	PROPN
iajs-3606	186	16	c.	c.	PROPN
iajs-3606	186	17	;	;	PUNCT
iajs-3606	186	18	kimball	kimball	PROPN
iajs-3606	186	19	,	,	PUNCT
iajs-3606	186	20	a.	a.	PROPN
iajs-3606	186	21	james	james	PROPN
iajs-3606	186	22	,	,	PUNCT
iajs-3606	186	23	a.	a.	NOUN
iajs-3606	186	24	;	;	PUNCT
iajs-3606	186	25	and	and	CCONJ
iajs-3606	186	26	jacobs	jacobs	PROPN
iajs-3606	186	27	,	,	PUNCT
iajs-3606	186	28	j.	j.	PROPN
iajs-3606	186	29	r.	r.	PROPN
iajs-3606	186	30	infecciones	infecciones	PROPN
iajs-3606	186	31	presintomáticas	presintomáticas	PROPN
iajs-3606	186	32	por	por	NOUN
iajs-3606	186	33	sars	sar	NOUN
iajs-3606	186	34	-	-	PUNCT
iajs-3606	186	35	cov-2	cov-2	NOUN
iajs-3606	186	36	y	y	PROPN
iajs-3606	186	37	transmisión	transmisión	PROPN
iajs-3606	186	38	en	en	PROPN
iajs-3606	186	39	un	un	PROPN
iajs-3606	186	40	centro	centro	PROPN
iajs-3606	186	41	de	de	PROPN
iajs-3606	186	42	enfermería	enfermería	PROPN
iajs-3606	186	43	especializada	especializada	PROPN
iajs-3606	186	44	.	.	PUNCT
iajs-3606	187	1	new	new	PROPN
iajs-3606	187	2	england	england	PROPN
iajs-3606	187	3	journal	journal	PROPN
iajs-3606	187	4	of	of	ADP
iajs-3606	187	5	medicine	medicine	NOUN
iajs-3606	187	6	,	,	PUNCT
iajs-3606	187	7	28	28	NUM
iajs-3606	187	8	:	:	SYM
iajs-3606	187	9	2081	2081	NUM
iajs-3606	187	10	-	-	SYM
iajs-3606	187	11	90	90	NUM
iajs-3606	187	12	.	.	NOUN
iajs-3606	187	13	8	8	NUM
iajs-3606	187	14	.	.	X
iajs-3606	188	1	nepal	nepal	PROPN
iajs-3606	188	2	,	,	PUNCT
iajs-3606	188	3	g.	g.	PROPN
iajs-3606	188	4	;	;	PUNCT
iajs-3606	188	5	rehrig	rehrig	ADJ
iajs-3606	188	6	,	,	PUNCT
iajs-3606	188	7	j.	j.	PROPN
iajs-3606	188	8	h.	h.	PROPN
iajs-3606	188	9	;	;	PUNCT
iajs-3606	188	10	shrestha	shrestha	PROPN
iajs-3606	188	11	,	,	PUNCT
iajs-3606	188	12	g.	g.	PROPN
iajs-3606	188	13	s.	s.	PROPN
iajs-3606	188	14	;	;	PUNCT
iajs-3606	188	15	shing	she	VERB
iajs-3606	188	16	,	,	PUNCT
iajs-3606	188	17	y.	y.	PROPN
iajs-3606	188	18	k.	k.	PROPN
iajs-3606	188	19	;	;	PUNCT
iajs-3606	188	20	yadav	yadav	PROPN
iajs-3606	188	21	,	,	PUNCT
iajs-3606	188	22	j.	j.	PROPN
iajs-3606	188	23	k.	k.	PROPN
iajs-3606	188	24	;	;	PUNCT
iajs-3606	188	25	ojha	ojha	PROPN
iajs-3606	188	26	,	,	PUNCT
iajs-3606	188	27	r.	r.	PROPN
iajs-3606	188	28	,	,	PUNCT
iajs-3606	188	29	and	and	CCONJ
iajs-3606	188	30	huang	huang	PROPN
iajs-3606	188	31	,	,	PUNCT
iajs-3606	188	32	d.	d.	PROPN
iajs-3606	188	33	y.	y.	PROPN
iajs-3606	188	34	neurological	neurological	ADJ
iajs-3606	188	35	manifestations	manifestation	NOUN
iajs-3606	188	36	of	of	ADP
iajs-3606	188	37	covid-19	covid-19	PROPN
iajs-3606	188	38	:	:	PUNCT
iajs-3606	188	39	a	a	DET
iajs-3606	188	40	systematic	systematic	ADJ
iajs-3606	188	41	review	review	NOUN
iajs-3606	188	42	.	.	PUNCT
iajs-3606	189	1	critical	critical	ADJ
iajs-3606	189	2	care	care	NOUN
iajs-3606	189	3	,	,	PUNCT
iajs-3606	189	4	2020	2020	NUM
iajs-3606	189	5	;	;	PUNCT
iajs-3606	189	6	24	24	NUM
iajs-3606	189	7	:	:	SYM
iajs-3606	189	8	1	1	NUM
iajs-3606	189	9	-	-	SYM
iajs-3606	189	10	11	11	NUM
iajs-3606	189	11	.	.	PUNCT
iajs-3606	190	1	https://doi.org/10.1186/s13054-020-03121-z	https://doi.org/10.1186/s13054-020-03121-z	NOUN
iajs-3606	190	2	9	9	NUM
iajs-3606	190	3	.	.	PUNCT
iajs-3606	191	1	kaur	kaur	PROPN
iajs-3606	191	2	,	,	PUNCT
iajs-3606	191	3	s.	s.	PROPN
iajs-3606	191	4	p.	p.	PROPN
iajs-3606	191	5	,	,	PUNCT
iajs-3606	191	6	and	and	CCONJ
iajs-3606	191	7	gupta	gupta	PROPN
iajs-3606	191	8	,	,	PUNCT
iajs-3606	191	9	v.	v.	ADP
iajs-3606	191	10	covid-19	covid-19	PROPN
iajs-3606	191	11	vaccine	vaccine	NOUN
iajs-3606	191	12	:	:	PUNCT
iajs-3606	191	13	a	a	DET
iajs-3606	191	14	comprehensive	comprehensive	ADJ
iajs-3606	191	15	status	status	NOUN
iajs-3606	191	16	report	report	NOUN
iajs-3606	191	17	.	.	PUNCT
iajs-3606	192	1	virus	virus	NOUN
iajs-3606	192	2	research	research	NOUN
iajs-3606	192	3	.	.	PUNCT
iajs-3606	193	1	2020	2020	NUM
iajs-3606	193	2	;	;	PUNCT
iajs-3606	193	3	288	288	NUM
iajs-3606	193	4	:	:	SYM
iajs-3606	193	5	198114	198114	NUM
iajs-3606	193	6	.	.	PUNCT
iajs-3606	194	1	https://doi.org/10.1016/j.virusres.2020.198114	https://doi.org/10.1016/j.virusres.2020.198114	NOUN
iajs-3606	194	2	10	10	NUM
iajs-3606	194	3	.	.	PUNCT
iajs-3606	195	1	world	world	PROPN
iajs-3606	195	2	health	health	PROPN
iajs-3606	195	3	organization	organization	PROPN
iajs-3606	195	4	,	,	PUNCT
iajs-3606	195	5	who	who	PRON
iajs-3606	195	6	confirms	confirm	VERB
iajs-3606	195	7	the	the	DET
iajs-3606	195	8	safety	safety	NOUN
iajs-3606	195	9	and	and	CCONJ
iajs-3606	195	10	efficacy	efficacy	NOUN
iajs-3606	195	11	of	of	ADP
iajs-3606	195	12	covid-19	covid-19	PROPN
iajs-3606	195	13	vaccines	vaccine	NOUN
iajs-3606	195	14	and	and	CCONJ
iajs-3606	195	15	urges	urge	VERB
iajs-3606	195	16	iraqis	iraqis	PROPN
iajs-3606	195	17	to	to	PART
iajs-3606	195	18	register	register	VERB
iajs-3606	195	19	and	and	CCONJ
iajs-3606	195	20	vaccinate	vaccinate	VERB
iajs-3606	195	21	to	to	PART
iajs-3606	195	22	help	help	VERB
iajs-3606	195	23	defeat	defeat	VERB
iajs-3606	195	24	the	the	DET
iajs-3606	195	25	pandemic	pandemic	NOUN
iajs-3606	195	26	cited	cite	VERB
iajs-3606	195	27	2021	2021	NUM
iajs-3606	195	28	11	11	NUM
iajs-3606	195	29	april	april	PROPN
iajs-3606	195	30	2021	2021	NUM
iajs-3606	195	31	.	.	PUNCT
iajs-3606	196	1	available	available	ADJ
iajs-3606	196	2	from	from	ADP
iajs-3606	196	3	:	:	PUNCT
iajs-3606	196	4	http://www.emro.who.int/irq/iraq-news	http://www.emro.who.int/irq/iraq-news	PROPN
iajs-3606	196	5	11	11	NUM
iajs-3606	196	6	.	.	PUNCT
iajs-3606	197	1	solomon	solomon	PROPN
iajs-3606	197	2	,	,	PUNCT
iajs-3606	197	3	y.	y.	PROPN
iajs-3606	197	4	;	;	PUNCT
iajs-3606	197	5	eshete	eshete	NOUN
iajs-3606	197	6	,	,	PUNCT
iajs-3606	197	7	t.	t.	PROPN
iajs-3606	197	8	;	;	PUNCT
iajs-3606	197	9	mekasha	mekasha	PROPN
iajs-3606	197	10	,	,	PUNCT
iajs-3606	197	11	b.	b.	PROPN
iajs-3606	197	12	,	,	PUNCT
iajs-3606	197	13	and	and	CCONJ
iajs-3606	197	14	assefa	assefa	PROPN
iajs-3606	197	15	,	,	PUNCT
iajs-3606	197	16	w.	w.	PROPN
iajs-3606	197	17	covid-19	covid-19	PROPN
iajs-3606	197	18	vaccine	vaccine	NOUN
iajs-3606	197	19	:	:	PUNCT
iajs-3606	197	20	side	side	NOUN
iajs-3606	197	21	effects	effect	NOUN
iajs-3606	197	22	after	after	ADP
iajs-3606	197	23	the	the	DET
iajs-3606	197	24	first	first	ADJ
iajs-3606	197	25	dose	dose	NOUN
iajs-3606	197	26	of	of	ADP
iajs-3606	197	27	the	the	DET
iajs-3606	197	28	oxford	oxford	PROPN
iajs-3606	197	29	astrazeneca	astrazeneca	PROPN
iajs-3606	197	30	vaccine	vaccine	NOUN
iajs-3606	197	31	among	among	ADP
iajs-3606	197	32	health	health	NOUN
iajs-3606	197	33	professionals	professional	NOUN
iajs-3606	197	34	in	in	ADP
iajs-3606	197	35	low	low	ADJ
iajs-3606	197	36	-	-	PUNCT
iajs-3606	197	37	income	income	NOUN
iajs-3606	197	38	country	country	NOUN
iajs-3606	197	39	:	:	PUNCT
iajs-3606	197	40	ethiopia	ethiopia	PROPN
iajs-3606	197	41	.	.	PROPN
iajs-3606	197	42	journal	journal	PROPN
iajs-3606	197	43	of	of	ADP
iajs-3606	197	44	multidisciplinary	multidisciplinary	ADJ
iajs-3606	197	45	healthcare	healthcare	NOUN
iajs-3606	197	46	,	,	PUNCT
iajs-3606	197	47	2021	2021	NUM
iajs-3606	197	48	:	:	PUNCT
iajs-3606	197	49	2577	2577	NUM
iajs-3606	197	50	-	-	SYM
iajs-3606	197	51	2585	2585	NUM
iajs-3606	197	52	.	.	PUNCT
iajs-3606	198	1	http://creativecommons.org/licenses/bync/4.0/	http://creativecommons.org/licenses/bync/4.0/	NOUN
iajs-3606	198	2	12	12	NUM
iajs-3606	198	3	.	.	PUNCT
iajs-3606	198	4	andrzejczak	andrzejczak	NOUN
iajs-3606	198	5	-	-	PUNCT
iajs-3606	198	6	grzadko	grzadko	PROPN
iajs-3606	198	7	,	,	PUNCT
iajs-3606	198	8	s.	s.	PROPN
iajs-3606	198	9	;	;	PUNCT
iajs-3606	198	10	czudy	czudy	PROPN
iajs-3606	198	11	,	,	PUNCT
iajs-3606	198	12	z.	z.	PROPN
iajs-3606	198	13	;	;	PUNCT
iajs-3606	198	14	and	and	CCONJ
iajs-3606	198	15	donderska	donderska	PROPN
iajs-3606	198	16	,	,	PUNCT
iajs-3606	198	17	m.	m.	NOUN
iajs-3606	198	18	side	side	NOUN
iajs-3606	198	19	effects	effect	NOUN
iajs-3606	198	20	after	after	ADP
iajs-3606	198	21	covid-19	covid-19	PROPN
iajs-3606	198	22	vaccinations	vaccination	NOUN
iajs-3606	198	23	among	among	ADP
iajs-3606	198	24	residents	resident	NOUN
iajs-3606	198	25	of	of	ADP
iajs-3606	198	26	poland	poland	PROPN
iajs-3606	198	27	.	.	PUNCT
iajs-3606	199	1	eur	eur	PROPN
iajs-3606	199	2	rev	rev	PROPN
iajs-3606	199	3	med	med	PROPN
iajs-3606	199	4	pharmacol	pharmacol	PROPN
iajs-3606	199	5	sci	sci	PROPN
iajs-3606	199	6	2021	2021	NUM
iajs-3606	199	7	;	;	PUNCT
iajs-3606	199	8	4418	4418	NUM
iajs-3606	199	9	-	-	SYM
iajs-3606	199	10	4421	4421	NUM
iajs-3606	199	11	.	.	PUNCT
iajs-3606	200	1	13	13	NUM
iajs-3606	200	2	.	.	PUNCT
iajs-3606	201	1	mehboob	mehboob	PROPN
iajs-3606	201	2	,	,	PUNCT
iajs-3606	201	3	r.	r.	PROPN
iajs-3606	201	4	;	;	PUNCT
iajs-3606	201	5	ahmad	ahmad	PROPN
iajs-3606	201	6	,	,	PUNCT
iajs-3606	201	7	f.	f.	PROPN
iajs-3606	201	8	j.	j.	PROPN
iajs-3606	201	9	;	;	PUNCT
iajs-3606	201	10	qayyum	qayyum	PROPN
iajs-3606	201	11	,	,	PUNCT
iajs-3606	201	12	a.	a.	NOUN
iajs-3606	201	13	;	;	PUNCT
iajs-3606	201	14	rana	rana	PROPN
iajs-3606	201	15	,	,	PUNCT
iajs-3606	201	16	m.	m.	NOUN
iajs-3606	201	17	a.	a.	PROPN
iajs-3606	201	18	;	;	PUNCT
iajs-3606	201	19	gilani	gilani	PROPN
iajs-3606	201	20	,	,	PUNCT
iajs-3606	201	21	s.	s.	PROPN
iajs-3606	201	22	a.	a.	PROPN
iajs-3606	201	23	;	;	PUNCT
iajs-3606	201	24	tariq	tariq	PROPN
iajs-3606	201	25	,	,	PUNCT
iajs-3606	201	26	m.	m.	NOUN
iajs-3606	201	27	a.	a.	NOUN
iajs-3606	201	28	;	;	PUNCT
iajs-3606	201	29	and	and	CCONJ
iajs-3606	201	30	akram	akram	PROPN
iajs-3606	201	31	,	,	PUNCT
iajs-3606	201	32	j.	j.	PROPN
iajs-3606	201	33	aprepitant	aprepitant	PROPN
iajs-3606	201	34	as	as	ADP
iajs-3606	201	35	a	a	DET
iajs-3606	201	36	combinant	combinant	NOUN
iajs-3606	201	37	with	with	ADP
iajs-3606	201	38	dexamethasone	dexamethasone	NOUN
iajs-3606	201	39	reduces	reduce	VERB
iajs-3606	201	40	the	the	DET
iajs-3606	201	41	inflammation	inflammation	NOUN
iajs-3606	201	42	via	via	ADP
iajs-3606	201	43	neurokinin	neurokinin	ADJ
iajs-3606	201	44	1	1	NUM
iajs-3606	201	45	receptor	receptor	NOUN
iajs-3606	201	46	antagonism	antagonism	NOUN
iajs-3606	201	47	in	in	ADP
iajs-3606	201	48	severe	severe	ADJ
iajs-3606	201	49	to	to	ADP
iajs-3606	201	50	critical	critical	ADJ
iajs-3606	201	51	covid-19	covid-19	PROPN
iajs-3606	201	52	patients	patient	NOUN
iajs-3606	201	53	and	and	CCONJ
iajs-3606	201	54	potentiates	potentiate	VERB
iajs-3606	201	55	respiratory	respiratory	ADJ
iajs-3606	201	56	recovery	recovery	NOUN
iajs-3606	201	57	:	:	PUNCT
iajs-3606	201	58	a	a	DET
iajs-3606	201	59	novel	novel	ADJ
iajs-3606	201	60	therapeutic	therapeutic	ADJ
iajs-3606	201	61	approach	approach	NOUN
iajs-3606	201	62	.	.	PUNCT
iajs-3606	202	1	medrxiv	medrxiv	PROPN
iajs-3606	202	2	.2020	.2020	PROPN
iajs-3606	202	3	;	;	PUNCT
iajs-3606	202	4	2020	2020	NUM
iajs-3606	202	5	-	-	SYM
iajs-3606	202	6	08	08	NUM
iajs-3606	202	7	.	.	PUNCT
iajs-3606	203	1	14	14	NUM
iajs-3606	203	2	.	.	PUNCT
iajs-3606	204	1	salahshoori	salahshoori	PROPN
iajs-3606	204	2	,	,	PUNCT
iajs-3606	204	3	i.	i.	NOUN
iajs-3606	204	4	;	;	PUNCT
iajs-3606	204	5	mobaraki	mobaraki	PROPN
iajs-3606	204	6	-	-	PUNCT
iajs-3606	204	7	asl	asl	PROPN
iajs-3606	204	8	,	,	PUNCT
iajs-3606	204	9	n.	n.	PROPN
iajs-3606	204	10	;	;	PUNCT
iajs-3606	204	11	seyfaee	seyfaee	PROPN
iajs-3606	204	12	,	,	PUNCT
iajs-3606	204	13	a.	a.	NOUN
iajs-3606	204	14	;	;	PUNCT
iajs-3606	204	15	mirzaei	mirzaei	PROPN
iajs-3606	204	16	nasirabad	nasirabad	PROPN
iajs-3606	204	17	,	,	PUNCT
iajs-3606	204	18	n.	n.	NOUN
iajs-3606	204	19	;	;	PUNCT
iajs-3606	204	20	dehghan	dehghan	PROPN
iajs-3606	204	21	,	,	PUNCT
iajs-3606	204	22	z.	z.	PROPN
iajs-3606	204	23	;	;	PUNCT
iajs-3606	204	24	faraji	faraji	NOUN
iajs-3606	204	25	,	,	PUNCT
iajs-3606	204	26	m.	m.	NOUN
iajs-3606	204	27	;	;	PUNCT
iajs-3606	204	28	and	and	CCONJ
iajs-3606	204	29	hamrang	hamrang	NOUN
iajs-3606	204	30	,	,	PUNCT
iajs-3606	204	31	a.	a.	NOUN
iajs-3606	204	32	overview	overview	NOUN
iajs-3606	204	33	of	of	ADP
iajs-3606	204	34	covid-19	covid-19	PROPN
iajs-3606	204	35	disease	disease	NOUN
iajs-3606	204	36	:	:	PUNCT
iajs-3606	204	37	virology	virology	NOUN
iajs-3606	204	38	,	,	PUNCT
iajs-3606	204	39	epidemiology	epidemiology	NOUN
iajs-3606	204	40	,	,	PUNCT
iajs-3606	204	41	prevention	prevention	NOUN
iajs-3606	204	42	diagnosis	diagnosis	NOUN
iajs-3606	204	43	,	,	PUNCT
iajs-3606	204	44	treatment	treatment	NOUN
iajs-3606	204	45	,	,	PUNCT
iajs-3606	204	46	and	and	CCONJ
iajs-3606	204	47	vaccines	vaccine	NOUN
iajs-3606	204	48	.	.	PUNCT
iajs-3606	205	1	biologics	biologic	NOUN
iajs-3606	205	2	,	,	PUNCT
iajs-3606	205	3	2021	2021	NUM
iajs-3606	205	4	;	;	PUNCT
iajs-3606	205	5	1(1	1(1	NUM
iajs-3606	205	6	):	):	PUNCT
iajs-3606	205	7	2	2	NUM
iajs-3606	205	8	-	-	SYM
iajs-3606	205	9	40	40	NUM
iajs-3606	205	10	.	.	PUNCT
iajs-3606	205	11	https://doi.org/10.3390/biologics1010002	https://doi.org/10.3390/biologics1010002	PROPN
iajs-3606	205	12	15	15	NUM
iajs-3606	205	13	.	.	PUNCT
iajs-3606	206	1	sinopharm	sinopharm	NOUN
iajs-3606	206	2	:	:	PUNCT
iajs-3606	207	1	chinese	chinese	ADJ
iajs-3606	207	2	covid	covid	PROPN
iajs-3606	207	3	vaccine	vaccine	NOUN
iajs-3606	207	4	gets	get	VERB
iajs-3606	207	5	who	who	PRON
iajs-3606	207	6	emergency	emergency	VERB
iajs-3606	207	7	approval	approval	NOUN
iajs-3606	207	8	.	.	PUNCT
iajs-3606	208	1	(	(	PUNCT
iajs-3606	208	2	2021	2021	NUM
iajs-3606	208	3	,	,	PUNCT
iajs-3606	208	4	may	may	AUX
iajs-3606	208	5	07	07	NUM
iajs-3606	208	6	)	)	PUNCT
iajs-3606	208	7	.	.	PUNCT
iajs-3606	209	1	retrieved	retrieve	VERB
iajs-3606	209	2	june	june	PROPN
iajs-3606	209	3	28	28	NUM
iajs-3606	209	4	,	,	PUNCT
iajs-3606	209	5	2021	2021	NUM
iajs-3606	209	6	,	,	PUNCT
iajs-3606	209	7	from	from	ADP
iajs-3606	209	8	https://www.bbc.com/news/world-asia-china-56967973	https://www.bbc.com/news/world-asia-china-56967973	ADJ
iajs-3606	209	9	https://doi.org/10.1016/j.ijsu.2020.02.034	https://doi.org/10.1016/j.ijsu.2020.02.034	NOUN
iajs-3606	209	10	https://doi.org/10.1016/j.ijid.2020.11.189	https://doi.org/10.1016/j.ijid.2020.11.189	PROPN
iajs-3606	209	11	https://doi.org/10.1016/j.ijantimicag.2020.105955	https://doi.org/10.1016/j.ijantimicag.2020.105955	ADJ
iajs-3606	209	12	https://www.who.int/news-room/commentaries/detail/	https://www.who.int/news-room/commentaries/detail/	PROPN
iajs-3606	209	13	https://www.who.int/news-room/commentaries/detail/	https://www.who.int/news-room/commentaries/detail/	PROPN
iajs-3606	209	14	https://doi.org/10.1186/s13054-020-03121-z	https://doi.org/10.1186/s13054-020-03121-z	VERB
iajs-3606	209	15	https://doi.org/10.1016/j.virusres.2020.198114	https://doi.org/10.1016/j.virusres.2020.198114	PROPN
iajs-3606	209	16	http://www.emro.who.int/irq/iraq-news	http://www.emro.who.int/irq/iraq-news	PROPN
iajs-3606	209	17	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	PRON
iajs-3606	209	18	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NOUN
iajs-3606	209	19	https://doi.org/10.3390/biologics1010002	https://doi.org/10.3390/biologics1010002	PROPN
iajs-3606	209	20	https://www.bbc.com/news/world-asia-china-56967973	https://www.bbc.com/news/world-asia-china-56967973	PROPN
iajs-3606	209	21	ihjpas	ihjpa	NOUN
iajs-3606	209	22	.	.	PUNCT
iajs-3606	210	1	2025	2025	NUM
iajs-3606	210	2	,	,	PUNCT
iajs-3606	210	3	38	38	NUM
iajs-3606	210	4	(	(	PUNCT
iajs-3606	210	5	1	1	NUM
iajs-3606	210	6	)	)	PUNCT
iajs-3606	210	7	119	119	NUM
iajs-3606	210	8	16	16	NUM
iajs-3606	210	9	.	.	PUNCT
iajs-3606	211	1	lu	lu	PROPN
iajs-3606	211	2	,	,	PUNCT
iajs-3606	211	3	l.	l.	PROPN
iajs-3606	211	4	;	;	PUNCT
iajs-3606	211	5	mok	mok	PROPN
iajs-3606	211	6	,	,	PUNCT
iajs-3606	211	7	b.	b.	PROPN
iajs-3606	211	8	w.	w.	PROPN
iajs-3606	211	9	y.	y.	PROPN
iajs-3606	211	10	;	;	PUNCT
iajs-3606	211	11	chen	chen	PROPN
iajs-3606	211	12	,	,	PUNCT
iajs-3606	211	13	l.	l.	PROPN
iajs-3606	211	14	l.	l.	PROPN
iajs-3606	211	15	;	;	PUNCT
iajs-3606	211	16	chan	chan	PROPN
iajs-3606	211	17	,	,	PUNCT
iajs-3606	211	18	j.	j.	PROPN
iajs-3606	211	19	m.	m.	PROPN
iajs-3606	211	20	c.	c.	PROPN
iajs-3606	211	21	;	;	PUNCT
iajs-3606	211	22	tsang	tsang	PROPN
iajs-3606	211	23	,	,	PUNCT
iajs-3606	211	24	o.	o.	PROPN
iajs-3606	211	25	t.	t.	PROPN
iajs-3606	211	26	y.	y.	PROPN
iajs-3606	211	27	;	;	PUNCT
iajs-3606	211	28	lam	lam	PROPN
iajs-3606	211	29	,	,	PUNCT
iajs-3606	211	30	b.	b.	PROPN
iajs-3606	211	31	h.	h.	PROPN
iajs-3606	211	32	s.	s.	PROPN
iajs-3606	211	33	,	,	PUNCT
iajs-3606	211	34	and	and	CCONJ
iajs-3606	211	35	to	to	ADP
iajs-3606	211	36	,	,	PUNCT
iajs-3606	211	37	k.	k.	PROPN
iajs-3606	211	38	k.	k.	PROPN
iajs-3606	212	1	w.	w.	PROPN
iajs-3606	212	2	neutralization	neutralization	PROPN
iajs-3606	212	3	of	of	ADP
iajs-3606	212	4	severe	severe	ADJ
iajs-3606	212	5	acute	acute	ADJ
iajs-3606	212	6	respiratory	respiratory	ADJ
iajs-3606	212	7	syndrome	syndrome	NOUN
iajs-3606	212	8	coronavirus	coronavirus	NOUN
iajs-3606	212	9	2	2	NUM
iajs-3606	212	10	omicron	omicron	PROPN
iajs-3606	212	11	variant	variant	NOUN
iajs-3606	212	12	by	by	ADP
iajs-3606	212	13	sera	sera	NOUN
iajs-3606	212	14	from	from	ADP
iajs-3606	212	15	bnt162b2	bnt162b2	NOUN
iajs-3606	212	16	or	or	CCONJ
iajs-3606	212	17	coronavac	coronavac	VERB
iajs-3606	212	18	vaccine	vaccine	NOUN
iajs-3606	212	19	recipients	recipient	NOUN
iajs-3606	212	20	.	.	PUNCT
iajs-3606	213	1	clinical	clinical	ADJ
iajs-3606	213	2	infectious	infectious	ADJ
iajs-3606	213	3	diseases	disease	NOUN
iajs-3606	213	4	2022;75(1	2022;75(1	NUM
iajs-3606	213	5	):	):	PUNCT
iajs-3606	213	6	e822	e822	PROPN
iajs-3606	213	7	-	-	PUNCT
iajs-3606	213	8	e826	e826	PROPN
iajs-3606	213	9	.	.	PUNCT
iajs-3606	214	1	https://doi.org/10.1093/cid/ciab1041	https://doi.org/10.1093/cid/ciab1041	NOUN
iajs-3606	214	2	17	17	NUM
iajs-3606	214	3	.	.	PUNCT
iajs-3606	215	1	chen	chen	PROPN
iajs-3606	215	2	,	,	PUNCT
iajs-3606	215	3	y.	y.	PROPN
iajs-3606	215	4	;	;	PUNCT
iajs-3606	215	5	shen	shen	PROPN
iajs-3606	215	6	,	,	PUNCT
iajs-3606	215	7	h.	h.	PROPN
iajs-3606	215	8	;	;	PUNCT
iajs-3606	215	9	huang	huang	PROPN
iajs-3606	215	10	,	,	PUNCT
iajs-3606	215	11	r.	r.	PROPN
iajs-3606	215	12	;	;	PUNCT
iajs-3606	215	13	tong	tong	PROPN
iajs-3606	215	14	,	,	PUNCT
iajs-3606	215	15	x.	x.	NOUN
iajs-3606	215	16	;	;	PUNCT
iajs-3606	215	17	and	and	CCONJ
iajs-3606	215	18	wu	wu	PROPN
iajs-3606	215	19	,	,	PUNCT
iajs-3606	215	20	c.	c.	PROPN
iajs-3606	215	21	serum	serum	NOUN
iajs-3606	215	22	neutralising	neutralise	VERB
iajs-3606	215	23	activity	activity	NOUN
iajs-3606	215	24	against	against	ADP
iajs-3606	215	25	sars	sar	NOUN
iajs-3606	215	26	-	-	PUNCT
iajs-3606	215	27	cov-2	cov-2	PART
iajs-3606	215	28	variants	variant	NOUN
iajs-3606	215	29	elicited	elicit	VERB
iajs-3606	215	30	by	by	ADP
iajs-3606	215	31	coronavac	coronavac	PROPN
iajs-3606	215	32	.	.	PUNCT
iajs-3606	216	1	the	the	DET
iajs-3606	216	2	lancet	lancet	ADJ
iajs-3606	216	3	infectious	infectious	ADJ
iajs-3606	216	4	diseases	disease	NOUN
iajs-3606	216	5	,	,	PUNCT
iajs-3606	216	6	2021	2021	NUM
iajs-3606	216	7	;	;	PUNCT
iajs-3606	216	8	21(8	21(8	NUM
iajs-3606	216	9	):	):	PUNCT
iajs-3606	216	10	1071	1071	NUM
iajs-3606	216	11	-	-	SYM
iajs-3606	216	12	1072	1072	NUM
iajs-3606	216	13	.	.	PUNCT
iajs-3606	217	1	https://doi.org/10.1016/s1473-3099(21)00287-5	https://doi.org/10.1016/s1473-3099(21)00287-5	PROPN
iajs-3606	217	2	18	18	NUM
iajs-3606	217	3	.	.	PUNCT
iajs-3606	217	4	hu	hu	PROPN
iajs-3606	217	5	,	,	PUNCT
iajs-3606	217	6	j.	j.	PROPN
iajs-3606	217	7	;	;	PUNCT
iajs-3606	217	8	wei	wei	PROPN
iajs-3606	217	9	,	,	PUNCT
iajs-3606	217	10	x.	x.	PROPN
iajs-3606	217	11	y.	y.	PROPN
iajs-3606	217	12	;	;	PUNCT
iajs-3606	217	13	xiang	xiang	PROPN
iajs-3606	217	14	,	,	PUNCT
iajs-3606	217	15	j.	j.	PROPN
iajs-3606	217	16	;	;	PUNCT
iajs-3606	217	17	peng	peng	PROPN
iajs-3606	217	18	,	,	PUNCT
iajs-3606	217	19	p.	p.	PROPN
iajs-3606	217	20	;	;	PUNCT
iajs-3606	217	21	xu	xu	PROPN
iajs-3606	217	22	,	,	PUNCT
iajs-3606	217	23	f.	f.	PROPN
iajs-3606	217	24	l.	l.	PROPN
iajs-3606	217	25	;	;	PUNCT
iajs-3606	217	26	wu	wu	PROPN
iajs-3606	217	27	,	,	PUNCT
iajs-3606	217	28	k.	k.	PROPN
iajs-3606	217	29	,	,	PUNCT
iajs-3606	217	30	and	and	CCONJ
iajs-3606	217	31	huang	huang	PROPN
iajs-3606	217	32	,	,	PUNCT
iajs-3606	217	33	a.	a.	PROPN
iajs-3606	217	34	l.	l.	PROPN
iajs-3606	217	35	reduced	reduce	VERB
iajs-3606	217	36	neutralization	neutralization	NOUN
iajs-3606	217	37	of	of	ADP
iajs-3606	217	38	sars	sars	PROPN
iajs-3606	217	39	-	-	PUNCT
iajs-3606	217	40	cov-2	cov-2	NOUN
iajs-3606	217	41	b.	b.	NOUN
iajs-3606	217	42	1.617	1.617	NUM
iajs-3606	217	43	variant	variant	NOUN
iajs-3606	217	44	by	by	ADP
iajs-3606	217	45	convalescent	convalescent	NOUN
iajs-3606	217	46	and	and	CCONJ
iajs-3606	217	47	vaccinated	vaccinated	ADJ
iajs-3606	217	48	sera	sera	NOUN
iajs-3606	217	49	.	.	PUNCT
iajs-3606	218	1	genes&diseases,2022	genes&diseases,2022	NOUN
iajs-3606	218	2	;	;	PUNCT
iajs-3606	218	3	9(5	9(5	NUM
iajs-3606	218	4	):	):	PUNCT
iajs-3606	218	5	12901300	12901300	NUM
iajs-3606	218	6	.	.	PUNCT
iajs-3606	219	1	https://doi.org/10.1016/j.gendis.2021.11.007	https://doi.org/10.1016/j.gendis.2021.11.007	VERB
iajs-3606	219	2	19	19	NUM
iajs-3606	219	3	.	.	PUNCT
iajs-3606	220	1	wang	wang	PROPN
iajs-3606	220	2	,	,	PUNCT
iajs-3606	220	3	g.	g.	PROPN
iajs-3606	220	4	l.	l.	PROPN
iajs-3606	220	5	;	;	PUNCT
iajs-3606	220	6	wang	wang	PROPN
iajs-3606	220	7	,	,	PUNCT
iajs-3606	220	8	z.	z.	PROPN
iajs-3606	220	9	y.	y.	PROPN
iajs-3606	220	10	;	;	PUNCT
iajs-3606	220	11	duan	duan	PROPN
iajs-3606	220	12	,	,	PUNCT
iajs-3606	220	13	l.	l.	PROPN
iajs-3606	220	14	j.	j.	PROPN
iajs-3606	220	15	;	;	PUNCT
iajs-3606	220	16	meng	meng	PROPN
iajs-3606	220	17	,	,	PUNCT
iajs-3606	220	18	q.	q.	PROPN
iajs-3606	220	19	c.	c.	PROPN
iajs-3606	220	20	;	;	PUNCT
iajs-3606	220	21	jiang	jiang	PROPN
iajs-3606	220	22	,	,	PUNCT
iajs-3606	220	23	m.	m.	PROPN
iajs-3606	220	24	d.	d.	PROPN
iajs-3606	220	25	;	;	PUNCT
iajs-3606	220	26	cao	cao	PROPN
iajs-3606	220	27	,	,	PUNCT
iajs-3606	220	28	j.	j.	PROPN
iajs-3606	220	29	,	,	PUNCT
iajs-3606	220	30	and	and	CCONJ
iajs-3606	220	31	ma	ma	PROPN
iajs-3606	220	32	,	,	PUNCT
iajs-3606	220	33	m.	m.	NOUN
iajs-3606	220	34	j.	j.	PROPN
iajs-3606	220	35	susceptibility	susceptibility	PROPN
iajs-3606	220	36	of	of	ADP
iajs-3606	220	37	circulating	circulate	VERB
iajs-3606	220	38	sars	sar	NOUN
iajs-3606	220	39	-	-	PUNCT
iajs-3606	220	40	cov-2	cov-2	NOUN
iajs-3606	220	41	variants	variant	NOUN
iajs-3606	220	42	to	to	PART
iajs-3606	220	43	neutralization	neutralization	VERB
iajs-3606	220	44	.	.	PUNCT
iajs-3606	221	1	new	new	PROPN
iajs-3606	221	2	england	england	PROPN
iajs-3606	221	3	journalofmedicine,2021;384(24):2354	journalofmedicine,2021;384(24):2354	PROPN
iajs-3606	221	4	-	-	PROPN
iajs-3606	221	5	2356	2356	NUM
iajs-3606	221	6	.	.	PUNCT
iajs-3606	222	1	https://doi.org/10.1056/nejmc2103022	https://doi.org/10.1056/nejmc2103022	PROPN
iajs-3606	222	2	20	20	NUM
iajs-3606	222	3	.	.	PUNCT
iajs-3606	223	1	cortés	cortés	NOUN
iajs-3606	223	2	-	-	PUNCT
iajs-3606	223	3	sarabia	sarabia	NOUN
iajs-3606	223	4	,	,	PUNCT
iajs-3606	223	5	k.	k.	PROPN
iajs-3606	223	6	;	;	PUNCT
iajs-3606	223	7	gutiérrez	gutiérrez	NOUN
iajs-3606	223	8	-	-	PUNCT
iajs-3606	223	9	torres	torre	NOUN
iajs-3606	223	10	,	,	PUNCT
iajs-3606	223	11	m.	m.	NOUN
iajs-3606	223	12	;	;	PUNCT
iajs-3606	223	13	mendoza	mendoza	PROPN
iajs-3606	223	14	-	-	PUNCT
iajs-3606	223	15	renteria	renteria	PROPN
iajs-3606	223	16	,	,	PUNCT
iajs-3606	223	17	e.	e.	PROPN
iajs-3606	223	18	m.	m.	PROPN
iajs-3606	223	19	;	;	PUNCT
iajs-3606	223	20	leyva	leyva	ADJ
iajs-3606	223	21	-	-	PUNCT
iajs-3606	223	22	vázquez	vázquez	NOUN
iajs-3606	223	23	,	,	PUNCT
iajs-3606	223	24	m.	m.	NOUN
iajs-3606	223	25	a.	a.	PROPN
iajs-3606	223	26	,	,	PUNCT
iajs-3606	223	27	vencesvelázquez	vencesvelázquez	NOUN
iajs-3606	223	28	,	,	PUNCT
iajs-3606	223	29	a.	a.	NOUN
iajs-3606	223	30	,	,	PUNCT
iajs-3606	223	31	hernández	hernández	PROPN
iajs-3606	223	32	-	-	PUNCT
iajs-3606	223	33	sotelo	sotelo	PROPN
iajs-3606	223	34	,	,	PUNCT
iajs-3606	223	35	d.	d.	PROPN
iajs-3606	223	36	,	,	PUNCT
iajs-3606	223	37	and	and	CCONJ
iajs-3606	223	38	illades	illade	VERB
iajs-3606	223	39	-	-	PUNCT
iajs-3606	223	40	aguiar	aguiar	NOUN
iajs-3606	223	41	,	,	PUNCT
iajs-3606	223	42	b.	b.	NOUN
iajs-3606	223	43	variation	variation	NOUN
iajs-3606	223	44	in	in	ADP
iajs-3606	223	45	the	the	DET
iajs-3606	223	46	humoral	humoral	ADJ
iajs-3606	223	47	immune	immune	ADJ
iajs-3606	223	48	response	response	NOUN
iajs-3606	223	49	induced	induce	VERB
iajs-3606	223	50	by	by	ADP
iajs-3606	223	51	the	the	DET
iajs-3606	223	52	administration	administration	NOUN
iajs-3606	223	53	of	of	ADP
iajs-3606	223	54	the	the	DET
iajs-3606	223	55	bnt162b2	bnt162b2	PROPN
iajs-3606	223	56	pfizer	pfizer	NOUN
iajs-3606	223	57	/	/	SYM
iajs-3606	223	58	biontech	biontech	NOUN
iajs-3606	223	59	vaccine	vaccine	NOUN
iajs-3606	223	60	:	:	PUNCT
iajs-3606	223	61	a	a	DET
iajs-3606	223	62	systematic	systematic	ADJ
iajs-3606	223	63	review	review	NOUN
iajs-3606	223	64	.	.	PUNCT
iajs-3606	224	1	vaccines	vaccine	NOUN
iajs-3606	224	2	,	,	PUNCT
iajs-3606	224	3	2022	2022	NUM
iajs-3606	224	4	;	;	PUNCT
iajs-3606	224	5	10(6	10(6	NUM
iajs-3606	224	6	):	):	PUNCT
iajs-3606	224	7	909	909	NUM
iajs-3606	224	8	.	.	PUNCT
iajs-3606	224	9	https://doi.org/10.3390/vaccines10060909	https://doi.org/10.3390/vaccines10060909	PROPN
iajs-3606	224	10	21	21	NUM
iajs-3606	224	11	.	.	PUNCT
iajs-3606	225	1	modenese	modenese	PROPN
iajs-3606	225	2	,	,	PUNCT
iajs-3606	225	3	a.p	a.p	PROPN
iajs-3606	225	4	.	.	PROPN
iajs-3606	225	5	;	;	PUNCT
iajs-3606	225	6	paduano	paduano	PROPN
iajs-3606	225	7	,	,	PUNCT
iajs-3606	225	8	s.	s.	PROPN
iajs-3606	225	9	;	;	PUNCT
iajs-3606	225	10	bargellini	bargellini	PROPN
iajs-3606	225	11	,	,	PUNCT
iajs-3606	225	12	a.	a.	NOUN
iajs-3606	225	13	;	;	PUNCT
iajs-3606	225	14	bellucci	bellucci	PROPN
iajs-3606	225	15	,	,	PUNCT
iajs-3606	225	16	r.	r.	PROPN
iajs-3606	225	17	;	;	PUNCT
iajs-3606	225	18	marchetti	marchetti	PROPN
iajs-3606	225	19	,	,	PUNCT
iajs-3606	225	20	s.	s.	PROPN
iajs-3606	225	21	;	;	PUNCT
iajs-3606	225	22	bruno	bruno	PROPN
iajs-3606	225	23	,	,	PUNCT
iajs-3606	225	24	f.	f.	PROPN
iajs-3606	225	25	;	;	PUNCT
iajs-3606	225	26	and	and	CCONJ
iajs-3606	225	27	gobba	gobba	NOUN
iajs-3606	225	28	,	,	PUNCT
iajs-3606	225	29	f.	f.	NOUN
iajs-3606	225	30	neutralizing	neutralize	VERB
iajs-3606	225	31	anti	anti	ADJ
iajs-3606	225	32	-	-	ADJ
iajs-3606	225	33	sars	sars	ADJ
iajs-3606	225	34	-	-	PUNCT
iajs-3606	225	35	cov-2	cov-2	NOUN
iajs-3606	225	36	antibody	antibody	NOUN
iajs-3606	225	37	titer	titer	NOUN
iajs-3606	225	38	and	and	CCONJ
iajs-3606	225	39	reported	report	VERB
iajs-3606	225	40	adverse	adverse	ADJ
iajs-3606	225	41	effects	effect	NOUN
iajs-3606	225	42	,	,	PUNCT
iajs-3606	225	43	in	in	ADP
iajs-3606	225	44	a	a	DET
iajs-3606	225	45	sample	sample	NOUN
iajs-3606	225	46	of	of	ADP
iajs-3606	225	47	italian	italian	ADJ
iajs-3606	225	48	nursing	nursing	NOUN
iajs-3606	225	49	home	home	NOUN
iajs-3606	225	50	personnel	personnel	NOUN
iajs-3606	225	51	after	after	SCONJ
iajs-3606	225	52	two	two	NUM
iajs-3606	225	53	doses	dose	NOUN
iajs-3606	225	54	of	of	ADP
iajs-3606	225	55	the	the	DET
iajs-3606	225	56	bnt162b2	bnt162b2	NOUN
iajs-3606	225	57	vaccine	vaccine	NOUN
iajs-3606	225	58	administered	administer	VERB
iajs-3606	225	59	four	four	NUM
iajs-3606	225	60	weeks	week	NOUN
iajs-3606	225	61	apart	apart	ADV
iajs-3606	225	62	.	.	PUNCT
iajs-3606	226	1	vaccines	vaccine	NOUN
iajs-3606	226	2	,	,	PUNCT
iajs-3606	226	3	2021	2021	NUM
iajs-3606	226	4	;	;	PUNCT
iajs-3606	226	5	9(6	9(6	NUM
iajs-3606	226	6	):	):	PUNCT
iajs-3606	226	7	652	652	NUM
iajs-3606	226	8	.	.	PUNCT
iajs-3606	227	1	https://doi.org/10.3390/vaccines9060652	https://doi.org/10.3390/vaccines9060652	PROPN
iajs-3606	227	2	22	22	NUM
iajs-3606	227	3	.	.	PUNCT
iajs-3606	228	1	sauré	sauré	PROPN
iajs-3606	228	2	,	,	PUNCT
iajs-3606	228	3	denis	denis	PROPN
iajs-3606	228	4	,	,	PUNCT
iajs-3606	228	5	et	et	PROPN
iajs-3606	228	6	al	al	PROPN
iajs-3606	228	7	.	.	PUNCT
iajs-3606	229	1	"	"	PUNCT
iajs-3606	229	2	covid-19	covid-19	PROPN
iajs-3606	229	3	lateral	lateral	ADJ
iajs-3606	229	4	flow	flow	NOUN
iajs-3606	229	5	igg	igg	PROPN
iajs-3606	229	6	seropositivity	seropositivity	NOUN
iajs-3606	229	7	and	and	CCONJ
iajs-3606	229	8	serum	serum	NOUN
iajs-3606	229	9	neutralising	neutralise	VERB
iajs-3606	229	10	antibody	antibody	NOUN
iajs-3606	229	11	responses	response	NOUN
iajs-3606	229	12	after	after	ADP
iajs-3606	229	13	primary	primary	ADJ
iajs-3606	229	14	and	and	CCONJ
iajs-3606	229	15	booster	booster	NOUN
iajs-3606	229	16	vaccinations	vaccination	NOUN
iajs-3606	229	17	in	in	ADP
iajs-3606	229	18	chile	chile	PROPN
iajs-3606	229	19	:	:	PUNCT
iajs-3606	229	20	a	a	DET
iajs-3606	229	21	cross	cross	ADJ
iajs-3606	229	22	-	-	ADJ
iajs-3606	229	23	sectional	sectional	ADJ
iajs-3606	229	24	study	study	NOUN
iajs-3606	229	25	.	.	PUNCT
iajs-3606	229	26	"	"	PUNCT
iajs-3606	230	1	the	the	DET
iajs-3606	230	2	lancet	lancet	PROPN
iajs-3606	230	3	microbe	microbe	NOUN
iajs-3606	230	4	4.3	4.3	NUM
iajs-3606	230	5	(	(	PUNCT
iajs-3606	230	6	2023	2023	NUM
iajs-3606	230	7	):	):	PUNCT
iajs-3606	230	8	e149	e149	PROPN
iajs-3606	230	9	-	-	PUNCT
iajs-3606	230	10	e158	e158	PROPN
iajs-3606	230	11	.	.	PUNCT
iajs-3606	231	1	https://doi.org/10.1016/s2666-5247(22)00290-7	https://doi.org/10.1016/s2666-5247(22)00290-7	PROPN
iajs-3606	231	2	23	23	NUM
iajs-3606	231	3	.	.	PUNCT
iajs-3606	232	1	gray	gray	ADJ
iajs-3606	232	2	,	,	PUNCT
iajs-3606	232	3	k.	k.	PROPN
iajs-3606	232	4	j.	j.	PROPN
iajs-3606	232	5	;	;	PUNCT
iajs-3606	232	6	bordt	bordt	PROPN
iajs-3606	232	7	,	,	PUNCT
iajs-3606	232	8	e.	e.	PROPN
iajs-3606	232	9	a.	a.	PROPN
iajs-3606	232	10	;	;	PUNCT
iajs-3606	232	11	atyeo	atyeo	VERB
iajs-3606	232	12	,	,	PUNCT
iajs-3606	232	13	c.	c.	NOUN
iajs-3606	232	14	;	;	PUNCT
iajs-3606	233	1	deriso	deriso	PROPN
iajs-3606	233	2	,	,	PUNCT
iajs-3606	233	3	e.	e.	PROPN
iajs-3606	233	4	,	,	PUNCT
iajs-3606	233	5	akinwunmi	akinwunmi	PROPN
iajs-3606	233	6	,	,	PUNCT
iajs-3606	233	7	b.	b.	PROPN
iajs-3606	233	8	;	;	PUNCT
iajs-3606	233	9	young	young	ADJ
iajs-3606	233	10	,	,	PUNCT
iajs-3606	233	11	n.	n.	NOUN
iajs-3606	233	12	;	;	PUNCT
iajs-3606	233	13	...	...	PUNCT
iajs-3606	233	14	and	and	CCONJ
iajs-3606	233	15	edlow	edlow	NOUN
iajs-3606	233	16	,	,	PUNCT
iajs-3606	233	17	a.	a.	NOUN
iajs-3606	233	18	g.	g.	PROPN
iajs-3606	233	19	covid19	covid19	PROPN
iajs-3606	233	20	vaccine	vaccine	NOUN
iajs-3606	233	21	response	response	NOUN
iajs-3606	233	22	in	in	ADP
iajs-3606	233	23	pregnant	pregnant	ADJ
iajs-3606	233	24	and	and	CCONJ
iajs-3606	233	25	lactating	lactate	VERB
iajs-3606	233	26	women	woman	NOUN
iajs-3606	233	27	:	:	PUNCT
iajs-3606	233	28	a	a	DET
iajs-3606	233	29	cohort	cohort	NOUN
iajs-3606	233	30	study	study	NOUN
iajs-3606	233	31	(	(	PUNCT
iajs-3606	233	32	preprint	preprint	NOUN
iajs-3606	233	33	)	)	PUNCT
iajs-3606	233	34	.	.	PUNCT
iajs-3606	234	1	2021	2021	NUM
iajs-3606	234	2	.	.	PUNCT
iajs-3606	235	1	https://doi.org	https://doi.org	VERB
iajs-3606	235	2	10.1101.2021.03.07.21253094	10.1101.2021.03.07.21253094	NUM
iajs-3606	235	3	24	24	NUM
iajs-3606	235	4	.	.	PUNCT
iajs-3606	236	1	rottenstreich	rottenstreich	PROPN
iajs-3606	236	2	,	,	PUNCT
iajs-3606	236	3	a.	a.	PROPN
iajs-3606	236	4	,	,	PUNCT
iajs-3606	236	5	zarbiv	zarbiv	PROPN
iajs-3606	236	6	,	,	PUNCT
iajs-3606	236	7	g.	g.	PROPN
iajs-3606	236	8	,	,	PUNCT
iajs-3606	236	9	oiknine	oiknine	NOUN
iajs-3606	236	10	-	-	PUNCT
iajs-3606	236	11	djian	djian	NOUN
iajs-3606	236	12	,	,	PUNCT
iajs-3606	236	13	e.	e.	PROPN
iajs-3606	236	14	,	,	PUNCT
iajs-3606	236	15	zigron	zigron	PROPN
iajs-3606	236	16	,	,	PUNCT
iajs-3606	236	17	r	r	PROPN
iajs-3606	236	18	..	..	PUNCT
iajs-3606	236	19	;	;	PUNCT
iajs-3606	236	20	wolf	wolf	PROPN
iajs-3606	236	21	,	,	PUNCT
iajs-3606	236	22	d.	d.	PROPN
iajs-3606	236	23	g.	g.	PROPN
iajs-3606	236	24	;	;	PUNCT
iajs-3606	236	25	and	and	CCONJ
iajs-3606	236	26	porat	porat	PROPN
iajs-3606	236	27	,	,	PUNCT
iajs-3606	236	28	s.	s.	PROPN
iajs-3606	236	29	efficient	efficient	ADJ
iajs-3606	236	30	maternofetal	maternofetal	ADJ
iajs-3606	236	31	transplacental	transplacental	ADJ
iajs-3606	236	32	transfer	transfer	NOUN
iajs-3606	236	33	of	of	ADP
iajs-3606	236	34	anti	anti	ADJ
iajs-3606	236	35	-	-	ADJ
iajs-3606	236	36	sars	sar	NOUN
iajs-3606	236	37	-	-	PUNCT
iajs-3606	236	38	cov-2	cov-2	NOUN
iajs-3606	236	39	spike	spike	NOUN
iajs-3606	236	40	antibodies	antibody	NOUN
iajs-3606	236	41	after	after	ADP
iajs-3606	236	42	antenatal	antenatal	ADJ
iajs-3606	236	43	sars	sar	NOUN
iajs-3606	236	44	-	-	PUNCT
iajs-3606	236	45	cov-2	cov-2	NOUN
iajs-3606	236	46	bnt162b2	bnt162b2	PROPN
iajs-3606	236	47	mrna	mrna	PROPN
iajs-3606	236	48	vaccination	vaccination	NOUN
iajs-3606	236	49	.	.	PUNCT
iajs-3606	237	1	medrxiv2021;2021	medrxiv2021;2021	NOUN
iajs-3606	237	2	-	-	PUNCT
iajs-3606	237	3	03	03	NUM
iajs-3606	237	4	.	.	PUNCT
iajs-3606	238	1	https://doi.org/10.1101/2021.03.11.21253352	https://doi.org/10.1101/2021.03.11.21253352	PROPN
iajs-3606	238	2	25	25	NUM
iajs-3606	238	3	.	.	PUNCT
iajs-3606	239	1	piernas	piernas	PROPN
iajs-3606	239	2	,	,	PUNCT
iajs-3606	239	3	c.	c.	NOUN
iajs-3606	239	4	;	;	PUNCT
iajs-3606	239	5	patone	patone	NOUN
iajs-3606	239	6	,	,	PUNCT
iajs-3606	239	7	m.	m.	NOUN
iajs-3606	239	8	;	;	PUNCT
iajs-3606	239	9	astbury	astbury	NOUN
iajs-3606	239	10	,	,	PUNCT
iajs-3606	239	11	n.	n.	NOUN
iajs-3606	239	12	m.	m.	NOUN
iajs-3606	239	13	,	,	PUNCT
iajs-3606	239	14	gao	gao	PROPN
iajs-3606	239	15	,	,	PUNCT
iajs-3606	239	16	m.	m.	NOUN
iajs-3606	239	17	;	;	PUNCT
iajs-3606	239	18	sheikh	sheikh	PROPN
iajs-3606	239	19	,	,	PUNCT
iajs-3606	239	20	a.	a.	NOUN
iajs-3606	239	21	;	;	PUNCT
iajs-3606	239	22	khunti	khunti	PROPN
iajs-3606	239	23	,	,	PUNCT
iajs-3606	239	24	k.	k.	PROPN
iajs-3606	239	25	;	;	PUNCT
iajs-3606	239	26	and	and	CCONJ
iajs-3606	239	27	jebb	jebb	PROPN
iajs-3606	239	28	,	,	PUNCT
iajs-3606	239	29	s.	s.	PROPN
iajs-3606	239	30	a.	a.	PROPN
iajs-3606	239	31	associations	association	NOUN
iajs-3606	239	32	of	of	ADP
iajs-3606	239	33	bmi	bmi	NOUN
iajs-3606	239	34	with	with	ADP
iajs-3606	239	35	covid-19	covid-19	PROPN
iajs-3606	239	36	vaccine	vaccine	NOUN
iajs-3606	239	37	uptake	uptake	VERB
iajs-3606	239	38	,	,	PUNCT
iajs-3606	239	39	vaccine	vaccine	NOUN
iajs-3606	239	40	effectiveness	effectiveness	NOUN
iajs-3606	239	41	,	,	PUNCT
iajs-3606	239	42	and	and	CCONJ
iajs-3606	239	43	risk	risk	NOUN
iajs-3606	239	44	of	of	ADP
iajs-3606	239	45	severe	severe	ADJ
iajs-3606	239	46	covid-19	covid-19	PROPN
iajs-3606	239	47	outcomes	outcome	NOUN
iajs-3606	239	48	after	after	ADP
iajs-3606	239	49	vaccination	vaccination	NOUN
iajs-3606	239	50	in	in	ADP
iajs-3606	239	51	england	england	PROPN
iajs-3606	239	52	:	:	PUNCT
iajs-3606	239	53	a	a	DET
iajs-3606	239	54	population	population	NOUN
iajs-3606	239	55	-	-	PUNCT
iajs-3606	239	56	based	base	VERB
iajs-3606	239	57	cohort	cohort	NOUN
iajs-3606	239	58	study	study	NOUN
iajs-3606	239	59	.	.	PUNCT
iajs-3606	240	1	the	the	DET
iajs-3606	240	2	lancet	lancet	PROPN
iajs-3606	240	3	diabetes	diabetes	PROPN
iajs-3606	240	4	&	&	CCONJ
iajs-3606	240	5	endocrinology	endocrinology	NOUN
iajs-3606	240	6	,	,	PUNCT
iajs-3606	240	7	2022	2022	NUM
iajs-3606	240	8	;	;	PUNCT
iajs-3606	240	9	10(8	10(8	NUM
iajs-3606	240	10	):	):	PUNCT
iajs-3606	240	11	571	571	NUM
iajs-3606	240	12	-	-	SYM
iajs-3606	240	13	580	580	NUM
iajs-3606	240	14	.	.	PUNCT
iajs-3606	241	1	https://doi.org/10.1016/s2213-8587(22)00158-9	https://doi.org/10.1016/s2213-8587(22)00158-9	PROPN
iajs-3606	241	2	26	26	NUM
iajs-3606	241	3	.	.	PUNCT
iajs-3606	242	1	ou	ou	PROPN
iajs-3606	242	2	,	,	PUNCT
iajs-3606	242	3	x.	x.	PROPN
iajs-3606	242	4	;	;	PUNCT
iajs-3606	242	5	jiang	jiang	PROPN
iajs-3606	242	6	.	.	PUNCT
iajs-3606	243	1	j.	j.	PROPN
iajs-3606	243	2	;	;	PUNCT
iajs-3606	243	3	lin	lin	PROPN
iajs-3606	243	4	.	.	PUNCT
iajs-3606	243	5	b.	b.	PROPN
iajs-3606	243	6	;	;	PUNCT
iajs-3606	243	7	liu	liu	PROPN
iajs-3606	243	8	.	.	PROPN
iajs-3606	243	9	q.	q.	PROPN
iajs-3606	243	10	;	;	PUNCT
iajs-3606	243	11	lin	lin	PROPN
iajs-3606	243	12	,	,	PUNCT
iajs-3606	243	13	w.	w.	PROPN
iajs-3606	243	14	;	;	PUNCT
iajs-3606	243	15	chen	chen	PROPN
iajs-3606	243	16	,	,	PUNCT
iajs-3606	243	17	g.	g.	PROPN
iajs-3606	243	18	;	;	PUNCT
iajs-3606	243	19	&	&	CCONJ
iajs-3606	243	20	wen	wen	PROPN
iajs-3606	243	21	,	,	PUNCT
iajs-3606	243	22	j.	j.	PROPN
iajs-3606	243	23	antibody	antibody	NOUN
iajs-3606	243	24	responses	response	NOUN
iajs-3606	243	25	to	to	ADP
iajs-3606	243	26	covid‐19	covid‐19	PROPN
iajs-3606	243	27	vaccination	vaccination	NOUN
iajs-3606	243	28	in	in	ADP
iajs-3606	243	29	people	people	NOUN
iajs-3606	243	30	with	with	ADP
iajs-3606	243	31	obesity	obesity	NOUN
iajs-3606	243	32	:	:	PUNCT
iajs-3606	243	33	a	a	DET
iajs-3606	243	34	systematic	systematic	ADJ
iajs-3606	243	35	review	review	NOUN
iajs-3606	243	36	and	and	CCONJ
iajs-3606	243	37	meta‐analysis	meta‐analysis	NOUN
iajs-3606	243	38	.	.	PUNCT
iajs-3606	244	1	influenza	influenza	NOUN
iajs-3606	244	2	and	and	CCONJ
iajs-3606	244	3	other	other	ADJ
iajs-3606	244	4	respiratory	respiratory	ADJ
iajs-3606	244	5	viruse	viruse	NOUN
iajs-3606	244	6	,	,	PUNCT
iajs-3606	244	7	2023	2023	NUM
iajs-3606	244	8	;	;	PUNCT
iajs-3606	244	9	17(1	17(1	NUM
iajs-3606	244	10	):	):	PUNCT
iajs-3606	244	11	e13078	e13078	NOUN
iajs-3606	244	12	.	.	PUNCT
iajs-3606	245	1	https://doi.org/10.1111/irv.13078	https://doi.org/10.1111/irv.13078	PROPN
iajs-3606	245	2	27	27	NUM
iajs-3606	245	3	.	.	PUNCT
iajs-3606	246	1	sun	sun	NOUN
iajs-3606	246	2	,	,	PUNCT
iajs-3606	246	3	t.	t.	PROPN
iajs-3606	246	4	;	;	PUNCT
iajs-3606	246	5	wang	wang	PROPN
iajs-3606	246	6	,	,	PUNCT
iajs-3606	246	7	y.	y.	PROPN
iajs-3606	246	8	;	;	PUNCT
iajs-3606	246	9	song	song	NOUN
iajs-3606	246	10	,	,	PUNCT
iajs-3606	246	11	x.	x.	PROPN
iajs-3606	246	12	;	;	PUNCT
iajs-3606	246	13	li	li	PROPN
iajs-3606	246	14	,	,	PUNCT
iajs-3606	246	15	r.	r.	PROPN
iajs-3606	246	16	,	,	PUNCT
iajs-3606	246	17	mei	mei	PROPN
iajs-3606	246	18	,	,	PUNCT
iajs-3606	246	19	f.	f.	PROPN
iajs-3606	246	20	;	;	PUNCT
iajs-3606	246	21	yang	yang	PROPN
iajs-3606	246	22	,	,	PUNCT
iajs-3606	246	23	m.	m.	NOUN
iajs-3606	246	24	;	;	PUNCT
iajs-3606	246	25	and	and	CCONJ
iajs-3606	246	26	zhang	zhang	PROPN
iajs-3606	246	27	,	,	PUNCT
iajs-3606	246	28	j.	j.	PROPN
iajs-3606	246	29	impaired	impair	VERB
iajs-3606	246	30	humoral	humoral	ADJ
iajs-3606	246	31	immunity	immunity	NOUN
iajs-3606	246	32	identified	identify	VERB
iajs-3606	246	33	in	in	ADP
iajs-3606	246	34	inactivated	inactivated	ADJ
iajs-3606	246	35	sars	sar	NOUN
iajs-3606	246	36	-	-	PUNCT
iajs-3606	246	37	cov-2	cov-2	PART
iajs-3606	246	38	vaccine	vaccine	NOUN
iajs-3606	246	39	recipients	recipient	NOUN
iajs-3606	246	40	without	without	ADP
iajs-3606	246	41	anti	anti	ADJ
iajs-3606	246	42	-	-	ADJ
iajs-3606	246	43	spike	spike	ADJ
iajs-3606	246	44	rbd	rbd	NOUN
iajs-3606	246	45	antibodies	antibodie	VERB
iajs-3606	246	46	.	.	PUNCT
iajs-3606	247	1	microbiology	microbiology	NOUN
iajs-3606	247	2	spectrum	spectrum	NOUN
iajs-3606	247	3	,	,	PUNCT
iajs-3606	247	4	2023;11(2	2023;11(2	NUM
iajs-3606	247	5	):	):	PUNCT
iajs-3606	247	6	e02783	e02783	PROPN
iajs-3606	247	7	-	-	PUNCT
iajs-3606	247	8	22	22	PROPN
iajs-3606	247	9	.	.	PUNCT
iajs-3606	248	1	https://doi.org/10.1128/spectrum.02783-22	https://doi.org/10.1128/spectrum.02783-22	PROPN
iajs-3606	248	2	28	28	NUM
iajs-3606	248	3	.	.	PUNCT
iajs-3606	249	1	cheng	cheng	PROPN
iajs-3606	249	2	,	,	PUNCT
iajs-3606	249	3	z.	z.	PROPN
iajs-3606	249	4	j.	j.	PROPN
iajs-3606	249	5	,	,	PUNCT
iajs-3606	249	6	xue	xue	PROPN
iajs-3606	249	7	,	,	PUNCT
iajs-3606	249	8	m.	m.	NOUN
iajs-3606	249	9	,	,	PUNCT
iajs-3606	249	10	zheng	zheng	PROPN
iajs-3606	249	11	,	,	PUNCT
iajs-3606	249	12	p.	p.	PROPN
iajs-3606	249	13	,	,	PUNCT
iajs-3606	249	14	lyu	lyu	NOUN
iajs-3606	249	15	,	,	PUNCT
iajs-3606	249	16	j.	j.	PROPN
iajs-3606	249	17	,	,	PUNCT
iajs-3606	249	18	zhan	zhan	PROPN
iajs-3606	249	19	,	,	PUNCT
iajs-3606	249	20	z.	z.	PROPN
iajs-3606	249	21	,	,	PUNCT
iajs-3606	249	22	hu	hu	PROPN
iajs-3606	249	23	,	,	PUNCT
iajs-3606	249	24	h.	h.	PROPN
iajs-3606	249	25	,	,	PUNCT
iajs-3606	249	26	and	and	CCONJ
iajs-3606	249	27	sun	sun	NOUN
iajs-3606	249	28	,	,	PUNCT
iajs-3606	249	29	b.	b.	PROPN
iajs-3606	249	30	factors	factor	NOUN
iajs-3606	249	31	affecting	affect	VERB
iajs-3606	249	32	the	the	DET
iajs-3606	249	33	antibody	antibody	NOUN
iajs-3606	249	34	immunogenicity	immunogenicity	NOUN
iajs-3606	249	35	of	of	ADP
iajs-3606	249	36	vaccines	vaccine	NOUN
iajs-3606	249	37	against	against	ADP
iajs-3606	249	38	sars	sar	NOUN
iajs-3606	249	39	-	-	PUNCT
iajs-3606	249	40	cov-2	cov-2	NOUN
iajs-3606	249	41	:	:	PUNCT
iajs-3606	249	42	a	a	DET
iajs-3606	249	43	focused	focused	ADJ
iajs-3606	249	44	review	review	NOUN
iajs-3606	249	45	.	.	PUNCT
iajs-3606	250	1	vaccine,2021	vaccine,2021	PROPN
iajs-3606	250	2	.	.	PUNCT
iajs-3606	250	3	;	;	PUNCT
iajs-3606	251	1	9(8	9(8	NUM
iajs-3606	251	2	):	):	PUNCT
iajs-3606	251	3	869	869	NUM
iajs-3606	251	4	.	.	PUNCT
iajs-3606	251	5	https://doi.org/10.3390/vaccines9080869	https://doi.org/10.3390/vaccines9080869	PROPN
iajs-3606	251	6	29	29	NUM
iajs-3606	251	7	.	.	PUNCT
iajs-3606	252	1	pellini	pellini	PROPN
iajs-3606	252	2	,	,	PUNCT
iajs-3606	252	3	r.	r.	PROPN
iajs-3606	252	4	;	;	PUNCT
iajs-3606	252	5	venuti	venuti	PROPN
iajs-3606	252	6	,	,	PUNCT
iajs-3606	252	7	a.	a.	NOUN
iajs-3606	252	8	;	;	PUNCT
iajs-3606	252	9	pimpinelli	pimpinelli	PROPN
iajs-3606	252	10	,	,	PUNCT
iajs-3606	252	11	f.	f.	PROPN
iajs-3606	252	12	;	;	PUNCT
iajs-3606	252	13	abril	abril	PROPN
iajs-3606	252	14	,	,	PUNCT
iajs-3606	252	15	e.	e.	PROPN
iajs-3606	252	16	;	;	PUNCT
iajs-3606	252	17	blandino	blandino	PROPN
iajs-3606	252	18	,	,	PUNCT
iajs-3606	252	19	g.	g.	PROPN
iajs-3606	252	20	;	;	PUNCT
iajs-3606	252	21	campo	campo	PROPN
iajs-3606	252	22	,	,	PUNCT
iajs-3606	252	23	f.	f.	PROPN
iajs-3606	252	24	;	;	PUNCT
iajs-3606	252	25	conti	conti	X
iajs-3606	252	26	,	,	PUNCT
iajs-3606	252	27	l.	l.	PROPN
iajs-3606	252	28	;	;	PUNCT
iajs-3606	252	29	de	de	PROPN
iajs-3606	252	30	virgilio	virgilio	PROPN
iajs-3606	252	31	,	,	PUNCT
iajs-3606	252	32	a.	a.	PROPN
iajs-3606	252	33	,	,	PUNCT
iajs-3606	252	34	de	de	PROPN
iajs-3606	252	35	marco	marco	PROPN
iajs-3606	252	36	,	,	PUNCT
iajs-3606	252	37	f.	f.	PROPN
iajs-3606	252	38	;	;	PUNCT
iajs-3606	252	39	di	di	PROPN
iajs-3606	252	40	domenico	domenico	PROPN
iajs-3606	252	41	,	,	PUNCT
iajs-3606	252	42	e.g.	e.g.	ADV
iajs-3606	252	43	;	;	PUNCT
iajs-3606	252	44	et	et	PROPN
iajs-3606	252	45	al	al	PROPN
iajs-3606	252	46	.	.	PROPN
iajs-3606	252	47	initial	initial	ADJ
iajs-3606	252	48	observations	observation	NOUN
iajs-3606	252	49	on	on	ADP
iajs-3606	252	50	age	age	NOUN
iajs-3606	252	51	,	,	PUNCT
iajs-3606	252	52	gender	gender	NOUN
iajs-3606	252	53	,	,	PUNCT
iajs-3606	252	54	bmi	bmi	NOUN
iajs-3606	252	55	and	and	CCONJ
iajs-3606	252	56	hypertension	hypertension	NOUN
iajs-3606	252	57	in	in	ADP
iajs-3606	252	58	https://doi.org/10.1093/cid/ciab1041	https://doi.org/10.1093/cid/ciab1041	NOUN
iajs-3606	252	59	https://doi.org/10.1016/s1473-3099(21)00287-5	https://doi.org/10.1016/s1473-3099(21)00287-5	PROPN
iajs-3606	252	60	https://doi.org/10.1016/j.gendis.2021.11.007	https://doi.org/10.1016/j.gendis.2021.11.007	VERB
iajs-3606	252	61	https://doi.org/10.1056/nejmc2103022	https://doi.org/10.1056/nejmc2103022	PROPN
iajs-3606	252	62	https://doi.org/10.3390/vaccines10060909	https://doi.org/10.3390/vaccines10060909	ADJ
iajs-3606	252	63	https://doi.org/10.3390/vaccines9060652	https://doi.org/10.3390/vaccines9060652	PROPN
iajs-3606	252	64	https://doi.org/10.1016/s2666-5247(22)00290-7	https://doi.org/10.1016/s2666-5247(22)00290-7	NOUN
iajs-3606	252	65	https://doi.org/10.1016/s2213-8587(22)00158-9	https://doi.org/10.1016/s2213-8587(22)00158-9	NOUN
iajs-3606	252	66	https://doi.org/10.1111/irv.13078	https://doi.org/10.1111/irv.13078	PROPN
iajs-3606	252	67	https://doi.org/10.1128/spectrum.02783-22	https://doi.org/10.1128/spectrum.02783-22	PROPN
iajs-3606	252	68	https://doi.org/10.3390/vaccines9080869	https://doi.org/10.3390/vaccines9080869	PROPN
iajs-3606	252	69	ihjpas	ihjpas	PROPN
iajs-3606	252	70	.	.	PUNCT
iajs-3606	253	1	2025	2025	NUM
iajs-3606	253	2	,	,	PUNCT
iajs-3606	253	3	38	38	NUM
iajs-3606	253	4	(	(	PUNCT
iajs-3606	253	5	1	1	NUM
iajs-3606	253	6	)	)	PUNCT
iajs-3606	253	7	120	120	NUM
iajs-3606	253	8	antibody	antibody	NOUN
iajs-3606	253	9	responses	response	NOUN
iajs-3606	253	10	to	to	ADP
iajs-3606	253	11	sars	sar	NOUN
iajs-3606	253	12	-	-	PUNCT
iajs-3606	253	13	cov-2	cov-2	PART
iajs-3606	253	14	bnt162b2	bnt162b2	NOUN
iajs-3606	253	15	vaccine.eclinicalmedicine,2021;36:100928	vaccine.eclinicalmedicine,2021;36:100928	PROPN
iajs-3606	253	16	.	.	PUNCT
iajs-3606	254	1	https://doi.org/10.1016/j.eclinm.2021.100928	https://doi.org/10.1016/j.eclinm.2021.100928	PROPN
iajs-3606	254	2	30	30	NUM
iajs-3606	254	3	.	.	PUNCT
iajs-3606	255	1	szczepanek	szczepanek	NOUN
iajs-3606	255	2	,	,	PUNCT
iajs-3606	255	3	joanna	joanna	PROPN
iajs-3606	255	4	,	,	PUNCT
iajs-3606	255	5	et	et	PROPN
iajs-3606	255	6	al	al	PROPN
iajs-3606	255	7	.	.	PUNCT
iajs-3606	256	1	"	"	PUNCT
iajs-3606	256	2	anti	anti	ADJ
iajs-3606	256	3	-	-	ADJ
iajs-3606	256	4	sars	sar	NOUN
iajs-3606	256	5	-	-	PUNCT
iajs-3606	256	6	cov-2	cov-2	NOUN
iajs-3606	256	7	igg	igg	NOUN
iajs-3606	256	8	against	against	ADP
iajs-3606	256	9	the	the	DET
iajs-3606	256	10	s	s	PART
iajs-3606	256	11	protein	protein	NOUN
iajs-3606	256	12	:	:	PUNCT
iajs-3606	256	13	a	a	DET
iajs-3606	256	14	comparison	comparison	NOUN
iajs-3606	256	15	of	of	ADP
iajs-3606	256	16	bnt162b2	bnt162b2	PROPN
iajs-3606	256	17	,	,	PUNCT
iajs-3606	256	18	mrna-1273	mrna-1273	ADJ
iajs-3606	256	19	,	,	PUNCT
iajs-3606	256	20	chadox1	chadox1	NOUN
iajs-3606	256	21	ncov-2019	ncov-2019	ADJ
iajs-3606	256	22	and	and	CCONJ
iajs-3606	256	23	ad26	ad26	PROPN
iajs-3606	256	24	.	.	PUNCT
iajs-3606	257	1	cov2	cov2	PROPN
iajs-3606	257	2	.	.	PUNCT
iajs-3606	258	1	s	s	VERB
iajs-3606	258	2	vaccines	vaccine	NOUN
iajs-3606	258	3	.	.	PUNCT
iajs-3606	258	4	"	"	PUNCT
iajs-3606	259	1	vaccines	vaccine	NOUN
iajs-3606	259	2	10.1	10.1	NUM
iajs-3606	259	3	(	(	PUNCT
iajs-3606	259	4	2022	2022	NUM
iajs-3606	259	5	):	):	PUNCT
iajs-3606	259	6	99	99	NUM
iajs-3606	259	7	.	.	PUNCT
iajs-3606	259	8	https://doi.org/10.3390/vaccines10010099	https://doi.org/10.3390/vaccines10010099	PROPN
iajs-3606	259	9	31	31	NUM
iajs-3606	259	10	.	.	PUNCT
iajs-3606	260	1	ganesan	ganesan	PROPN
iajs-3606	260	2	,	,	PUNCT
iajs-3606	260	3	s.	s.	PROPN
iajs-3606	260	4	;	;	PUNCT
iajs-3606	260	5	al	al	PROPN
iajs-3606	260	6	ketbi	ketbi	PROPN
iajs-3606	260	7	,	,	PUNCT
iajs-3606	260	8	l.	l.	PROPN
iajs-3606	260	9	m.	m.	PROPN
iajs-3606	260	10	b.	b.	PROPN
iajs-3606	260	11	;	;	PUNCT
iajs-3606	260	12	al	al	PROPN
iajs-3606	260	13	kaabi	kaabi	PROPN
iajs-3606	260	14	,	,	PUNCT
iajs-3606	260	15	n.	n.	PROPN
iajs-3606	260	16	;	;	PUNCT
iajs-3606	260	17	al	al	PROPN
iajs-3606	260	18	mansoori	mansoori	PROPN
iajs-3606	260	19	,	,	PUNCT
iajs-3606	260	20	m.	m.	NOUN
iajs-3606	260	21	;	;	PUNCT
iajs-3606	260	22	al	al	PROPN
iajs-3606	260	23	maskari	maskari	PROPN
iajs-3606	260	24	,	,	PUNCT
iajs-3606	260	25	n.	n.	PROPN
iajs-3606	260	26	n.	n.	PROPN
iajs-3606	260	27	;	;	PUNCT
iajs-3606	260	28	al	al	PROPN
iajs-3606	260	29	shamsi	shamsi	PROPN
iajs-3606	260	30	,	,	PUNCT
iajs-3606	260	31	m.	m.	NOUN
iajs-3606	260	32	s.	s.	PROPN
iajs-3606	260	33	;	;	PUNCT
iajs-3606	260	34	&	&	CCONJ
iajs-3606	260	35	zaher	zaher	PROPN
iajs-3606	260	36	,	,	PUNCT
iajs-3606	260	37	w.	w.	PROPN
iajs-3606	260	38	vaccine	vaccine	PROPN
iajs-3606	260	39	side	side	NOUN
iajs-3606	260	40	effects	effect	NOUN
iajs-3606	260	41	following	follow	VERB
iajs-3606	260	42	covid-19	covid-19	PROPN
iajs-3606	260	43	vaccination	vaccination	NOUN
iajs-3606	260	44	among	among	ADP
iajs-3606	260	45	the	the	DET
iajs-3606	260	46	residents	resident	NOUN
iajs-3606	260	47	of	of	ADP
iajs-3606	260	48	the	the	DET
iajs-3606	260	49	uae	uae	PROPN
iajs-3606	260	50	—	—	PUNCT
iajs-3606	260	51	an	an	DET
iajs-3606	260	52	observational	observational	ADJ
iajs-3606	260	53	study	study	NOUN
iajs-3606	260	54	.	.	PUNCT
iajs-3606	261	1	frontiers	frontier	NOUN
iajs-3606	261	2	in	in	ADP
iajs-3606	261	3	public	public	ADJ
iajs-3606	261	4	health,2022	health,2022	NOUN
iajs-3606	261	5	;	;	PUNCT
iajs-3606	261	6	10.2022	10.2022	NUM
iajs-3606	261	7	.	.	PUNCT
iajs-3606	262	1	https://doi.org/10.3389/fpubh.2022.876336	https://doi.org/10.3389/fpubh.2022.876336	PROPN
iajs-3606	262	2	32	32	NUM
iajs-3606	262	3	.	.	PUNCT
iajs-3606	263	1	li	li	PROPN
iajs-3606	263	2	,	,	PUNCT
iajs-3606	263	3	j.	j.	PROPN
iajs-3606	263	4	,	,	PUNCT
iajs-3606	263	5	wang	wang	PROPN
iajs-3606	263	6	,	,	PUNCT
iajs-3606	263	7	x.	x.	PROPN
iajs-3606	263	8	;	;	PUNCT
iajs-3606	263	9	chen	chen	PROPN
iajs-3606	263	10	,	,	PUNCT
iajs-3606	263	11	j.	j.	PROPN
iajs-3606	263	12	;	;	PUNCT
iajs-3606	263	13	cai	cai	PROPN
iajs-3606	263	14	,	,	PUNCT
iajs-3606	263	15	y.	y.	PROPN
iajs-3606	263	16	;	;	PUNCT
iajs-3606	263	17	deng	deng	PROPN
iajs-3606	263	18	,	,	PUNCT
iajs-3606	263	19	a.	a.	PROPN
iajs-3606	263	20	;	;	PUNCT
iajs-3606	263	21	and	and	CCONJ
iajs-3606	263	22	yang	yang	PROPN
iajs-3606	263	23	,	,	PUNCT
iajs-3606	263	24	m.	m.	NOUN
iajs-3606	263	25	association	association	NOUN
iajs-3606	263	26	between	between	ADP
iajs-3606	263	27	abo	abo	NOUN
iajs-3606	263	28	blood	blood	NOUN
iajs-3606	263	29	groups	group	NOUN
iajs-3606	263	30	and	and	CCONJ
iajs-3606	263	31	risk	risk	NOUN
iajs-3606	263	32	of	of	ADP
iajs-3606	263	33	sars‐cov‐2	sars‐cov‐2	PROPN
iajs-3606	263	34	pneumonia	pneumonia	NOUN
iajs-3606	263	35	.	.	PUNCT
iajs-3606	264	1	british	british	ADJ
iajs-3606	264	2	journal	journal	PROPN
iajs-3606	264	3	of	of	ADP
iajs-3606	264	4	haematology	haematology	NOUN
iajs-3606	264	5	,	,	PUNCT
iajs-3606	264	6	2020	2020	NUM
iajs-3606	264	7	;	;	PUNCT
iajs-3606	264	8	190(1	190(1	NUM
iajs-3606	264	9	):	):	PUNCT
iajs-3606	264	10	24	24	NUM
iajs-3606	264	11	.	.	PUNCT
iajs-3606	265	1	https://doi.org/10.1111/bjh.16797	https://doi.org/10.1111/bjh.16797	PROPN
iajs-3606	265	2	33	33	NUM
iajs-3606	265	3	.	.	PUNCT
iajs-3606	266	1	tsatsakis	tsatsakis	PROPN
iajs-3606	266	2	,	,	PUNCT
iajs-3606	266	3	a.	a.	NOUN
iajs-3606	266	4	;	;	PUNCT
iajs-3606	266	5	vakonaki	vakonaki	PROPN
iajs-3606	266	6	,	,	PUNCT
iajs-3606	266	7	e.	e.	PROPN
iajs-3606	266	8	;	;	PUNCT
iajs-3606	266	9	tzatzarakis	tzatzarakis	PROPN
iajs-3606	266	10	,	,	PUNCT
iajs-3606	266	11	m.	m.	NOUN
iajs-3606	266	12	;	;	PUNCT
iajs-3606	266	13	flamourakis	flamouraki	NOUN
iajs-3606	266	14	,	,	PUNCT
iajs-3606	266	15	m.	m.	NOUN
iajs-3606	266	16	;	;	PUNCT
iajs-3606	266	17	nikolouzakis	nikolouzaki	NOUN
iajs-3606	266	18	,	,	PUNCT
iajs-3606	266	19	t.	t.	PROPN
iajs-3606	266	20	k.	k.	PROPN
iajs-3606	266	21	,	,	PUNCT
iajs-3606	266	22	poulas	poulas	PROPN
iajs-3606	266	23	,	,	PUNCT
iajs-3606	266	24	k.	k.	PROPN
iajs-3606	266	25	,	,	PUNCT
iajs-3606	266	26	...	...	PUNCT
iajs-3606	266	27	&	&	CCONJ
iajs-3606	266	28	spandidos	spandidos	PROPN
iajs-3606	266	29	,	,	PUNCT
iajs-3606	266	30	d.	d.	PROPN
iajs-3606	266	31	a.	a.	PROPN
iajs-3606	266	32	immune	immune	PROPN
iajs-3606	266	33	response	response	NOUN
iajs-3606	266	34	(	(	PUNCT
iajs-3606	266	35	igg	igg	PROPN
iajs-3606	266	36	)	)	PUNCT
iajs-3606	266	37	following	follow	VERB
iajs-3606	266	38	full	full	ADJ
iajs-3606	266	39	inoculation	inoculation	NOUN
iajs-3606	266	40	with	with	ADP
iajs-3606	266	41	bnt162b2	bnt162b2	PROPN
iajs-3606	266	42	covid‑19	covid‑19	PROPN
iajs-3606	266	43	mrna	mrna	NOUN
iajs-3606	266	44	among	among	ADP
iajs-3606	266	45	healthcare	healthcare	NOUN
iajs-3606	266	46	professionals	professional	NOUN
iajs-3606	266	47	.	.	PUNCT
iajs-3606	267	1	international	international	ADJ
iajs-3606	267	2	journal	journal	NOUN
iajs-3606	267	3	of	of	ADP
iajs-3606	267	4	molecular	molecular	PROPN
iajs-3606	267	5	medicine,2021	medicine,2021	PROPN
iajs-3606	267	6	;	;	PUNCT
iajs-3606	267	7	48(5	48(5	NUM
iajs-3606	267	8	):	):	PUNCT
iajs-3606	267	9	1	1	NUM
iajs-3606	267	10	-	-	SYM
iajs-3606	267	11	10	10	NUM
iajs-3606	267	12	.	.	PUNCT
iajs-3606	268	1	https://doi.org/10.3892/ijmm.2021.5033	https://doi.org/10.3892/ijmm.2021.5033	PROPN
iajs-3606	268	2	34	34	NUM
iajs-3606	268	3	.	.	PUNCT
iajs-3606	268	4	ferrara	ferrara	PROPN
iajs-3606	268	5	,	,	PUNCT
iajs-3606	268	6	p.	p.	PROPN
iajs-3606	268	7	,	,	PUNCT
iajs-3606	268	8	ponticelli	ponticelli	PROPN
iajs-3606	268	9	,	,	PUNCT
iajs-3606	268	10	d.	d.	PROPN
iajs-3606	268	11	,	,	PUNCT
iajs-3606	268	12	agüero	agüero	PROPN
iajs-3606	268	13	,	,	PUNCT
iajs-3606	268	14	f.	f.	PROPN
iajs-3606	268	15	,	,	PUNCT
iajs-3606	268	16	caci	caci	NOUN
iajs-3606	268	17	,	,	PUNCT
iajs-3606	268	18	g.	g.	PROPN
iajs-3606	268	19	,	,	PUNCT
iajs-3606	268	20	vitale	vitale	PROPN
iajs-3606	268	21	,	,	PUNCT
iajs-3606	268	22	a.	a.	PROPN
iajs-3606	268	23	,	,	PUNCT
iajs-3606	268	24	borrelli	borrelli	PROPN
iajs-3606	268	25	,	,	PUNCT
iajs-3606	268	26	m.	m.	NOUN
iajs-3606	268	27	,	,	PUNCT
iajs-3606	268	28	and	and	CCONJ
iajs-3606	268	29	polosa	polosa	PROPN
iajs-3606	268	30	,	,	PUNCT
iajs-3606	268	31	r.	r.	PROPN
iajs-3606	268	32	does	do	AUX
iajs-3606	268	33	smoking	smoking	NOUN
iajs-3606	268	34	have	have	VERB
iajs-3606	268	35	an	an	DET
iajs-3606	268	36	impact	impact	NOUN
iajs-3606	268	37	on	on	ADP
iajs-3606	268	38	the	the	DET
iajs-3606	268	39	immunological	immunological	ADJ
iajs-3606	268	40	response	response	NOUN
iajs-3606	268	41	to	to	ADP
iajs-3606	268	42	covid-19	covid-19	PROPN
iajs-3606	268	43	vaccines	vaccine	NOUN
iajs-3606	268	44	?	?	PUNCT
iajs-3606	269	1	evidence	evidence	NOUN
iajs-3606	269	2	from	from	ADP
iajs-3606	269	3	the	the	DET
iajs-3606	269	4	vasco	vasco	PROPN
iajs-3606	269	5	study	study	NOUN
iajs-3606	269	6	and	and	CCONJ
iajs-3606	269	7	need	need	VERB
iajs-3606	269	8	for	for	ADP
iajs-3606	269	9	further	further	ADJ
iajs-3606	269	10	studies	study	NOUN
iajs-3606	269	11	.	.	PUNCT
iajs-3606	270	1	public	public	ADJ
iajs-3606	270	2	health.2022;203	health.2022;203	PROPN
iajs-3606	270	3	:	:	PUNCT
iajs-3606	270	4	97	97	NUM
iajs-3606	270	5	-	-	SYM
iajs-3606	270	6	99	99	NUM
iajs-3606	270	7	.	.	PUNCT
iajs-3606	271	1	https://doi.org/10.1016/j.puhe.2021.12.013	https://doi.org/10.1016/j.puhe.2021.12.013	NUM
iajs-3606	271	2	35	35	NUM
iajs-3606	271	3	.	.	PUNCT
iajs-3606	272	1	nomura	nomura	NOUN
iajs-3606	272	2	,	,	PUNCT
iajs-3606	272	3	y.	y.	PROPN
iajs-3606	272	4	;	;	PUNCT
iajs-3606	272	5	sawahata	sawahata	NOUN
iajs-3606	272	6	,	,	PUNCT
iajs-3606	272	7	m.	m.	NOUN
iajs-3606	272	8	;	;	PUNCT
iajs-3606	272	9	nakamura	nakamura	PROPN
iajs-3606	272	10	,	,	PUNCT
iajs-3606	272	11	y.	y.	PROPN
iajs-3606	272	12	;	;	PUNCT
iajs-3606	272	13	kurihara	kurihara	PROPN
iajs-3606	272	14	,	,	PUNCT
iajs-3606	272	15	m.	m.	NOUN
iajs-3606	272	16	;	;	PUNCT
iajs-3606	272	17	koike	koike	PROPN
iajs-3606	272	18	,	,	PUNCT
iajs-3606	272	19	r.	r.	PROPN
iajs-3606	272	20	;	;	PUNCT
iajs-3606	272	21	katsube	katsube	ADJ
iajs-3606	272	22	,	,	PUNCT
iajs-3606	272	23	o.	o.	INTJ
iajs-3606	272	24	,	,	PUNCT
iajs-3606	272	25	and	and	CCONJ
iajs-3606	272	26	sugiyama	sugiyama	NOUN
iajs-3606	272	27	,	,	PUNCT
iajs-3606	272	28	k.	k.	NOUN
iajs-3606	272	29	age	age	PROPN
iajs-3606	272	30	and	and	CCONJ
iajs-3606	272	31	smoking	smoking	NOUN
iajs-3606	272	32	predict	predict	VERB
iajs-3606	272	33	antibody	antibody	NOUN
iajs-3606	272	34	titres	titre	NOUN
iajs-3606	272	35	at	at	ADP
iajs-3606	272	36	3	3	NUM
iajs-3606	272	37	months	month	NOUN
iajs-3606	272	38	after	after	ADP
iajs-3606	272	39	the	the	DET
iajs-3606	272	40	second	second	ADJ
iajs-3606	272	41	dose	dose	NOUN
iajs-3606	272	42	of	of	ADP
iajs-3606	272	43	the	the	DET
iajs-3606	272	44	bnt162b2	bnt162b2	PROPN
iajs-3606	272	45	covid-19	covid-19	PROPN
iajs-3606	272	46	vaccine	vaccine	NOUN
iajs-3606	272	47	.	.	PUNCT
iajs-3606	273	1	vaccines,2021	vaccines,2021	NOUN
iajs-3606	273	2	;	;	PUNCT
iajs-3606	273	3	9(9	9(9	NUM
iajs-3606	273	4	):	):	PUNCT
iajs-3606	273	5	1042	1042	NUM
iajs-3606	273	6	.	.	PUNCT
iajs-3606	274	1	https://doi.org/10.3390/vaccines9091042	https://doi.org/10.3390/vaccines9091042	PROPN
iajs-3606	274	2	https://doi.org/10.1016/j.eclinm.2021.100928	https://doi.org/10.1016/j.eclinm.2021.100928	PROPN
iajs-3606	274	3	https://doi.org/10.3390/vaccines10010099	https://doi.org/10.3390/vaccines10010099	PROPN
iajs-3606	274	4	https://doi.org/10.3389/fpubh.2022.876336	https://doi.org/10.3389/fpubh.2022.876336	PROPN
iajs-3606	274	5	https://doi.org/10.1111/bjh.16797	https://doi.org/10.1111/bjh.16797	PROPN
iajs-3606	274	6	https://doi.org/10.3892/ijmm.2021.5033	https://doi.org/10.3892/ijmm.2021.5033	PROPN
iajs-3606	274	7	https://doi.org/10.1016/j.puhe.2021.12.013	https://doi.org/10.1016/j.puhe.2021.12.013	NUM
iajs-3606	275	1	https://doi.org/10.3390/vaccines9091042	https://doi.org/10.3390/vaccines9091042	NOUN